Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),A1BG,Alpha-1B-glycoprotein,19683,165,1.16 [0.48-2.79],0.7402947691458324
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AAMDC,Mth938 domain-containing protein,19166,163,1.02 [0.77-1.36],0.8890635576257938
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AARSD1,Alanyl-tRNA editing protein Aarsd1,22474,209,0.92 [0.74-1.15],0.4784035826116517
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ABCA2,ATP-binding cassette sub-family A member 2,18980,160,0.75 [0.48-1.17],0.2012863752240008
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ABHD14B,Protein ABHD14B,22327,210,1.14 [0.92-1.42],0.2191307787316237
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ABL1,Tyrosine-protein kinase ABL1,22474,209,1.13 [0.95-1.35],0.1801860014430535
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ABO,Histo-blood group ABO system transferase,19664,165,1.03 [0.93-1.14],0.5450447281896702
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ABRAXAS2,BRISC complex subunit Abraxas 2,18980,160,0.89 [0.70-1.13],0.3297948021669901
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",22080,202,1.21 [1.04-1.40],0.0121947143991812
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",19299,165,1.05 [0.86-1.29],0.5978423766357148
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",19653,166,1.08 [0.92-1.27],0.3562021883721434
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACAN,Aggrecan core protein,22354,211,1.34 [0.86-2.09],0.1932277945781739
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACE,Angiotensin-converting enzyme,19664,165,1.16 [0.67-1.99],0.6024216489704549
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACE2,Angiotensin-converting enzyme 2,22162,199,1.30 [1.05-1.62],0.0151860334662972
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACHE,Acetylcholinesterase,19241,159,1.11 [0.70-1.76],0.6484116563056646
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACOT13,Acyl-coenzyme A thioesterase 13,19559,166,1.06 [0.93-1.21],0.4052413463349942
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,22584,212,1.22 [0.98-1.51],0.0758261248111663
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACP1,Low molecular weight phosphotyrosine protein phosphatase,19069,160,0.60 [0.41-0.87],0.0074077330330009
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACP5,Tartrate-resistant acid phosphatase type 5,22708,211,1.22 [0.84-1.77],0.3023478166432466
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACP6,Lysophosphatidic acid phosphatase type 6,22724,210,1.11 [0.92-1.35],0.2623001868281915
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACRBP,Acrosin-binding protein,19559,167,1.26 [0.91-1.74],0.1662172405363543
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACRV1,Acrosomal protein SP-10,19069,160,1.13 [0.94-1.37],0.1997675325374527
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACSL1,Long-chain-fatty-acid--CoA ligase 1,18980,160,1.09 [0.75-1.60],0.6441250049174179
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACTA2,"Actin, aortic smooth muscle",22162,199,1.43 [1.14-1.80],0.0022415316767285
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACTN2,Alpha-actinin-2,18980,160,1.39 [1.10-1.75],0.0052221044331607
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACTN4,Alpha-actinin-4,22144,200,1.01 [0.68-1.48],0.9795526271689756
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACVRL1,Serine/threonine-protein kinase receptor R3,22352,209,1.77 [1.13-2.78],0.0126005719714687
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACY1,Aminoacylase-1,22584,212,1.03 [0.84-1.26],0.7770219692208
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,18980,160,1.20 [0.92-1.56],0.1760913518044881
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ACYP1,Acylphosphatase-1,19168,159,1.05 [0.83-1.32],0.6983783778219219
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADA,Adenosine deaminase,22801,212,0.82 [0.57-1.17],0.2704043923353767
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADA2,Adenosine deaminase 2,22474,211,1.49 [1.14-1.95],0.003757807724908
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,19069,160,1.35 [0.87-2.11],0.1808299980001272
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,22162,199,1.28 [0.86-1.93],0.2277918425775468
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,22387,210,1.14 [0.81-1.59],0.4633958278232369
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,22801,212,0.79 [0.57-1.08],0.1371819541687416
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,22723,209,1.46 [0.97-2.21],0.0700158898561515
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,19559,166,1.55 [0.97-2.47],0.0676877059261569
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,19069,160,1.01 [0.61-1.65],0.9812056702019942
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,22865,212,0.62 [0.38-1.03],0.062971885473159
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,22474,209,1.01 [0.76-1.34],0.9429881788160144
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,22162,199,1.07 [0.72-1.58],0.7531110118645686
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,19069,160,1.04 [0.67-1.60],0.8706421043879595
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,22673,210,0.73 [0.56-0.96],0.0218621097309336
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADAMTSL2,ADAMTS-like protein 2,19664,164,1.39 [0.91-2.13],0.1323840778862161
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADAMTSL4,ADAMTS-like protein 4,19166,163,0.79 [0.41-1.52],0.477943282614682
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADAMTSL5,ADAMTS-like protein 5,19653,166,0.80 [0.54-1.17],0.2408444208777639
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,22080,202,1.18 [0.90-1.53],0.2357506853814861
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADD1,Alpha-adducin,19241,159,0.98 [0.79-1.22],0.849947476419532
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADGRB3,Adhesion G protein-coupled receptor B3,22352,209,1.38 [0.96-1.97],0.0810234747724069
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADGRD1,Adhesion G-protein coupled receptor D1,19241,159,1.41 [0.96-2.09],0.0821287353226495
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADGRE1,Adhesion G protein-coupled receptor E1,19559,166,1.21 [0.94-1.57],0.1441761152965945
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADGRE2,Adhesion G protein-coupled receptor E2,22676,208,1.26 [0.82-1.95],0.2878645582532954
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADGRE5,Adhesion G protein-coupled receptor E5,22771,212,1.07 [0.73-1.59],0.7206569935529655
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADGRF5,Adhesion G protein-coupled receptor F5,19653,166,1.22 [0.72-2.07],0.4516795353461615
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADGRG1,Adhesion G-protein coupled receptor G1,22474,209,1.21 [1.06-1.37],0.0049790088529344
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADGRG2,Adhesion G-protein coupled receptor G2,22584,212,0.74 [0.47-1.17],0.1947171820755908
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADGRV1,Adhesion G-protein coupled receptor V1,19004,158,1.01 [0.82-1.26],0.9067281684969062
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADH1B,All-trans-retinol dehydrogenase,19241,159,1.17 [0.96-1.42],0.1124444219445829
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,22162,199,1.08 [0.93-1.26],0.3138954624415339
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADIPOQ,Adiponectin,19683,165,1.22 [0.98-1.51],0.0718425007719685
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADM,Pro-adrenomedullin,22761,210,1.69 [1.05-2.71],0.0309672615291429
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ADRA2A,Alpha-2A adrenergic receptor,18980,160,0.86 [0.68-1.11],0.2455492447671734
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AFAP1,Actin filament-associated protein 1,19241,159,0.87 [0.71-1.05],0.1493216152594492
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AFM,Afamin,19683,165,1.22 [0.58-2.59],0.6006190599436636
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AFP,Alpha-fetoprotein,22310,209,0.97 [0.81-1.17],0.7787831244903158
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AGBL2,Cytosolic carboxypeptidase 2,19004,158,1.04 [0.87-1.23],0.6676412527294305
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AGER,Advanced glycosylation end product-specific receptor,22534,205,1.12 [0.83-1.51],0.4462597696365706
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AGR2,Anterior gradient protein 2 homolog,21872,198,1.23 [1.09-1.39],0.0008670443330032
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AGR3,Anterior gradient protein 3,22034,202,1.17 [0.96-1.43],0.1297909292056387
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AGRN,Agrin,22676,208,1.65 [1.21-2.26],0.0016942734008461
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AGRP,Agouti-related protein,22801,212,1.26 [0.99-1.60],0.056859350884378
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AGT,Angiotensinogen,19664,165,1.07 [0.56-2.07],0.8294391105429417
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AGXT,Serine--pyruvate aminotransferase,22584,212,1.22 [1.05-1.42],0.0095864297924455
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AHCY,Adenosylhomocysteinase,22584,212,1.07 [0.90-1.28],0.4349046300019457
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AHNAK,Neuroblast differentiation-associated protein AHNAK,19166,163,0.78 [0.47-1.28],0.3250954131210211
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AHNAK2,Protein AHNAK2,19166,163,1.25 [0.78-2.02],0.3575113328902803
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,19559,167,1.16 [0.95-1.41],0.1438001650427235
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AHSG,Alpha-2-HS-glycoprotein,19664,165,1.12 [0.64-1.93],0.6975058159930316
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AHSP,Alpha-hemoglobin-stabilizing protein,22567,209,0.94 [0.81-1.08],0.3893597903718468
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AIDA,"Axin interactor, dorsalization-associated protein",19122,159,0.98 [0.82-1.18],0.8320883772640336
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AIF1,Allograft inflammatory factor 1,22080,202,1.18 [0.93-1.49],0.1758291134034659
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AIF1L,Allograft inflammatory factor 1-like,19166,163,0.88 [0.65-1.19],0.3969720978548398
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AIFM1,"Apoptosis-inducing factor 1, mitochondrial",22441,209,1.13 [1.01-1.27],0.0352236431020648
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AK1,Adenylate kinase isoenzyme 1,22584,212,0.88 [0.73-1.07],0.2089720295109481
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AK2,"Adenylate kinase 2, mitochondrial",19617,166,1.08 [0.93-1.24],0.3103684769322637
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AKAP12,A-kinase anchor protein 12,19241,159,1.00 [0.48-2.07],0.9935068018445848
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AKR1B1,Aldo-keto reductase family 1 member B1,22080,202,1.11 [0.94-1.31],0.2192347673344232
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AKR1B10,Aldo-keto reductase family 1 member B10,19122,159,1.14 [0.91-1.43],0.2484803139315338
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AKR1C4,Aldo-keto reductase family 1 member C4,22162,199,1.10 [0.89-1.37],0.3666858497277964
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AKR7L,Aflatoxin B1 aldehyde reductase member 4,19069,160,1.20 [0.98-1.46],0.0810563840236044
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AKT1S1,Proline-rich AKT1 substrate 1,22060,200,1.09 [0.90-1.31],0.4000491519296988
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AKT2,RAC-beta serine/threonine-protein kinase,19611,164,1.02 [0.91-1.15],0.6875295100065657
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AKT3,RAC-gamma serine/threonine-protein kinase,21987,202,1.14 [0.92-1.42],0.2300269324859467
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ALCAM,CD166 antigen,22865,212,1.80 [0.98-3.33],0.059772782026571
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ALDH1A1,Retinal dehydrogenase 1,22610,209,0.98 [0.78-1.23],0.8578639011010056
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ALDH2,"Aldehyde dehydrogenase, mitochondrial",19559,167,1.25 [1.01-1.53],0.0387196935949653
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",22475,210,1.10 [0.93-1.29],0.280394721675427
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",19611,164,1.17 [0.86-1.58],0.3179160470240411
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ALMS1,Alstrom syndrome protein 1,19299,165,1.02 [0.73-1.42],0.8993964617493599
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ALPI,Intestinal-type alkaline phosphatase,19069,160,1.04 [0.92-1.17],0.568696427544163
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ALPP,"Alkaline phosphatase, placental type",22474,209,1.08 [0.96-1.22],0.1937582357641259
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AMBN,Ameloblastin,22144,200,0.73 [0.44-1.22],0.2334677362395047
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AMBP,Protein AMBP,22725,210,2.04 [1.14-3.64],0.0160012341880475
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,19664,164,0.91 [0.51-1.61],0.7348168242094668
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AMFR,E3 ubiquitin-protein ligase AMFR,22060,200,1.34 [1.14-1.57],0.0004170985910877
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AMIGO1,Amphoterin-induced protein 1,19122,159,1.22 [0.95-1.56],0.1236136080561143
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AMIGO2,Amphoterin-induced protein 2,22474,209,1.13 [0.67-1.92],0.6474054345359574
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AMN,Protein amnionless,22144,200,1.39 [1.08-1.78],0.0096531718817005
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AMOT,Angiomotin,19241,159,0.87 [0.58-1.31],0.5133828434771083
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AMOTL2,Angiomotin-like protein 2,19475,165,0.89 [0.63-1.24],0.4875686221971047
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AMPD3,AMP deaminase 3,19617,166,0.79 [0.65-0.98],0.0278173951244235
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,18408,157,0.80 [0.58-1.10],0.1655479587383482
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AMY2A,Pancreatic alpha-amylase,21698,205,0.87 [0.67-1.12],0.2873055147024535
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AMY2B,Alpha-amylase 2B,21051,200,0.88 [0.68-1.14],0.3255906299315593
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANG,Angiogenin,22556,211,1.34 [0.95-1.90],0.0997930099435157
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANGPT1,Angiopoietin-1,22478,205,1.11 [0.96-1.29],0.1703684934409185
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANGPT2,Angiopoietin-2,22761,210,1.39 [1.01-1.90],0.044557215265058
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANGPTL1,Angiopoietin-related protein 1,22270,211,1.25 [0.82-1.92],0.2984155004105352
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANGPTL2,Angiopoietin-related protein 2,22604,208,0.91 [0.67-1.23],0.5312373858128248
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANGPTL3,Angiopoietin-related protein 3,22622,211,0.98 [0.70-1.38],0.929271895255608
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANGPTL4,Angiopoietin-related protein 4,22636,206,1.51 [1.14-1.98],0.0036620801941266
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANGPTL7,Angiopoietin-related protein 7,22761,210,1.08 [0.77-1.52],0.6414542240166141
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANK2,Ankyrin-2,18980,160,0.94 [0.76-1.17],0.5981321215945037
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,19069,160,1.08 [0.89-1.30],0.4394550625391857
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANKRA2,Ankyrin repeat family A protein 2,18946,158,0.87 [0.65-1.16],0.3417231051245076
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANKRD54,Ankyrin repeat domain-containing protein 54,22080,202,1.04 [0.84-1.28],0.72540136978595
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,19166,163,1.21 [0.88-1.66],0.2386837737422621
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANPEP,Aminopeptidase N,22673,212,1.74 [1.16-2.61],0.007046983809617
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANXA1,Annexin A1,19134,157,0.88 [0.61-1.28],0.5141404883264431
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANXA10,Annexin A10,22060,200,1.14 [1.00-1.31],0.0551489217267395
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANXA11,Annexin A11,22491,211,0.99 [0.82-1.18],0.8904521776228105
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANXA2,Annexin A2,18859,159,0.96 [0.77-1.19],0.6829840168575316
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANXA3,Annexin A3,22723,209,1.11 [0.93-1.31],0.2553404135252354
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANXA4,Annexin A4,22487,211,1.10 [0.93-1.30],0.2796399144063016
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ANXA5,Annexin A5,21992,200,1.24 [0.83-1.86],0.3012296648403327
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AOC1,Amiloride-sensitive amine oxidase [copper-containing],22144,200,1.15 [0.95-1.39],0.1513331800162567
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AOC3,Membrane primary amine oxidase,22706,212,1.49 [0.99-2.24],0.0577200847529462
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AP1G2,AP-1 complex subunit gamma-like 2,19559,167,0.99 [0.82-1.19],0.8757738784504713
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AP2B1,AP-2 complex subunit beta,19122,159,0.89 [0.64-1.23],0.4711073855503376
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AP3B1,AP-3 complex subunit beta-1,19559,166,1.07 [0.88-1.29],0.5110737893211339
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AP3S2,AP-3 complex subunit sigma-2,19617,166,0.96 [0.70-1.32],0.7998112400818198
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,22474,209,1.14 [0.88-1.48],0.3133360279610326
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APCS,Serum amyloid P-component,19493,164,0.89 [0.57-1.39],0.6071349691787504
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,22679,209,1.05 [0.85-1.28],0.6603570824723943
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APLP1,Amyloid-like protein 1,22584,212,1.17 [0.93-1.48],0.1843444354403729
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APOA1,Apolipoprotein A-I,19683,165,0.73 [0.40-1.34],0.3135251856397414
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APOA2,Apolipoprotein A-II,19664,165,1.13 [0.84-1.52],0.4250562788101784
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APOA4,Apolipoprotein A-IV,19683,165,1.32 [0.90-1.92],0.1537251441899249
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APOB,Apolipoprotein B-100,19664,165,1.15 [0.59-2.22],0.6808528278488976
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APOBR,Apolipoprotein B receptor,19166,163,0.94 [0.66-1.34],0.7339086787103246
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APOC1,Apolipoprotein C-I,19650,164,0.67 [0.44-1.04],0.0717296756843453
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APOD,Apolipoprotein D,18839,155,0.87 [0.57-1.31],0.4960982451984687
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APOE,Apolipoprotein E,19683,165,0.85 [0.66-1.10],0.2278171924630261
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APOF,Apolipoprotein F,19664,165,0.61 [0.43-0.86],0.0048198928996305
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APOH,Beta-2-glycoprotein 1,22610,209,1.39 [1.02-1.90],0.0372751035676118
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APOL1,Apolipoprotein L1,19664,165,0.98 [0.76-1.27],0.8807143280758951
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APOM,Apolipoprotein M,22659,212,0.86 [0.56-1.32],0.4838467665172472
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APP,Amyloid-beta precursor protein,22583,209,1.23 [1.02-1.47],0.0264726999028643
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APPL2,DCC-interacting protein 13-beta,19241,159,1.02 [0.89-1.17],0.7930409060409715
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),APRT,Adenine phosphoribosyltransferase,22337,210,1.05 [0.81-1.37],0.68937511931664
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARAF,Serine/threonine-protein kinase A-Raf,19299,165,1.02 [0.82-1.26],0.8823396850650782
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AREG,Amphiregulin,22474,209,1.88 [1.48-2.38],2.1243354098205803e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARF6,ADP-ribosylation factor 6,19559,166,1.11 [0.96-1.28],0.1484749168344272
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARFIP1,Arfaptin-1,19611,164,0.89 [0.72-1.12],0.3252460429658003
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARG1,Arginase-1,22415,206,0.78 [0.61-0.98],0.0332838847039437
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARG2,"Arginase-2, mitochondrial",19559,167,1.15 [0.84-1.58],0.3884902834306275
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARHGAP1,Rho GTPase-activating protein 1,22080,202,1.09 [0.83-1.44],0.5420431711535035
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARHGAP25,Rho GTPase-activating protein 25,22080,202,1.02 [0.83-1.26],0.8207287800321819
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARHGAP30,Rho GTPase-activating protein 30,19299,165,1.05 [0.72-1.53],0.8055192093922096
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARHGAP45,Rho GTPase-activating protein 45,19241,159,0.96 [0.80-1.16],0.6962622911935343
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARHGAP5,Rho GTPase-activating protein 5,18946,158,1.04 [0.86-1.26],0.6510752528861146
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARHGEF1,Rho guanine nucleotide exchange factor 1,19617,166,0.97 [0.82-1.14],0.7001372989106386
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARHGEF10,Rho guanine nucleotide exchange factor 10,19611,164,1.00 [0.86-1.18],0.957561138610233
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARHGEF12,Rho guanine nucleotide exchange factor 12,22522,211,1.01 [0.89-1.13],0.9155643353273276
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARHGEF5,Rho guanine nucleotide exchange factor 5,19004,158,1.16 [0.96-1.40],0.131330614462197
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARID3A,AT-rich interactive domain-containing protein 3A,19004,158,0.69 [0.45-1.04],0.079480641607214
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARID4B,AT-rich interactive domain-containing protein 4B,22060,200,0.97 [0.72-1.31],0.8588806724786197
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARL13B,ADP-ribosylation factor-like protein 13B,18980,160,1.03 [0.83-1.28],0.7775900684125473
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,18980,160,1.03 [0.71-1.51],0.8714389999925279
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARMCX2,Armadillo repeat-containing X-linked protein 2,19004,158,1.08 [0.86-1.36],0.489190360347259
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARNT,Aryl hydrocarbon receptor nuclear translocator,22144,200,1.13 [0.82-1.58],0.4507650111825154
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,18980,160,0.96 [0.71-1.29],0.7784467074893462
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARSA,Arylsulfatase A,22610,209,1.10 [0.85-1.44],0.4677775694780627
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARSB,Arylsulfatase B,22474,209,1.18 [0.95-1.46],0.1334228443876671
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ART3,Ecto-ADP-ribosyltransferase 3,22706,212,1.06 [0.75-1.50],0.7216873417777933
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ART5,Ecto-ADP-ribosyltransferase 5,19004,158,0.87 [0.66-1.15],0.3291951374596021
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ARTN,Artemin,22144,200,1.10 [0.85-1.43],0.4718583742634302
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ASAH1,Acid ceramidase,19460,162,1.22 [0.91-1.62],0.1832770324932474
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ASAH2,Neutral ceramidase,22387,210,0.82 [0.67-1.01],0.0606580455079649
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ASGR1,Asialoglycoprotein receptor 1,22387,210,1.85 [1.27-2.69],0.0012128313212257
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ASGR2,Asialoglycoprotein receptor 2,19664,165,1.33 [0.77-2.30],0.3055075838260533
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ASPN,Asporin,19653,166,0.89 [0.52-1.55],0.6888245324176394
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ASPSCR1,Tether containing UBX domain for GLUT4,19611,164,1.02 [0.82-1.28],0.8355160667642993
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ASRGL1,Isoaspartyl peptidase/L-asparaginase,19166,163,0.98 [0.85-1.14],0.8102210563632664
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ASS1,Argininosuccinate synthase,18980,160,1.18 [0.97-1.43],0.0989343947103404
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATF2,Cyclic AMP-dependent transcription factor ATF-2,22060,200,1.10 [0.94-1.29],0.219366957965769
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATF4,Cyclic AMP-dependent transcription factor ATF-4,18946,158,1.31 [0.88-1.97],0.1828053727205978
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATG16L1,Autophagy-related protein 16-1,19559,166,1.04 [0.87-1.24],0.697534241789245
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATG4A,Cysteine protease ATG4A,22080,202,0.97 [0.79-1.20],0.7889467158266648
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATOX1,Copper transport protein ATOX1,22673,210,1.23 [1.03-1.47],0.0244592148884441
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,18980,160,0.84 [0.58-1.21],0.3524124042964789
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,18980,160,0.88 [0.54-1.43],0.5977991385123672
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,18980,160,0.94 [0.63-1.41],0.7716769146789242
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATP1B4,Protein ATP1B4,18946,158,1.41 [1.05-1.90],0.0232049449420992
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATP2B4,Plasma membrane calcium-transporting ATPase 4,18980,160,0.98 [0.76-1.26],0.8524222176725962
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATP5F1D,"ATP synthase subunit delta, mitochondrial",18980,160,0.80 [0.56-1.13],0.2097217867614899
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATP5IF1,"ATPase inhibitor, mitochondrial",22676,208,1.08 [0.96-1.20],0.2032179882174634
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATP5PO,"ATP synthase subunit O, mitochondrial",22060,200,1.25 [0.97-1.60],0.0883954857988334
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATP6AP2,Renin receptor,22080,202,1.29 [0.99-1.68],0.0567221037785351
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATP6V1D,V-type proton ATPase subunit D,22474,209,0.62 [0.37-1.03],0.0651044166608155
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATP6V1F,V-type proton ATPase subunit F,22025,200,1.14 [0.94-1.37],0.1811284035122364
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATP6V1G1,V-type proton ATPase subunit G 1,19166,163,0.96 [0.78-1.19],0.7321543246941442
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATP6V1G2,V-type proton ATPase subunit G 2,18980,160,1.06 [0.91-1.23],0.4778301156133623
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATRAID,All-trans retinoic acid-induced differentiation factor,19559,166,1.47 [0.97-2.24],0.0675971257361986
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATRN,"Attractin, Isoform 2",19683,165,0.59 [0.24-1.43],0.2381905607605414
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATXN10,Ataxin-10,22060,200,1.11 [0.93-1.33],0.2414157933109306
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATXN2,Ataxin-2,19004,158,1.08 [0.96-1.22],0.2121892488489345
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATXN2L,Ataxin-2-like protein,19611,164,0.89 [0.64-1.25],0.5128039060817949
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ATXN3,Ataxin-3,19617,166,0.90 [0.71-1.14],0.3909095289821918
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AXIN1,Axin-1,22522,211,1.01 [0.89-1.15],0.8899214942680004
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AXL,Tyrosine-protein kinase receptor UFO,22706,212,1.83 [1.20-2.79],0.0049113647039862
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AZI2,5-azacytidine-induced protein 2,19611,164,1.01 [0.77-1.32],0.95658763267448
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),AZU1,Azurocidin,21893,206,0.98 [0.84-1.16],0.8307972733267618
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),B2M,Beta-2-microglobulin,19683,165,1.30 [0.91-1.86],0.1462273721386914
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,18980,160,0.65 [0.29-1.42],0.2754550603692347
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",19166,163,1.38 [0.91-2.09],0.1254765496175788
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),B4GALT1,"Beta-1,4-galactosyltransferase 1",22676,208,1.91 [1.24-2.92],0.0030521665689566
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),B4GAT1,"Beta-1,4-glucuronyltransferase 1",22610,209,1.29 [0.77-2.14],0.3291524932947784
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BABAM1,BRISC and BRCA1-A complex member 1,19069,160,0.82 [0.47-1.44],0.4870247367239877
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BACH1,Transcription regulator protein BACH1,22522,211,1.06 [0.90-1.26],0.4756022169126439
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BAG3,BAG family molecular chaperone regulator 3,22352,209,1.40 [1.02-1.91],0.0369988391255713
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BAG4,BAG family molecular chaperone regulator 4,19069,160,1.01 [0.74-1.39],0.9320023251941256
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BAG6,Large proline-rich protein BAG6,22162,199,1.29 [0.91-1.83],0.1490483165660983
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,22080,202,1.24 [1.03-1.48],0.0239237429150664
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BAMBI,BMP and activin membrane-bound inhibitor homolog,22080,202,1.94 [1.34-2.81],0.0004727863897232
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BANK1,B-cell scaffold protein with ankyrin repeats,22522,211,0.99 [0.88-1.11],0.8228708663928557
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BAP18,Chromatin complexes subunit BAP18,19617,166,1.03 [0.84-1.28],0.7643233229812508
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BATF,Basic leucine zipper transcriptional factor ATF-like,19122,159,0.92 [0.75-1.12],0.3895006489437446
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BAX,Apoptosis regulator BAX,22026,200,1.11 [0.97-1.28],0.141385331120155
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BCAM,Basal cell adhesion molecule,22610,209,1.44 [0.89-2.33],0.1407089448184109
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BCAN,Brevican core protein,22387,210,0.98 [0.69-1.40],0.922199213909608
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",19653,166,1.45 [0.93-2.25],0.1001824381344322
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",19004,158,1.02 [0.77-1.35],0.8768794422699903
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BCHE,Cholinesterase,19312,163,0.65 [0.42-1.00],0.0501854274799166
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BCL2,Apoptosis regulator Bcl-2,19559,166,1.02 [0.79-1.32],0.88926882859364
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BCL2L1,Bcl-2-like protein 1,19617,166,1.02 [0.88-1.19],0.7617762870634661
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",22522,211,1.35 [1.00-1.84],0.0532896509884218
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BCL2L15,Bcl-2-like protein 15,19069,160,0.81 [0.60-1.08],0.1467277298086341
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BCL7A,B-cell CLL/lymphoma 7 protein family member A,18946,158,0.96 [0.74-1.23],0.7255139708308485
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BCL7B,B-cell CLL/lymphoma 7 protein family member B,19559,167,0.95 [0.68-1.33],0.7723933418908908
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BCR,Breakpoint cluster region protein,22522,211,1.00 [0.88-1.15],0.9670121766330424
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BDNF,Brain-derived neurotrophic factor,19664,164,0.99 [0.83-1.18],0.9287087392841538
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BECN1,Beclin-1,19166,163,0.95 [0.73-1.23],0.6989722979108607
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BEX3,Protein BEX3,18946,158,1.30 [1.02-1.65],0.0328891005784051
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BGLAP,Osteocalcin,19664,164,0.83 [0.70-0.97],0.0221599475834283
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BGN,Biglycan,22037,202,0.92 [0.82-1.02],0.1167138765851869
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BHLHE40,Class E basic helix-loop-helix protein 40,19004,158,1.00 [0.81-1.24],0.9732017258614792
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,18980,160,1.07 [0.59-1.94],0.8141477749174403
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BID,BH3-interacting domain death agonist,22522,211,1.00 [0.83-1.20],0.9999076146639524
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BIN2,Bridging integrator 2,22610,209,1.10 [0.96-1.26],0.1516557267530134
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BIRC2,Baculoviral IAP repeat-containing protein 2,22080,202,1.19 [0.98-1.45],0.0730007522165145
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BLMH,Bleomycin hydrolase,22865,212,1.19 [0.82-1.74],0.3616854736350775
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BLNK,B-cell linker protein,19069,160,0.63 [0.40-0.99],0.0443086136772305
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,19004,158,0.80 [0.63-1.02],0.0688557772674251
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,19617,166,1.08 [0.75-1.56],0.6927460845160818
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BLVRB,Flavin reductase,22610,209,0.88 [0.73-1.06],0.1925537362540148
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BMP10,Bone morphogenetic protein 10,19241,159,1.00 [0.58-1.71],0.9936484378009665
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BMP4,Bone morphogenetic protein 4,22352,209,1.18 [0.91-1.52],0.209292163569056
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BMP6,Bone morphogenetic protein 6,22134,199,1.22 [0.89-1.67],0.2089295281374481
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BMPER,BMP-binding endothelial regulator protein,19241,159,1.36 [0.71-2.62],0.3573206533335115
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,19653,166,1.14 [0.75-1.75],0.5423053714112491
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,19069,160,1.15 [0.82-1.61],0.4235499781895637
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BOC,Brother of CDO,22162,199,1.26 [0.73-2.16],0.4099012522136254
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BOLA1,BolA-like protein 1,19004,158,1.08 [0.83-1.42],0.5586526041331593
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BOLA2_BOLA2B,BolA-like protein 2,19166,163,0.78 [0.59-1.03],0.0747432109356857
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BPIFA2,BPI fold-containing family A member 2,18501,160,0.90 [0.78-1.04],0.147802035967906
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BPIFB1,BPI fold-containing family B member 1,22526,208,0.88 [0.73-1.07],0.2094424336207043
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BPIFB2,BPI fold-containing family B member 2,19608,165,0.97 [0.78-1.21],0.7901294866441133
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BRAP,BRCA1-associated protein,19382,165,0.98 [0.86-1.13],0.8251076511332021
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BRD1,Bromodomain-containing protein 1,19299,165,1.15 [0.72-1.84],0.5649462739307265
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BRD2,Bromodomain-containing protein 2,19004,158,1.13 [0.75-1.70],0.5669174998483344
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BRD3,Bromodomain-containing protein 3,18980,160,1.08 [0.81-1.45],0.5906143397201931
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BRDT,Bromodomain testis-specific protein,18980,160,1.21 [0.81-1.81],0.3485637471101235
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BRK1,Protein BRICK1,22060,200,1.35 [1.03-1.77],0.0288227930043192
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BRME1,Break repair meiotic recombinase recruitment factor 1,19004,158,0.77 [0.51-1.18],0.2339863604438766
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BRSK2,Serine/threonine-protein kinase BRSK2,19611,164,1.19 [0.82-1.72],0.3658510521374142
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BSG,Basigin,22768,212,1.15 [0.64-2.06],0.6457128087887494
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BSND,Barttin,18946,158,0.92 [0.57-1.46],0.7182870928945344
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,22765,209,1.26 [0.93-1.70],0.1429094018439698
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BST2,Bone marrow stromal antigen 2,22765,209,1.47 [1.21-1.78],8.850747358154378e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BTC,Probetacellulin,22080,202,1.01 [0.86-1.19],0.902018343253358
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BTD,Biotinidase,19683,165,1.26 [0.60-2.62],0.543857124594354
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BTLA,B- and T-lymphocyte attenuator,18946,158,1.11 [0.96-1.29],0.1489250652870969
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BTN1A1,Butyrophilin subfamily 1 member A1,19518,167,1.04 [0.73-1.49],0.8178544519439613
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BTN2A1,Butyrophilin subfamily 2 member A1,22676,208,2.14 [1.42-3.21],0.0002533727739964
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BTN3A2,Butyrophilin subfamily 3 member A2,22522,211,1.37 [1.03-1.83],0.0326694613001827
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),BTNL10,Butyrophilin-like protein 10,18946,158,1.20 [0.88-1.63],0.2415524215551617
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C19orf12,Protein C19orf12,22060,200,1.21 [1.02-1.43],0.0291365161636323
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C1GALT1C1,C1GALT1-specific chaperone 1,18980,160,1.31 [0.87-1.98],0.1979208859310687
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C1QA,Complement C1q subcomponent subunit A,22695,210,1.23 [0.71-2.15],0.4586331830486926
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",19611,164,0.94 [0.75-1.18],0.5815821144503933
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C1QL2,Complement C1q-like protein 2,19069,160,1.04 [0.74-1.46],0.8296560424261223
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,22706,212,1.02 [0.76-1.35],0.9140916081180264
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,19241,159,0.73 [0.50-1.07],0.1090475005252797
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,19611,164,0.90 [0.56-1.46],0.6774838188766357
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,19204,159,0.71 [0.53-0.95],0.0202279804904283
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C1R,Complement C1r subcomponent,19683,165,0.42 [0.16-1.08],0.0722587086713059
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C1RL,Complement C1r subcomponent-like protein,19645,165,1.19 [0.55-2.55],0.6600639457122012
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C1S,Complement C1s subcomponent,19683,165,0.62 [0.31-1.25],0.1813814912842989
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C2,Complement C2,22659,212,2.03 [1.11-3.70],0.0214141101079187
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C2CD2L,Phospholipid transfer protein C2CD2L,22025,200,1.02 [0.76-1.37],0.9072586222667248
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C2orf69,UPF0565 protein C2orf69,19122,159,0.95 [0.73-1.25],0.7327073103540264
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C3,Complement C3,18663,156,1.27 [0.94-1.72],0.1260058034963847
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C4BPB,C4b-binding protein beta chain,22673,210,1.17 [0.86-1.58],0.3247520655804113
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C5,Complement C5,19683,165,1.41 [0.53-3.74],0.4944969064613181
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C7,Complement component C7,19204,162,1.91 [1.19-3.08],0.0078535207836523
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C7orf50,Uncharacterized protein C7orf50,19617,166,0.73 [0.34-1.56],0.4157594766205097
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C8B,Complement component C8 beta chain,19683,165,0.99 [0.60-1.61],0.9608018352739645
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C9,Complement component C9,19664,165,1.08 [0.81-1.43],0.6142838461478598
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),C9orf40,Uncharacterized protein C9orf40,19559,166,0.86 [0.72-1.03],0.1071441109242052
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CA1,Carbonic anhydrase 1,22119,208,0.82 [0.67-1.00],0.0555632392466715
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CA11,Carbonic anhydrase-related protein 11,22080,202,0.71 [0.44-1.14],0.1561102141712702
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CA12,Carbonic anhydrase 12,22474,209,1.50 [1.04-2.15],0.0302227483765652
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CA13,Carbonic anhydrase 13,22354,209,1.06 [0.94-1.20],0.3269951814482768
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CA14,Carbonic anhydrase 14,22761,210,0.84 [0.59-1.19],0.321949091561848
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CA2,Carbonic anhydrase 2,22522,209,0.92 [0.77-1.10],0.3559767667601745
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CA3,Carbonic anhydrase 3,22829,212,1.14 [0.94-1.39],0.1743671247316104
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CA4,Carbonic anhydrase 4,22865,212,1.30 [0.79-2.15],0.3016478914124724
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CA5A,"Carbonic anhydrase 5A, mitochondrial",22162,199,1.19 [1.05-1.36],0.0077786499428839
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CA6,Carbonic anhydrase 6,22543,208,0.77 [0.64-0.94],0.0098913824906933
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CA7,Carbonic anhydrase 7,19299,165,1.38 [0.98-1.95],0.0646592372791088
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CA8,Carbonic anhydrase-related protein,19069,160,0.52 [0.24-1.11],0.0892971652284146
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CA9,Carbonic anhydrase 9,22761,210,1.18 [0.93-1.51],0.1749048311545852
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CABP2,Calcium-binding protein 2,19122,159,1.11 [0.88-1.38],0.3842251096808905
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,19004,158,1.16 [0.76-1.78],0.491134560443872
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,18980,160,1.00 [0.77-1.29],0.9760545196139336
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,19004,158,1.01 [0.79-1.31],0.9180164209750622
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,19611,164,1.06 [0.89-1.27],0.5161591763626154
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CACYBP,Calcyclin-binding protein,19213,159,1.03 [0.89-1.20],0.6772438665433262
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CADPS,Calcium-dependent secretion activator 1,19122,159,1.03 [0.72-1.46],0.8821194071465656
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CALB1,Calbindin,22474,209,1.22 [0.92-1.61],0.1609016201225318
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CALB2,Calretinin,22060,200,1.32 [1.00-1.75],0.0510412833076714
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CALCA,Calcitonin,22352,210,1.08 [0.90-1.31],0.4079540504241001
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CALCB,Calcitonin gene-related peptide 2,19617,166,1.08 [0.75-1.54],0.6881643774116513
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,22684,210,1.04 [0.92-1.17],0.5384805756459818
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,19166,163,1.05 [0.86-1.28],0.609152119820829
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CALY,Neuron-specific vesicular protein calcyon,18980,160,1.13 [0.79-1.61],0.5012499111921723
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,22080,202,1.48 [1.16-1.90],0.0018817273307688
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CAMLG,Guided entry of tail-anchored proteins factor CAMLG,19122,159,1.18 [0.91-1.52],0.2072947812576939
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,19611,164,1.02 [0.89-1.17],0.7730182928819973
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CANT1,Soluble calcium-activated nucleotidase 1,22505,212,1.82 [1.01-3.28],0.0458683286289182
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CAPG,Macrophage-capping protein,22377,207,0.86 [0.69-1.06],0.1540462003270757
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CAPN3,Calpain-3,19559,167,1.35 [1.00-1.82],0.0484779791787396
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CAPS,Calcyphosin,19617,166,1.04 [0.91-1.19],0.5203655206847269
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CARHSP1,Calcium-regulated heat-stable protein 1,22060,200,0.85 [0.66-1.09],0.192077934985944
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CASC3,Protein CASC3,19122,159,0.91 [0.63-1.33],0.6404342359524662
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CASP1,Caspase-1,22060,200,1.12 [0.95-1.33],0.169330857188297
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CASP10,Caspase-10,22060,200,1.14 [0.95-1.36],0.149158379053325
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CASP2,Caspase-2,22522,211,1.09 [0.92-1.30],0.329410190063013
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CASP3,Caspase-3,22865,212,1.04 [0.91-1.20],0.5390351450915551
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CASP4,Caspase-4,19299,165,0.95 [0.86-1.04],0.2460624753870071
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CASP7,Caspase-7,19617,166,0.99 [0.83-1.19],0.92640778156756
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CASP8,Caspase-8,22688,210,1.06 [0.87-1.28],0.5715297318870372
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CASP9,Caspase-9,19069,160,1.01 [0.79-1.29],0.9454598867838614
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CASQ2,Calsequestrin-2,18980,160,0.91 [0.64-1.28],0.5781012402336329
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CAT,Catalase,19378,162,0.86 [0.65-1.14],0.3079158845446186
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CBLIF,Cobalamin binding intrinsic factor,22541,212,1.01 [0.87-1.18],0.8837182171155727
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CBLN1,Cerebellin-1,19004,158,1.02 [0.87-1.20],0.7710872953728359
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CBLN4,Cerebellin-4,22761,210,0.56 [0.39-0.82],0.0024980538262543
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CBS,Cystathionine beta-synthase,19166,163,1.10 [0.83-1.46],0.506165980462197
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CBX2,Chromobox protein homolog 2,18980,160,1.09 [0.77-1.54],0.6173547970034892
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CC2D1A,Coiled-coil and C2 domain-containing protein 1A,22387,210,1.09 [0.93-1.29],0.2884286106541624
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCAR2,Cell cycle and apoptosis regulator protein 2,19617,166,0.75 [0.53-1.07],0.117817815015472
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCDC134,Coiled-coil domain-containing protein 134,19559,167,1.02 [0.76-1.39],0.8796155241304413
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCDC28A,Coiled-coil domain-containing protein 28A,19122,159,0.87 [0.52-1.46],0.5992578776542044
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCDC50,Coiled-coil domain-containing protein 50,19611,164,1.14 [0.96-1.35],0.1462723177238997
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCDC80,Coiled-coil domain-containing protein 80,22584,212,1.18 [0.85-1.62],0.3187782441873552
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCER2,Coiled-coil domain-containing glutamate-rich protein 2,19166,163,1.24 [0.98-1.56],0.073177050465382
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL11,Eotaxin,22801,212,1.34 [0.96-1.86],0.0827849946901456
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL13,C-C motif chemokine 13,22765,212,0.96 [0.81-1.15],0.6539985100322147
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL14,C-C motif chemokine 14,22556,211,1.39 [1.06-1.83],0.018872602136288
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL15,C-C motif chemokine 15,22865,212,1.21 [0.93-1.58],0.1626086543630607
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL16,C-C motif chemokine 16,22865,212,1.15 [0.91-1.47],0.2404308725274996
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL17,C-C motif chemokine 17,22537,205,1.07 [0.93-1.22],0.3469253365158909
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL18,C-C motif chemokine 18,22293,209,1.19 [1.01-1.39],0.0346300016484552
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL19,C-C motif chemokine 19,22765,209,1.01 [0.92-1.11],0.8577641050929585
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL2,C-C motif chemokine 2,22352,209,1.02 [0.81-1.28],0.8942504354722481
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL20,C-C motif chemokine 20,22801,212,1.12 [0.99-1.26],0.0704794111158354
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL21,C-C motif chemokine 21,22676,208,1.29 [1.01-1.64],0.0414948372823005
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL22,C-C motif chemokine 22,22378,205,0.99 [0.78-1.25],0.9292778018781908
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL23,C-C motif chemokine 23,22676,208,1.13 [0.84-1.51],0.4209324528914058
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL24,C-C motif chemokine 24,22636,206,0.89 [0.76-1.03],0.1219716626189462
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL25,C-C motif chemokine 25,22801,212,1.23 [0.95-1.58],0.1106291166480488
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL26,C-C motif chemokine 26,22522,211,1.00 [0.87-1.14],0.9437617388410148
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL27,C-C motif chemokine 27,22584,212,0.92 [0.75-1.13],0.4415365827817599
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL28,C-C motif chemokine 28,22439,210,1.06 [0.86-1.30],0.5778227520562764
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL3,C-C motif chemokine 3,22522,211,1.19 [1.02-1.40],0.0307775701152341
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL4,C-C motif chemokine 4,22610,208,1.04 [0.88-1.24],0.6134427894319605
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL5,C-C motif chemokine 5,22706,212,1.12 [0.99-1.26],0.0724967205121901
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL7,C-C motif chemokine 7,22522,211,1.14 [0.94-1.39],0.1739426218942596
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCL8,C-C motif chemokine 8,22725,210,1.11 [0.91-1.37],0.2982496692794124
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCN1,CCN family member 1,22431,209,1.08 [0.91-1.28],0.37797350421219
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCN2,CCN family member 2,22546,206,1.18 [0.95-1.47],0.1440149909534117
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCN3,CCN family member 3,22826,211,1.55 [1.12-2.16],0.0088238317893692
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCN4,CCN family member 4,22761,210,1.37 [1.03-1.84],0.0318737906809493
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCN5,CCN family member 5,22610,209,1.32 [0.96-1.81],0.0842426576582698
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCND2,G1/S-specific cyclin-D2,19299,165,1.20 [0.79-1.81],0.3900618137710008
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCNE1,G1/S-specific cyclin-E1,19069,160,1.00 [0.84-1.19],0.9760019725544627
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCS,Copper chaperone for superoxide dismutase,22387,210,0.99 [0.76-1.28],0.9277256316234777
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CCT5,T-complex protein 1 subunit epsilon,22080,202,1.21 [0.93-1.56],0.1590448484072606
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD101,Immunoglobulin superfamily member 2,19559,166,1.22 [0.87-1.72],0.2545289118128149
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD109,CD109 antigen,22610,209,0.87 [0.60-1.26],0.4690253398312186
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD14,Monocyte differentiation antigen CD14,22186,208,1.22 [0.90-1.63],0.1965950248638834
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD160,CD160 antigen,22801,212,1.07 [0.83-1.37],0.6164724743529273
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD163,Scavenger receptor cysteine-rich type 1 protein M130,22706,212,1.40 [1.06-1.84],0.0160938036166809
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD164,Sialomucin core protein 24,22610,209,1.39 [1.02-1.88],0.0343783999536452
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD164L2,CD164 sialomucin-like 2 protein,19122,159,0.99 [0.65-1.51],0.969952917675977
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD177,CD177 antigen,22572,208,1.08 [0.98-1.19],0.1379469756879506
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD1C,T-cell surface glycoprotein CD1c,22673,210,0.74 [0.45-1.20],0.2186176412853104
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD2,T-cell surface antigen CD2,18980,160,1.03 [0.70-1.50],0.8954529957079871
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD200,OX-2 membrane glycoprotein,22522,211,0.94 [0.59-1.48],0.7743107994069964
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD200R1,Cell surface glycoprotein CD200 receptor 1,22454,210,0.85 [0.60-1.21],0.3673695226543145
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD207,C-type lectin domain family 4 member K,22074,206,1.04 [0.75-1.42],0.8300773150521443
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD209,CD209 antigen,22663,211,1.07 [0.78-1.46],0.6861223609173941
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD22,B-cell receptor CD22,22801,212,0.95 [0.72-1.26],0.7273747616625592
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD226,CD226 antigen,19069,160,1.22 [0.85-1.74],0.2829217259042645
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD244,Natural killer cell receptor 2B4,22801,212,1.85 [1.20-2.83],0.0050468775668444
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD248,Endosialin,19664,164,0.83 [0.57-1.21],0.3332220423727684
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD27,CD27 antigen,22673,210,1.51 [1.16-1.98],0.0022683492677756
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD274,Programmed cell death 1 ligand 1,22387,210,1.67 [1.22-2.27],0.0011660654062514
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD276,CD276 antigen,22569,205,1.47 [1.03-2.08],0.0327736521641426
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD28,T-cell-specific surface glycoprotein CD28,22080,202,1.40 [1.05-1.87],0.0230847740519814
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD2AP,CD2-associated protein,22584,212,1.03 [0.85-1.25],0.7422827714167999
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD300A,CMRF35-like molecule 8,19241,159,1.44 [0.88-2.35],0.1468327260635347
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD300C,CMRF35-like molecule 6,22765,209,1.96 [1.41-2.71],5.206898321054816e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD300E,CMRF35-like molecule 2,22686,210,1.52 [1.15-2.00],0.0029670585925322
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD300LF,CMRF35-like molecule 1,22761,210,1.04 [0.85-1.27],0.7002487239899516
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD300LG,CMRF35-like molecule 9,22610,209,1.26 [0.92-1.74],0.1543438827553979
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD302,CD302 antigen,22474,209,1.71 [1.19-2.46],0.0035714304595029
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD33,Myeloid cell surface antigen CD33,22673,210,1.03 [0.88-1.20],0.726372825610865
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD34,Hematopoietic progenitor cell antigen CD34,22701,209,0.98 [0.59-1.64],0.950886332776794
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD36,Platelet glycoprotein 4,19069,160,1.00 [0.71-1.40],0.9849313452916134
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,22474,209,1.08 [0.74-1.57],0.6954029946101048
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD3D,T-cell surface glycoprotein CD3 delta chain,19004,158,1.30 [0.91-1.88],0.1529066451146212
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD3E,T-cell surface glycoprotein CD3 epsilon chain,19299,165,1.08 [0.73-1.59],0.7081330292829259
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD3G,T-cell surface glycoprotein CD3 gamma chain,19069,160,1.06 [0.90-1.24],0.4705654104015095
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD4,T-cell surface glycoprotein CD4,22486,211,1.25 [0.87-1.80],0.2281194822615682
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD40,Tumor necrosis factor receptor superfamily member 5,22570,206,1.45 [1.15-1.83],0.0016796587097541
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD40LG,CD40 ligand,22801,212,1.09 [0.94-1.28],0.2529948384074801
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD46,Membrane cofactor protein,22482,211,1.71 [1.17-2.51],0.0060945934636307
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD48,CD48 antigen,22636,206,1.84 [1.25-2.71],0.0021230962242861
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD5,T-cell surface glycoprotein CD5,22725,210,1.05 [0.75-1.48],0.7656197158066819
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD55,Complement decay-accelerating factor,21818,203,1.31 [0.84-2.06],0.2349356465211852
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD58,Lymphocyte function-associated antigen 3,22539,205,0.98 [0.49-1.98],0.9585197096545964
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD59,CD59 glycoprotein,21801,197,2.21 [1.43-3.42],0.0003710419514553
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD5L,CD5 antigen-like,19571,164,1.27 [0.92-1.73],0.1414987253005468
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD6,T-cell differentiation antigen CD6,22768,212,0.81 [0.64-1.02],0.0713312830082073
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD63,CD63 antigen,22352,209,1.10 [0.87-1.41],0.4285216144306893
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD69,Early activation antigen CD69,22492,212,1.04 [0.91-1.20],0.5517173281879014
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD7,T-cell antigen CD7,19024,160,0.87 [0.61-1.25],0.4554587119830903
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD70,CD70 antigen,22522,211,0.92 [0.69-1.22],0.546789651969297
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD72,B-cell differentiation antigen CD72,19241,159,0.97 [0.68-1.38],0.8658424860289933
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD74,HLA class II histocompatibility antigen gamma chain,22765,209,1.57 [1.12-2.19],0.0085878784997753
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD79B,B-cell antigen receptor complex-associated protein beta chain,22801,212,1.23 [0.95-1.58],0.1122566385038712
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD80,T-lymphocyte activation antigen CD80,19653,166,1.79 [1.20-2.66],0.0040703436222393
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD82,CD82 antigen,19299,165,1.16 [0.84-1.60],0.3596007324720097
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD83,CD83 antigen,22522,211,1.46 [1.04-2.04],0.0300416262825108
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD84,SLAM family member 5,22522,211,1.23 [0.84-1.82],0.289765279513914
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD86,T-lymphocyte activation antigen CD86,19559,166,1.15 [0.69-1.91],0.5943442755121888
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD8A,T-cell surface glycoprotein CD8 alpha chain,22765,209,1.06 [0.84-1.35],0.6035616214409851
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD93,Complement component C1q receptor,21781,204,1.33 [0.90-1.97],0.1519675496999397
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD99,CD99 antigen,22610,209,2.33 [1.31-4.16],0.0040135009521274
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CD99L2,CD99 antigen-like protein 2,22610,209,2.27 [1.39-3.69],0.0009988414680916
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDA,Cytidine deaminase,19608,166,0.97 [0.71-1.33],0.8673406390645553
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDAN1,Codanin-1,19617,166,1.10 [0.61-1.99],0.7538684833844627
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDC123,Cell division cycle protein 123 homolog,18946,158,0.79 [0.59-1.05],0.1004383540955796
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDC25A,M-phase inducer phosphatase 1,18946,158,1.22 [0.87-1.70],0.2453233348368691
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDC26,Anaphase-promoting complex subunit CDC26,19517,166,1.14 [0.92-1.41],0.2375452824535397
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDC27,Cell division cycle protein 27 homolog,22080,202,1.14 [0.93-1.39],0.2081171431922267
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDC37,Hsp90 co-chaperone Cdc37,22673,210,1.11 [0.96-1.28],0.1700559796739456
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDC42BPB,Serine/threonine-protein kinase MRCK beta,19559,166,1.02 [0.88-1.17],0.8398089650380549
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDCP1,CUB domain-containing protein 1,22387,210,1.37 [1.11-1.70],0.0034415086831657
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDH1,Cadherin-1,21866,208,1.48 [1.14-1.92],0.0034686057323068
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDH15,Cadherin-15,22730,209,0.91 [0.75-1.11],0.3637762784599562
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDH17,Cadherin-17,22584,212,1.01 [0.84-1.20],0.9389213565262295
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDH2,Cadherin-2,22584,212,1.26 [0.90-1.78],0.1842755790194449
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDH22,Cadherin-22,19299,165,1.07 [0.65-1.79],0.782383122806058
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDH23,Cadherin-23,19617,166,1.09 [0.62-1.91],0.7581130955916647
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDH3,Cadherin-3,22765,209,1.39 [1.01-1.92],0.0428458476717005
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDH4,Cadherin-4,19004,158,1.33 [1.04-1.72],0.0255901341843041
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDH5,Cadherin-5,22865,212,0.86 [0.57-1.29],0.4599939602360969
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDH6,Cadherin-6,22584,212,1.06 [0.77-1.46],0.7111924606903929
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDHR1,Cadherin-related family member 1,22060,200,1.11 [0.84-1.46],0.4539183377704241
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDHR2,Cadherin-related family member 2,22474,209,0.95 [0.79-1.13],0.5500724621792843
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDHR5,Cadherin-related family member 5,22584,212,0.89 [0.65-1.22],0.4699859205118397
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDK1,Cyclin-dependent kinase 1,18946,158,1.07 [0.71-1.63],0.7460251862968248
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDK5RAP3,CDK5 regulatory subunit-associated protein 3,19611,164,0.99 [0.76-1.28],0.934396348676812
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDKL5,Cyclin-dependent kinase-like 5,19004,158,1.23 [0.98-1.55],0.0795254858696831
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDKN1A,Cyclin-dependent kinase inhibitor 1,22474,209,1.06 [0.95-1.19],0.2993933711785925
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDKN2D,Cyclin-dependent kinase 4 inhibitor D,22474,209,1.03 [0.90-1.18],0.6464999421829114
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDNF,Cerebral dopamine neurotrophic factor,22474,209,1.23 [0.87-1.74],0.2506779950869177
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDON,Cell adhesion molecule-related/down-regulated by oncogenes,22603,205,1.24 [0.76-2.02],0.3820118065645804
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CDSN,Corneodesmosin,22733,211,1.22 [0.93-1.61],0.1560520223419886
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,22634,210,1.74 [0.99-3.08],0.0563371718879305
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,19559,166,0.87 [0.72-1.06],0.1674546524650075
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,19299,165,1.09 [0.90-1.32],0.3929434994694515
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,19559,166,1.22 [0.85-1.76],0.2760365909843829
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,19299,165,1.14 [0.83-1.56],0.4195504671279301
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,22522,211,1.20 [1.05-1.37],0.0078731280395873
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,22080,202,1.12 [0.87-1.43],0.3752379818180043
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,21819,201,1.04 [0.85-1.26],0.7254323237655502
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,19664,164,1.21 [0.84-1.74],0.3134351703722687
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,22162,199,1.11 [0.87-1.42],0.4051711482826162
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEBPA,CCAAT/enhancer-binding protein alpha,19069,160,1.04 [0.69-1.58],0.836605614211119
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEBPB,CCAAT/enhancer-binding protein beta,22162,199,0.94 [0.68-1.32],0.7399820963999044
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CELA2A,Chymotrypsin-like elastase family member 2A,19664,164,0.88 [0.69-1.11],0.2769500927678431
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CELA3A,Chymotrypsin-like elastase family member 3A,22830,212,0.97 [0.79-1.19],0.7728012674540901
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,19241,159,1.04 [0.62-1.73],0.8805848496382437
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEMIP2,Cell surface hyaluronidase,19069,160,0.96 [0.60-1.53],0.868045007674177
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEND1,Cell cycle exit and neuronal differentiation protein 1,19004,158,1.00 [0.77-1.29],0.976462575529681
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CENPF,Centromere protein F,19299,165,0.89 [0.68-1.18],0.4273520371329918
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CENPJ,Centromere protein J,19299,165,0.88 [0.70-1.11],0.2947098227388132
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEP112,Centrosomal protein of 112 kDa,18980,160,0.79 [0.52-1.19],0.2585051018212126
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEP152,Centrosomal protein of 152 kDa,18946,158,1.12 [0.80-1.57],0.5197614071541308
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEP164,Centrosomal protein of 164 kDa,22144,200,1.06 [0.89-1.27],0.4993834323543745
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEP170,Centrosomal protein of 170 kDa,19166,163,1.05 [0.86-1.27],0.6506437565184386
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEP20,Centrosomal protein 20,22080,202,1.20 [1.02-1.41],0.0266283735109355
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEP290,Centrosomal protein of 290 kDa,19299,165,0.98 [0.74-1.30],0.8930888507308838
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEP350,Centrosome-associated protein 350,18946,158,0.93 [0.62-1.40],0.7303410719030119
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEP43,Centrosomal protein 43,21985,195,1.06 [0.88-1.27],0.5541559653859252
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CEP85,Centrosomal protein of 85 kDa,22080,202,1.24 [1.03-1.50],0.0204509517063128
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CERT,Ceramide transfer protein,22060,200,1.14 [0.93-1.40],0.2205578741206136
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CES1,Liver carboxylesterase 1,22662,212,1.04 [0.90-1.21],0.5590915718720665
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CES2,Cocaine esterase,22474,209,1.03 [0.83-1.28],0.8032724328577122
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CES3,Carboxylesterase 3,22474,209,0.98 [0.83-1.17],0.8573714648325307
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CETN2,Centrin-2,22060,200,1.14 [0.95-1.37],0.1482807706892149
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CETN3,Centrin-3,19559,166,1.08 [0.89-1.31],0.4312692379790417
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CFB,Complement factor B,19328,164,1.29 [0.81-2.07],0.2835888776443798
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CFC1,Cryptic protein,22080,202,1.34 [1.05-1.71],0.0196273633227664
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CFD,Complement factor D,19683,165,0.82 [0.39-1.72],0.5974793696901015
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CFH,Complement factor H,18525,155,1.21 [0.61-2.40],0.5893699433903358
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CFHR2,Complement factor H-related protein 2,19535,165,1.20 [0.91-1.59],0.18601198038688
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CFHR4,Complement factor H-related protein 4,19647,164,1.33 [1.07-1.65],0.0106335136605622
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CFHR5,Complement factor H-related protein 5,19399,161,1.02 [0.71-1.46],0.9277562812791212
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CFI,Complement factor I,19683,165,0.69 [0.32-1.46],0.3291294699408932
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CFP,Properdin,19683,165,0.46 [0.22-0.97],0.0398970364227656
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CGA,Glycoprotein hormones alpha chain,22610,209,1.06 [0.87-1.29],0.5589044004694146
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,19664,165,1.47 [0.99-2.19],0.0572470446585308
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CGN,Cingulin,19122,159,1.17 [0.84-1.63],0.3576710051423606
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CGREF1,Cell growth regulator with EF hand domain protein 1,22584,212,1.40 [1.06-1.84],0.0169246204538189
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,22080,202,1.07 [0.87-1.31],0.5314682862943632
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHAD,Chondroadherin,19241,159,0.75 [0.56-1.01],0.0546803648249445
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",19617,166,1.59 [1.16-2.17],0.0038252410067885
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHCHD6,MICOS complex subunit MIC25,19559,167,1.34 [0.84-2.14],0.2177940025226335
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHEK2,Serine/threonine-protein kinase Chk2,22162,199,1.06 [0.72-1.56],0.7642383950593361
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHGA,Chromogranin-A,19664,164,1.05 [0.90-1.22],0.5475717063133687
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHGB,Secretogranin-1,22699,209,1.51 [1.14-1.99],0.0040426089605156
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHI3L1,Chitinase-3-like protein 1,22135,207,1.20 [1.04-1.38],0.0106741662720145
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHIT1,Chitotriosidase-1,22689,212,1.02 [0.94-1.10],0.7099587170571213
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHL1,Neural cell adhesion molecule L1-like protein,22670,211,0.92 [0.61-1.38],0.6705798512075716
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHM,Rab proteins geranylgeranyltransferase component A 1,19122,159,1.01 [0.78-1.29],0.96573826905548
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHMP1A,Charged multivesicular body protein 1a,22387,210,1.06 [0.91-1.24],0.4465652538766129
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHMP6,Charged multivesicular body protein 6,19653,166,0.99 [0.76-1.30],0.969995156197815
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHP1,Calcineurin B homologous protein 1,19004,158,0.99 [0.80-1.22],0.8937939299829161
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHRDL1,Chordin-like protein 1,22636,206,1.62 [1.11-2.38],0.0132834073769131
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHRDL2,Chordin-like protein 2,22584,212,0.91 [0.70-1.18],0.4653869364226708
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CHRM1,Muscarinic acetylcholine receptor M1,19122,159,1.30 [0.92-1.83],0.1346697923815414
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CIAPIN1,Anamorsin,22673,210,1.14 [0.94-1.39],0.1901002078727249
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CILP,Cartilage intermediate layer protein 1,19664,164,1.12 [0.84-1.48],0.4368438970502866
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CINP,Cyclin-dependent kinase 2-interacting protein,19299,165,0.89 [0.62-1.27],0.5091069422306908
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CIRBP,Cold-inducible RNA-binding protein,19559,166,1.06 [0.91-1.24],0.4695741682035093
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CIT,Citron Rho-interacting kinase,19122,159,0.83 [0.58-1.18],0.2988852583978983
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CKAP4,Cytoskeleton-associated protein 4,22703,212,1.49 [1.01-2.21],0.0464315544812738
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CKB,Creatine kinase B-type,19664,164,1.15 [0.90-1.49],0.2640407965820122
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",22506,206,1.16 [0.96-1.40],0.134046039355103
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLASP1,CLIP-associating protein 1,18946,158,0.90 [0.72-1.13],0.382791031995223
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLC,Galectin-10,22545,212,1.01 [0.84-1.21],0.9453437836201888
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC10A,C-type lectin domain family 10 member A,22387,210,0.97 [0.69-1.37],0.8838137454548229
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC11A,C-type lectin domain family 11 member A,22575,209,1.29 [1.00-1.66],0.0494845937147848
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC12A,C-type lectin domain family 12 member A,19069,160,0.94 [0.44-1.99],0.8642096796145291
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC14A,C-type lectin domain family 14 member A,22610,209,1.52 [1.06-2.18],0.0235667087762331
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC1A,C-type lectin domain family 1 member A,22162,199,1.16 [0.80-1.67],0.4416713972400143
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC1B,C-type lectin domain family 1 member B,22765,209,1.10 [0.97-1.25],0.1461772477679467
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC2L,C-type lectin domain family 2 member L,19122,159,1.03 [0.77-1.39],0.8364980235667318
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC3B,Tetranectin,19210,163,0.74 [0.36-1.53],0.4132523279641699
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC4A,C-type lectin domain family 4 member A,22522,211,0.79 [0.57-1.11],0.1809009822620022
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC4C,C-type lectin domain family 4 member C,22522,211,0.90 [0.70-1.16],0.4227192200194074
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC4D,C-type lectin domain family 4 member D,22522,211,1.08 [0.89-1.31],0.4575659817318179
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC4G,C-type lectin domain family 4 member G,22522,211,1.36 [0.94-1.95],0.0998613261206066
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC4M,C-type lectin domain family 4 member M,19628,164,1.11 [0.82-1.51],0.4831192190742935
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC5A,C-type lectin domain family 5 member A,22520,212,1.49 [1.01-2.21],0.0454320081434042
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC6A,C-type lectin domain family 6 member A,22080,202,1.30 [1.01-1.68],0.0450297551209951
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLEC7A,C-type lectin domain family 7 member A,22801,212,1.32 [1.04-1.69],0.0233622626813337
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLGN,Calmegin,19122,159,1.09 [0.78-1.50],0.6161067595645887
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLIC5,Chloride intracellular channel protein 5,19122,159,1.27 [0.82-1.96],0.2815011509365792
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLINT1,Clathrin interactor 1,18946,158,0.79 [0.54-1.16],0.2344749748415313
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLIP2,CAP-Gly domain-containing linker protein 2,22522,211,1.07 [0.96-1.19],0.2403712170862385
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLMP,CXADR-like membrane protein,22761,210,1.31 [0.75-2.30],0.3394514817657698
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLNS1A,Methylosome subunit pICln,19122,159,1.01 [0.65-1.59],0.951364595449538
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",22352,210,1.13 [1.00-1.29],0.0533464185363635
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLPS,Colipase,22567,209,1.03 [0.87-1.23],0.7009811633626943
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLSPN,Claspin,22025,200,1.09 [0.78-1.52],0.616952282700316
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLSTN1,Calsyntenin-1,22060,200,0.88 [0.68-1.13],0.3211963167473911
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLSTN2,Calsyntenin-2,22801,212,1.12 [0.83-1.52],0.4564430207067369
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLSTN3,Calsyntenin-3,19617,166,1.21 [0.75-1.95],0.4409576085594524
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLTA,Clathrin light chain A,22162,199,1.13 [0.87-1.45],0.357377783978961
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLU,Clusterin,19683,165,0.99 [0.59-1.67],0.9679220497379696
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CLUL1,Clusterin-like protein 1,22548,212,1.25 [0.96-1.63],0.0973915739123024
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CMC1,COX assembly mitochondrial protein homolog,19653,166,1.09 [0.93-1.28],0.3017974895587548
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CMIP,C-Maf-inducing protein,19559,167,1.06 [0.89-1.26],0.5329115673770474
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CNDP1,Beta-Ala-His dipeptidase,22706,212,0.78 [0.61-1.00],0.0476923016089326
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CNGB3,Cyclic nucleotide-gated cation channel beta-3,19004,158,0.84 [0.61-1.17],0.3054707426552466
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",19131,163,1.04 [0.86-1.25],0.7140258567732899
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CNPY2,Protein canopy homolog 2,22162,199,1.11 [0.92-1.33],0.2800996785646444
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CNPY4,Protein canopy homolog 4,22474,209,1.09 [0.93-1.29],0.2801574341619244
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CNST,Consortin,22584,212,1.02 [0.91-1.14],0.7429300557744662
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CNTF,Ciliary neurotrophic factor,19004,158,1.09 [0.70-1.70],0.6973479435994275
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CNTN1,Contactin-1,22865,212,0.67 [0.44-1.02],0.0632213506612843
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CNTN2,Contactin-2,22761,210,0.90 [0.68-1.18],0.441398107001351
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CNTN3,Contactin-3,22610,209,0.96 [0.65-1.42],0.8270609358736468
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CNTN4,Contactin-4,22610,209,1.16 [0.70-1.94],0.5632990840814304
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CNTN5,Contactin-5,22627,209,0.50 [0.36-0.71],6.692589561734579e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CNTNAP2,Contactin-associated protein-like 2,22522,211,1.12 [0.84-1.50],0.450603305848621
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CNTNAP4,Contactin-associated protein-like 4,19122,159,1.03 [0.89-1.19],0.6889100453663416
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COCH,Cochlin,19653,166,1.12 [0.82-1.54],0.463552440340596
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COL15A1,Collagen alpha-1(XV) chain,19664,164,0.60 [0.34-1.05],0.0715607640927399
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COL18A1,Collagen alpha-1(XVIII) chain,22706,212,2.33 [1.41-3.85],0.0009163314842354
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COL1A1,Collagen alpha-1(I) chain,22865,212,0.82 [0.50-1.34],0.4321790109391904
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COL24A1,Collagen alpha-1(XXIV) chain,19559,166,1.28 [0.97-1.69],0.0753709768034476
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COL28A1,Collagen alpha-1(XXVIII) chain,19122,159,0.74 [0.60-0.92],0.0055469770457837
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COL2A1,Collagen alpha-1(II) chain,19166,163,1.10 [0.92-1.33],0.3033568194131093
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COL3A1,Collagen alpha-1(III) chain,19664,164,1.44 [0.76-2.70],0.2620907710833622
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COL4A1,Collagen alpha-1(IV) chain,22584,212,1.52 [1.13-2.04],0.0059403903854259
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COL4A4,Collagen alpha-4(IV) chain,19269,165,1.02 [0.77-1.36],0.8764228519945111
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COL5A1,Collagen alpha-1(V) chain,19241,159,1.33 [0.92-1.91],0.1256458001237533
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COL6A3,Collagen alpha-3(VI) chain,22865,212,1.64 [1.20-2.23],0.0017794786522777
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COL9A1,Collagen alpha-1(IX) chain,22522,211,0.88 [0.68-1.14],0.3457801330225547
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COL9A2,Collagen alpha-2(IX) chain,19299,165,1.12 [0.82-1.52],0.468687537732581
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COLEC12,Collectin-12,22569,205,2.11 [1.37-3.23],0.0006268725523551
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COMMD1,COMM domain-containing protein 1,19166,163,1.15 [0.90-1.47],0.2683232244114746
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COMMD9,COMM domain-containing protein 9,19559,167,1.12 [0.80-1.58],0.5058903244333601
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COMP,Cartilage oligomeric matrix protein,22360,210,0.85 [0.59-1.23],0.3959966955119757
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COMT,Catechol O-methyltransferase,21930,196,1.07 [0.92-1.25],0.3811844160424151
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COPB2,Coatomer subunit beta',18980,160,0.80 [0.56-1.16],0.2388466847957694
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COPE,Coatomer subunit epsilon,22060,200,1.14 [0.90-1.44],0.2679184453370659
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",19166,163,1.08 [0.77-1.52],0.642478362995978
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CORO1A,Coronin-1A,22121,205,1.08 [0.94-1.23],0.2701580983408667
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CORO6,Coronin-6,19004,158,1.26 [0.87-1.83],0.2232033802890375
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",22474,209,1.16 [0.98-1.37],0.0918676211731128
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),COX6B1,Cytochrome c oxidase subunit 6B1,19653,166,1.32 [0.85-2.05],0.2120194004514913
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CPA1,Carboxypeptidase A1,22865,212,1.02 [0.84-1.24],0.8467072225075462
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CPA2,Carboxypeptidase A2,22699,209,0.98 [0.81-1.18],0.8199494354894751
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CPA4,Carboxypeptidase A4,18855,155,1.26 [0.88-1.81],0.2121203318611453
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CPB1,Carboxypeptidase B,22865,212,1.06 [0.87-1.30],0.5505271981277138
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CPB2,Carboxypeptidase B2,19650,164,0.70 [0.36-1.37],0.2971813927589132
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CPE,Carboxypeptidase E,22568,208,0.84 [0.62-1.14],0.2647037395202979
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CPLX2,Complexin-2,18946,158,0.66 [0.39-1.12],0.1236824469682213
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CPM,Carboxypeptidase M,22646,209,1.51 [1.07-2.14],0.0200394896463217
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",19069,160,1.08 [0.63-1.84],0.7767789252133943
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CPPED1,Serine/threonine-protein phosphatase CPPED1,22765,209,1.01 [0.84-1.22],0.9053666881664526
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CPQ,Carboxypeptidase Q,19625,164,1.09 [0.72-1.66],0.690392878083832
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CPTP,Ceramide-1-phosphate transfer protein,18980,160,0.94 [0.63-1.40],0.7616611531284033
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CPVL,Probable serine carboxypeptidase CPVL,22729,210,1.08 [0.80-1.46],0.6099584771933307
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CPXM1,Probable carboxypeptidase X1,22673,210,1.23 [1.04-1.46],0.0163965711922266
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CPXM2,Inactive carboxypeptidase-like protein X2,19653,166,1.15 [0.65-2.01],0.6337542736920918
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CR1,Complement receptor type 1,19589,164,1.13 [0.74-1.73],0.5593027418440384
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CR2,Complement receptor type 2,22706,212,1.04 [0.80-1.34],0.7737360358409667
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRACR2A,EF-hand calcium-binding domain-containing protein 4B,22080,202,1.11 [0.97-1.28],0.1313160994679036
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRADD,Death domain-containing protein CRADD,22352,210,1.07 [0.91-1.26],0.4009868476497268
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CREB3,Cyclic AMP-responsive element-binding protein 3,18946,158,1.35 [1.09-1.68],0.0063870137550761
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CREBZF,CREB/ATF bZIP transcription factor,18946,158,1.76 [1.07-2.90],0.0264014308475343
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CREG1,Protein CREG1,22318,208,1.02 [0.75-1.40],0.8861652995946129
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRELD1,Protein disulfide isomerase CRELD1,19241,159,1.28 [0.85-1.92],0.2342316365213563
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRELD2,Protein disulfide isomerase CRELD2,22636,206,1.26 [1.00-1.59],0.0547577678311215
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRH,Corticoliberin,22041,202,0.92 [0.80-1.07],0.3019161701904855
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRHBP,Corticotropin-releasing factor-binding protein,22569,205,1.62 [1.03-2.53],0.0356769960849438
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRHR1,Corticotropin-releasing factor receptor 1,22162,199,1.00 [0.82-1.23],0.9858124552890783
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRIM1,Cysteine-rich motor neuron 1 protein,22676,208,2.62 [1.48-4.64],0.0009973465436482
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRIP2,Cysteine-rich protein 2,22387,210,1.38 [1.04-1.84],0.0235304929091214
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRISP2,Cysteine-rich secretory protein 2,22761,210,0.97 [0.79-1.19],0.7621813099341772
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRISP3,Cysteine-rich secretory protein 3,19492,164,0.73 [0.43-1.26],0.2636612102093369
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRKL,Crk-like protein,22606,206,1.06 [0.94-1.19],0.340103347027461
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRLF1,Cytokine receptor-like factor 1,22676,208,1.45 [0.88-2.37],0.1441056136479242
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRNN,Cornulin,21959,204,1.20 [1.00-1.43],0.0468855785795781
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRTAC1,Cartilage acidic protein 1,22865,212,0.67 [0.45-0.99],0.0448260097998637
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRTAM,Cytotoxic and regulatory T-cell molecule,22387,210,1.35 [1.06-1.70],0.0136713294440339
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRTAP,Cartilage-associated protein,19122,159,0.89 [0.63-1.25],0.4956764748786113
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRX,Cone-rod homeobox protein,22162,199,0.88 [0.77-1.02],0.0808431355921116
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRYBB1,Beta-crystallin B1,19653,166,1.20 [0.96-1.51],0.1116492747184022
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRYBB2,Beta-crystallin B2,19617,166,1.41 [1.28-1.56],2.0022810477720022e-11
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRYGD,Gamma-crystallin D,19617,166,0.95 [0.82-1.11],0.534818481777702
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRYM,Ketimine reductase mu-crystallin,19004,158,0.98 [0.79-1.20],0.8191883615498674
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CRYZL1,Quinone oxidoreductase-like protein 1,19166,163,1.02 [0.86-1.20],0.8420372374357611
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CSDE1,Cold shock domain-containing protein E1,18980,160,1.02 [0.90-1.16],0.7393066257012417
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CSF1,Macrophage colony-stimulating factor 1,22676,208,1.95 [1.27-3.00],0.0021813931140916
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CSF1R,Macrophage colony-stimulating factor 1 receptor,19664,165,1.35 [0.93-1.95],0.1140752362549296
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CSF2,Granulocyte-macrophage colony-stimulating factor,18980,160,0.76 [0.49-1.18],0.2244715604039258
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,22387,210,1.02 [0.84-1.24],0.8307295228589828
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CSF2RB,Cytokine receptor common subunit beta,19069,160,1.04 [0.73-1.49],0.8139664934299317
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CSF3,Granulocyte colony-stimulating factor,22144,200,0.96 [0.74-1.25],0.7755312254279906
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CSF3R,Granulocyte colony-stimulating factor receptor,19069,160,0.63 [0.36-1.08],0.0910791877438137
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CSH1,Chorionic somatomammotropin hormone 1,19664,165,1.02 [0.61-1.71],0.9413087076226058
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CSNK1D,Casein kinase I isoform delta,19069,160,1.03 [0.81-1.32],0.7794100424516143
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CSNK2A1,Casein kinase II subunit alpha,19611,164,1.21 [0.87-1.68],0.251639424676891
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CSPG4,Chondroitin sulfate proteoglycan 4,19664,164,1.14 [0.72-1.80],0.5757361913903456
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CSPG5,Chondroitin sulfate proteoglycan 5,19004,158,0.96 [0.70-1.31],0.8034131352761997
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CSRP3,Cysteine and glycine-rich protein 3,18980,160,1.14 [0.99-1.31],0.0746879541523522
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CST1,Cystatin-SN,17097,138,0.94 [0.80-1.11],0.4943578741052754
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CST3,Cystatin-C,22669,212,1.88 [1.28-2.76],0.001323639963111
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CST5,Cystatin-D,22155,207,0.99 [0.79-1.23],0.9258029932322008
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CST6,Cystatin-M,21972,200,1.05 [0.81-1.35],0.7157721760691069
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CST7,Cystatin-F,22610,208,1.05 [0.93-1.18],0.459004561797105
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CSTB,Cystatin-B,22283,208,1.29 [0.97-1.71],0.0754438439826197
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTAG1A_CTAG1B,Cancer/testis antigen 1,19267,165,1.17 [0.88-1.56],0.2713261322087739
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTBS,Di-N-acetylchitobiase,19356,163,0.98 [0.56-1.74],0.957302359606257
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTF1,Cardiotrophin-1,22162,199,1.05 [0.90-1.21],0.5361427439793278
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTHRC1,Collagen triple helix repeat-containing protein 1,19664,164,1.84 [1.14-2.97],0.0128895162036766
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTLA4,Cytotoxic T-lymphocyte protein 4,19664,164,0.84 [0.51-1.39],0.4939920147696029
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTNNA1,Catenin alpha-1,19004,158,1.21 [0.84-1.74],0.3185528130373655
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTRB1,Chymotrypsinogen B,22610,209,0.99 [0.80-1.22],0.902013054206312
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTRC,Chymotrypsin-C,22571,205,0.88 [0.73-1.06],0.1748388222956377
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTRL,Chymotrypsin-like protease CTRL-1,19617,166,0.97 [0.79-1.20],0.7908976551864737
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTSB,Cathepsin B,22634,212,0.97 [0.77-1.22],0.7786290525659243
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTSC,Dipeptidyl peptidase 1,22529,208,1.28 [0.97-1.67],0.0763480882037064
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTSD,Cathepsin D,21180,201,1.12 [0.83-1.51],0.4518478775628258
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTSE,Cathepsin E,19241,159,1.07 [0.80-1.44],0.651608458820804
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTSF,Cathepsin F,22673,210,0.80 [0.58-1.09],0.1618928436476964
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTSH,Pro-cathepsin H,22082,199,1.02 [0.86-1.21],0.8381933116315294
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTSL,Cathepsin L1,22584,212,1.58 [0.97-2.56],0.0633740780578259
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTSO,Cathepsin O,22801,212,1.41 [0.96-2.07],0.078678685421968
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTSS,Cathepsin S,17659,168,1.89 [1.03-3.48],0.0396975580372062
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTSV,Cathepsin L2,22686,210,0.71 [0.53-0.97],0.0300462580570803
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CTSZ,Cathepsin Z,22644,212,1.34 [0.92-1.96],0.1238334453774058
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CUZD1,CUB and zona pellucida-like domain-containing protein 1,19122,159,0.98 [0.66-1.47],0.9221001766745592
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CWC15,Spliceosome-associated protein CWC15 homolog,19439,164,1.12 [0.89-1.40],0.3318509725699649
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CX3CL1,Fractalkine,22387,210,1.48 [1.05-2.10],0.0256771463530763
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CXADR,Coxsackievirus and adenovirus receptor,22522,211,1.52 [1.23-1.87],9.504240553302478e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CXCL1,Growth-regulated alpha protein,22537,208,1.00 [0.88-1.14],0.965862726499506
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CXCL10,C-X-C motif chemokine 10,22676,208,1.25 [1.06-1.48],0.0085931308809082
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CXCL11,C-X-C motif chemokine 11,22765,209,1.10 [0.95-1.27],0.1832565086131218
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CXCL12,Stromal cell-derived factor 1,22144,200,1.15 [0.84-1.57],0.3887015942215165
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CXCL13,C-X-C motif chemokine 13,22765,209,1.06 [0.88-1.28],0.5147665254086505
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CXCL14,C-X-C motif chemokine 14,22144,200,1.23 [1.04-1.46],0.0181973593624264
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CXCL16,C-X-C motif chemokine 16,22836,212,2.09 [1.27-3.43],0.0037305464912099
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CXCL17,C-X-C motif chemokine 17,22801,212,1.06 [0.79-1.41],0.7038870061104437
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CXCL3,C-X-C motif chemokine 3,22570,206,1.04 [0.91-1.19],0.5458464789942188
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CXCL5,C-X-C motif chemokine 5,22516,212,1.04 [0.93-1.15],0.4972528068889228
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CXCL6,C-X-C motif chemokine 6,22801,212,1.06 [0.91-1.25],0.4356701658097808
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CXCL8,Interleukin-8,22412,208,0.99 [0.83-1.18],0.9281999238544484
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CXCL9,C-X-C motif chemokine 9,22676,208,1.20 [1.01-1.42],0.0366397918132095
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CYB5A,Cytochrome b5,18946,158,0.78 [0.61-1.01],0.0569525463606425
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CYB5R2,NADH-cytochrome b5 reductase 2,19357,166,0.94 [0.72-1.24],0.6786555008029901
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",18980,160,0.80 [0.64-1.00],0.0490827010299307
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CYTH3,Cytohesin-3,18946,158,0.87 [0.69-1.10],0.2417091780655774
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),CYTL1,Cytokine-like protein 1,19664,164,0.73 [0.40-1.33],0.305796245584843
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DAAM1,Disheveled-associated activator of morphogenesis 1,19241,159,1.02 [0.84-1.22],0.872259036269742
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DAB2,Disabled homolog 2,22761,210,1.08 [0.97-1.21],0.1608496940424382
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DAG1,Dystroglycan,22676,208,1.30 [1.00-1.69],0.0489267818250037
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DAND5,DAN domain family member 5,19069,160,1.05 [0.80-1.36],0.728042977350948
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DAPK2,Death-associated protein kinase 2,19069,160,0.94 [0.70-1.25],0.6484168377790873
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,22522,211,1.00 [0.91-1.11],0.9464919682203592
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DARS1,"Aspartate--tRNA ligase, cytoplasmic",22352,210,1.07 [0.90-1.26],0.4627328450056011
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DBH,Dopamine beta-hydroxylase,19619,165,1.03 [0.89-1.18],0.7074343441424344
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DBI,Acyl-CoA-binding protein,22509,207,1.20 [1.02-1.40],0.025601128536036
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DBN1,Drebrin,19069,160,1.08 [0.79-1.46],0.6321015242838449
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DBNL,Drebrin-like protein,22676,208,1.06 [0.93-1.21],0.3978108825452505
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",22673,210,1.78 [1.27-2.50],0.0009239284675142
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DCC,Netrin receptor DCC,19122,159,0.92 [0.45-1.88],0.823522021468164
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DCDC2C,Doublecortin domain-containing protein 2C,18946,158,0.90 [0.69-1.16],0.4114393563725732
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DCLRE1C,Protein artemis,18946,158,0.77 [0.46-1.28],0.3087739983242575
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DCN,Decorin,22162,199,1.28 [0.76-2.17],0.3471956912300568
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DCTD,Deoxycytidylate deaminase,19241,159,1.04 [0.88-1.22],0.6450040496624755
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DCTN1,Dynactin subunit 1,22761,210,1.02 [0.85-1.23],0.8396575101175178
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DCTN2,Dynactin subunit 2,22474,209,1.07 [0.94-1.22],0.2791888242655012
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DCTN6,Dynactin subunit 6,22060,200,1.05 [0.89-1.25],0.5359379676083553
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DCTPP1,dCTP pyrophosphatase 1,22584,212,0.98 [0.66-1.45],0.9219758757644606
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DCUN1D1,DCN1-like protein 1,19004,158,0.95 [0.77-1.18],0.6457097468875146
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DCUN1D2,DCN1-like protein 2,18946,158,0.94 [0.77-1.14],0.5181161899482244
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DCXR,L-xylulose reductase,22673,210,1.07 [0.85-1.35],0.565781514670366
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DDA1,DET1- and DDB1-associated protein 1,18980,160,0.93 [0.62-1.38],0.7050871739757636
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",22474,209,1.32 [1.01-1.71],0.0389246641083407
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DDC,Aromatic-L-amino-acid decarboxylase,22541,212,1.20 [0.94-1.55],0.1485527377361988
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DDHD2,Phospholipase DDHD2,19611,164,0.99 [0.79-1.25],0.9288482563436538
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DDI2,Protein DDI1 homolog 2,19241,159,0.85 [0.70-1.03],0.0985503290733134
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DDR1,Epithelial discoidin domain-containing receptor 1,22765,209,1.55 [0.92-2.61],0.0972407399698326
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DDT,D-dopachrome decarboxylase,19664,164,0.77 [0.53-1.12],0.174179918043447
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DDX1,ATP-dependent RNA helicase DDX1,19559,166,1.02 [0.75-1.37],0.9184518372154494
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DDX25,ATP-dependent RNA helicase DDX25,19122,159,0.91 [0.59-1.39],0.6599348106489181
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DDX39A,ATP-dependent RNA helicase DDX39A,19069,160,0.81 [0.40-1.61],0.543221335946188
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DDX4,Probable ATP-dependent RNA helicase DDX4,19069,160,1.08 [0.82-1.41],0.5882204223279944
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DDX53,Probable ATP-dependent RNA helicase DDX53,19122,159,0.90 [0.58-1.39],0.6276952652771332
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DDX58,Antiviral innate immune response receptor RIG-I,22080,202,1.19 [0.98-1.44],0.0770615245239613
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",22522,211,1.06 [0.93-1.20],0.3935496524785172
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DEFA1_DEFA1B,Neutrophil defensin 1,22151,207,1.05 [0.85-1.31],0.6385964126622162
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DEFB103A_DEFB103B,Beta-defensin 103,18910,158,1.31 [1.01-1.71],0.0421131679918109
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DEFB104A_DEFB104B,Beta-defensin 104,19004,158,1.19 [0.92-1.53],0.1804076569418091
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DEFB116,Beta-defensin 116,19004,158,1.10 [0.91-1.31],0.3242896777561981
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DEFB118,Beta-defensin 118,19004,158,0.93 [0.69-1.24],0.6144577384455874
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DEFB4A_DEFB4B,Beta-defensin 4A,22281,208,1.04 [0.95-1.12],0.3978472269493526
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DENND2B,DENN domain-containing protein 2B,18980,160,1.05 [0.78-1.41],0.7524946514112079
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DENR,Density-regulated protein,19069,160,0.99 [0.75-1.30],0.932000924497323
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DFFA,DNA fragmentation factor subunit alpha,22801,212,1.08 [0.90-1.29],0.4010320814436984
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DGCR6,Protein DGCR6,19004,158,1.27 [0.97-1.67],0.0828607658551795
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DGKA,Diacylglycerol kinase alpha,19069,160,1.06 [0.80-1.40],0.6835724922655153
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DGKZ,Diacylglycerol kinase zeta,22144,200,1.35 [0.96-1.89],0.085083121932673
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DHODH,Dihydroorotate dehydrogenase,18980,160,0.95 [0.68-1.32],0.7613524402898806
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DHPS,Deoxyhypusine synthase,19559,167,0.90 [0.61-1.32],0.5890319051630616
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,19617,166,1.20 [0.90-1.59],0.2101951268749279
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DIABLO,"Diablo homolog, mitochondrial",22520,212,1.05 [0.94-1.17],0.4316005973157271
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DIPK1C,Divergent protein kinase domain 1C,19122,159,0.94 [0.65-1.37],0.7660994955732621
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DIPK2B,Divergent protein kinase domain 2B,19241,159,0.95 [0.54-1.65],0.8485686816838852
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DKK1,Dickkopf-related protein 1,22765,209,1.22 [0.99-1.50],0.0593266944785176
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DKK3,Dickkopf-related protein 3,22865,212,1.36 [0.91-2.03],0.1374964049816717
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DKK4,Dickkopf-related protein 4,22356,210,1.18 [0.91-1.52],0.2101010080912891
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DKKL1,Dickkopf-like protein 1,22474,209,1.04 [0.91-1.20],0.5570221055878108
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DLG4,Disks large homolog 4,19617,166,1.04 [0.84-1.28],0.7324237743662941
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DLGAP5,Disks large-associated protein 5,19611,164,1.13 [0.88-1.45],0.3295158607351748
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DLK1,Protein delta homolog 1,22865,212,0.93 [0.74-1.16],0.4978848137229344
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DLL1,Delta-like protein 1,22673,210,1.64 [1.12-2.41],0.0110353834911188
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DLL4,Delta-like protein 4,19166,163,0.88 [0.70-1.11],0.2802406003340796
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DMD,Dystrophin,19166,163,1.26 [0.97-1.62],0.0826881605472572
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DMP1,Dentin matrix acidic phosphoprotein 1,19166,163,0.81 [0.65-1.02],0.0730915746136114
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DNAJA1,DnaJ homolog subfamily A member 1,18946,158,0.88 [0.62-1.26],0.4990688736766078
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DNAJA2,DnaJ homolog subfamily A member 2,22736,212,1.08 [0.93-1.26],0.287910267291619
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DNAJA4,DnaJ homolog subfamily A member 4,19617,166,0.83 [0.67-1.02],0.071938030546147
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DNAJB1,DnaJ homolog subfamily B member 1,22474,209,0.98 [0.85-1.13],0.7830838290748
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DNAJB14,DnaJ homolog subfamily B member 14,19559,166,1.06 [0.84-1.33],0.6418367811130612
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DNAJB2,DnaJ homolog subfamily B member 2,19241,159,0.87 [0.65-1.16],0.349841427278297
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DNAJB6,DnaJ homolog subfamily B member 6,19058,158,1.00 [0.83-1.21],0.977973740557013
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DNAJB8,DnaJ homolog subfamily B member 8,22162,199,1.08 [0.88-1.33],0.4471603978020146
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DNAJC21,DnaJ homolog subfamily C member 21,19617,166,0.81 [0.54-1.22],0.3219100522818691
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DNAJC6,Putative tyrosine-protein phosphatase auxilin,19166,163,1.00 [0.83-1.20],0.9831252581866438
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DNAJC9,DnaJ homolog subfamily C member 9,19559,166,0.94 [0.77-1.14],0.5081527727972059
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DNER,Delta and Notch-like epidermal growth factor-related receptor,22528,205,0.69 [0.42-1.13],0.1430548020957527
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DNLZ,DNL-type zinc finger protein,19004,158,1.04 [0.89-1.23],0.5998187189608974
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DNM1,Dynamin-1,19559,166,1.02 [0.90-1.16],0.7513809887571083
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DNM3,Dynamin-3,19611,164,1.05 [0.80-1.38],0.73077914973993
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DNMBP,Dynamin-binding protein,22387,210,1.14 [0.94-1.39],0.1802288007895754
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DNPEP,Aspartyl aminopeptidase,19617,166,1.16 [0.89-1.51],0.2836353138409865
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,22646,208,0.92 [0.72-1.16],0.4649781538824562
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DOC2B,Double C2-like domain-containing protein beta,19122,159,1.24 [0.87-1.78],0.2326859966664852
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DOCK9,Dedicator of cytokinesis protein 9,19004,158,0.94 [0.82-1.08],0.4029446737098484
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DOK1,Docking protein 1,19617,166,1.02 [0.91-1.14],0.7642659873200673
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DOK2,Docking protein 2,22584,212,1.05 [0.95-1.16],0.3800667221848388
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DPEP1,Dipeptidase 1,22352,210,0.80 [0.63-1.02],0.073680950679985
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DPEP2,Dipeptidase 2,22474,209,0.95 [0.63-1.45],0.8258755588556812
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DPP10,Inactive dipeptidyl peptidase 10,22522,211,1.05 [0.75-1.48],0.7591469360546661
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DPP4,Dipeptidyl peptidase 4,22207,209,0.82 [0.53-1.28],0.3790280425954137
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DPP6,Dipeptidyl aminopeptidase-like protein 6,22474,209,1.03 [0.72-1.49],0.8539166726927991
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DPP7,Dipeptidyl peptidase 2,22415,212,1.09 [0.89-1.33],0.4027887016881637
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DPT,Dermatopontin,22865,212,1.14 [0.70-1.86],0.6028531274630928
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DPY30,Protein dpy-30 homolog,22679,209,1.22 [1.01-1.47],0.0418687485418255
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DRAXIN,Draxin,22387,210,1.19 [0.90-1.57],0.2300792950061093
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DRG2,Developmentally-regulated GTP-binding protein 2,22474,209,1.10 [0.89-1.37],0.366259694563632
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DSC2,Desmocollin-2,22384,207,1.78 [1.29-2.45],0.0004160033692827
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DSCAM,Down syndrome cell adhesion molecule,19611,164,0.79 [0.52-1.21],0.2724773460520595
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DSG2,Desmoglein-2,22610,209,1.42 [0.92-2.20],0.1161206749561143
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DSG3,Desmoglein-3,22676,209,1.20 [0.85-1.71],0.3067141087623914
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DSG4,Desmoglein-4,22407,209,0.93 [0.73-1.19],0.5602883264877787
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DTD1,D-aminoacyl-tRNA deacylase 1,19241,159,1.10 [0.93-1.32],0.2733155978519208
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DTNB,Dystrobrevin beta,19517,167,1.47 [1.06-2.04],0.0204486409710106
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DTX2,Probable E3 ubiquitin-protein ligase DTX2,19122,159,1.05 [0.83-1.33],0.66379290687852
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DTX3,Probable E3 ubiquitin-protein ligase DTX3,22474,209,1.23 [0.76-2.00],0.4026918504364899
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DTYMK,Thymidylate kinase,19653,166,0.99 [0.79-1.23],0.9011690201028648
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DUOX2,Dual oxidase 2,22162,199,0.98 [0.82-1.17],0.7866830706062276
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DUSP13,Dual specificity protein phosphatase 13 isoform A,19559,167,0.76 [0.52-1.11],0.1604271763465265
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DUSP29,Dual specificity phosphatase 29,19122,159,1.11 [0.90-1.37],0.3231484045229226
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DUSP3,Dual specificity protein phosphatase 3,22060,200,1.01 [0.88-1.17],0.8638615334562842
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",19559,166,1.02 [0.88-1.18],0.7657971892023925
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DXO,Decapping and exoribonuclease protein,19617,166,1.10 [0.80-1.53],0.5557764525034566
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,19559,167,1.17 [0.89-1.54],0.268128019041694
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DYNLT1,Dynein light chain Tctex-type 1,19122,159,0.98 [0.81-1.19],0.846370831675671
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),DYNLT3,Dynein light chain Tctex-type 3,19559,167,0.93 [0.66-1.31],0.6966616713155943
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,22387,210,1.09 [0.96-1.25],0.1690954037745939
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EBI3_IL27,Interleukin-27,22724,210,1.36 [0.91-2.02],0.1296234278343561
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ECE1,Endothelin-converting enzyme 1,22060,200,1.56 [1.17-2.08],0.002657610091857
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",19653,166,1.16 [0.96-1.41],0.1239744568029125
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ECHS1,"Enoyl-CoA hydratase, mitochondrial",19166,163,1.12 [0.96-1.31],0.1512224013946261
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ECI2,Enoyl-CoA delta isomerase 2,18980,160,0.99 [0.77-1.27],0.943449889359294
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ECM1,Extracellular matrix protein 1,19165,161,0.82 [0.55-1.20],0.3026618290192783
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ECSCR,Endothelial cell-specific chemotaxis regulator,19004,158,0.94 [0.68-1.28],0.6790594099399867
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EDA2R,Tumor necrosis factor receptor superfamily member 27,22761,210,1.81 [1.36-2.41],4.775764432156295e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EDAR,Tumor necrosis factor receptor superfamily member EDAR,22522,211,1.01 [0.88-1.15],0.9260066362914692
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EDDM3B,Epididymal secretory protein E3-beta,19559,167,0.97 [0.72-1.29],0.8175327864631847
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,18980,160,1.19 [0.83-1.71],0.3528184557917302
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EDF1,Endothelial differentiation-related factor 1,19611,164,0.95 [0.76-1.19],0.6691483507630118
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,22162,199,1.24 [0.86-1.79],0.2511151589587088
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EDN1,Endothelin-1,19166,163,0.99 [0.59-1.65],0.9703928442327058
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EDNRB,Endothelin receptor type B,19069,160,0.95 [0.66-1.37],0.7817584797081386
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EEF1D,Elongation factor 1-delta,19653,166,1.05 [0.89-1.23],0.5499324325358714
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EFCAB14,EF-hand calcium-binding domain-containing protein 14,19559,166,1.12 [0.68-1.85],0.6521288580905239
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EFCAB2,Dynein regulatory complex protein 8,19299,165,1.18 [0.78-1.79],0.4337648380764355
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,22677,212,1.71 [1.18-2.48],0.0048943506502597
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EFHD1,EF-hand domain-containing protein D1,19611,164,1.33 [0.90-1.95],0.1493224393688249
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EFNA1,Ephrin-A1,22578,209,2.34 [1.62-3.39],6.097845429560946e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EFNA4,Ephrin-A4,22352,209,2.19 [1.61-2.96],4.75336738080647e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EFNB2,Ephrin-B2,19122,159,1.10 [0.86-1.42],0.4431993507247515
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EGF,Pro-epidermal growth factor,22537,205,1.07 [0.95-1.20],0.2947759540301516
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EGFL7,Epidermal growth factor-like protein 7,22080,202,1.18 [0.87-1.59],0.2887294204047665
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EGFLAM,Pikachurin,19559,166,1.47 [0.97-2.24],0.0697988867119341
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EGFR,Epidermal growth factor receptor,22865,212,0.33 [0.16-0.67],0.0024546696204657
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EGLN1,Egl nine homolog 1,22522,211,1.02 [0.82-1.26],0.8752604650251556
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EHBP1,EH domain-binding protein 1,19653,166,1.06 [0.87-1.29],0.5590620844941778
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EHD3,EH domain-containing protein 3,19166,163,0.96 [0.84-1.09],0.5091711593266475
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",19617,166,1.02 [0.78-1.33],0.8854943334486851
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",19472,164,1.02 [0.89-1.17],0.7597738995352901
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,18980,160,0.96 [0.76-1.21],0.7279571465212609
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,19166,163,1.01 [0.70-1.45],0.9779834179805412
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EIF4B,Eukaryotic translation initiation factor 4B,22387,210,1.17 [0.94-1.45],0.1644381200590341
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EIF4E,Eukaryotic translation initiation factor 4E,19069,160,1.01 [0.85-1.20],0.8835936488503717
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,22584,212,0.99 [0.82-1.20],0.9552710895172968
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,22801,212,1.09 [0.96-1.24],0.171045635937873
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,19611,164,1.07 [0.86-1.34],0.5328146024969445
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EIF5,Eukaryotic translation initiation factor 5,18980,160,0.99 [0.69-1.40],0.9373636074293336
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EIF5A,Eukaryotic translation initiation factor 5A-1,22144,200,0.97 [0.63-1.48],0.8733104699175046
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ELAC1,Zinc phosphodiesterase ELAC protein 1,19611,164,1.08 [0.91-1.29],0.3817329175190488
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ELAVL4,ELAV-like protein 4,19004,158,1.10 [0.92-1.30],0.2974414558034913
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ELN,Elastin,19653,166,1.15 [0.76-1.74],0.5094223657207375
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ELOA,Elongin-A,22474,209,1.05 [0.85-1.30],0.6554220545731043
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ELOB,Elongin-B,18980,160,1.53 [1.20-1.95],0.000518704075991
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENAH,Protein enabled homolog,22144,200,1.33 [1.04-1.70],0.0249255279104908
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENDOU,Poly(U)-specific endoribonuclease,18128,154,0.76 [0.56-1.03],0.0732301896066759
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENG,Endoglin,22865,212,0.70 [0.35-1.42],0.3208991139595843
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENO1,Alpha-enolase,22564,208,1.09 [0.93-1.28],0.2783663094219677
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENO2,Gamma-enolase,22765,209,1.16 [0.96-1.40],0.1186470057906302
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENO3,Beta-enolase,19166,163,0.88 [0.67-1.16],0.3523324263158912
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENOPH1,Enolase-phosphatase E1,19559,167,0.82 [0.59-1.14],0.23085623210692
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENOX2,Ecto-NOX disulfide-thiol exchanger 2,18980,160,0.58 [0.32-1.04],0.0693960200066785
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENPEP,Glutamyl aminopeptidase,18980,160,1.09 [0.80-1.48],0.581734749627969
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,22865,212,1.46 [0.95-2.24],0.0868699309140086
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,22676,208,0.88 [0.67-1.16],0.3673612171175993
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,19166,163,1.13 [0.75-1.72],0.5567700461532161
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,21825,204,1.01 [0.87-1.17],0.8690970667166203
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENSA,Alpha-endosulfine,19559,167,1.26 [0.99-1.61],0.0588481677072984
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,22080,202,1.34 [1.02-1.76],0.0369923619847546
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,22162,199,1.39 [0.77-2.53],0.2765677512532198
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,22162,199,1.44 [0.88-2.34],0.1450668081778863
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ENTR1,Endosome-associated-trafficking regulator 1,19166,163,0.97 [0.74-1.26],0.7938284620384309
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EP300,Histone acetyltransferase p300,19069,160,0.96 [0.59-1.57],0.8663722265534388
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EPB41L5,Band 4.1-like protein 5,19122,159,0.89 [0.69-1.16],0.4066845735138807
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EPCAM,Epithelial cell adhesion molecule,22559,205,1.06 [0.93-1.20],0.3900955254746961
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EPGN,Epigen,19559,167,0.93 [0.65-1.33],0.6972843824202068
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EPHA1,Ephrin type-A receptor 1,22646,208,1.48 [1.01-2.16],0.043307655687543
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EPHA10,Ephrin type-A receptor 10,22060,200,0.96 [0.78-1.17],0.6548905036348179
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EPHA2,Ephrin type-A receptor 2,21758,196,1.71 [1.21-2.39],0.0020579443285415
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EPHA4,Ephrin type-A receptor 4,19241,159,0.93 [0.55-1.57],0.7783875229373508
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EPHB4,Ephrin type-B receptor 4,22865,212,2.17 [1.42-3.33],0.0003863617881775
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EPHB6,Ephrin type-B receptor 6,22352,210,1.32 [0.92-1.91],0.1341874353780995
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EPHX2,Bifunctional epoxide hydrolase 2,22162,199,0.94 [0.76-1.16],0.5360508848326224
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EPN1,Epsin-1,19299,165,1.04 [0.75-1.46],0.8011315665323653
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EPO,Erythropoietin,22522,211,1.00 [0.85-1.18],0.9790504375547622
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EPPK1,Epiplakin,19166,163,1.01 [0.82-1.24],0.9281100631692908
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,22716,209,1.55 [1.06-2.27],0.0222208328221897
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ERBB2,Receptor tyrosine-protein kinase erbB-2,22673,210,1.13 [0.67-1.90],0.6400747438566863
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ERBB3,Receptor tyrosine-protein kinase erbB-3,22507,205,1.00 [0.52-1.91],0.999316226722514
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ERBB4,Receptor tyrosine-protein kinase erbB-4,22673,210,0.93 [0.55-1.55],0.7731914334428168
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ERBIN,Erbin,22474,209,1.07 [0.95-1.20],0.2997163538749499
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ERC2,ERC protein 2,19122,159,0.93 [0.75-1.16],0.5239340612425951
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ERCC1,DNA excision repair protein ERCC-1,18946,158,0.97 [0.61-1.55],0.904775227615038
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EREG,Proepiregulin,22352,210,1.07 [0.92-1.24],0.3725085323531586
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ERI1,3'-5' exoribonuclease 1,19299,165,0.88 [0.56-1.39],0.583524163028502
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ERMAP,Erythroid membrane-associated protein,19069,160,0.97 [0.68-1.37],0.8593603076425945
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,19559,167,1.14 [0.78-1.67],0.5042165946240423
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ERP29,Endoplasmic reticulum resident protein 29,19241,159,1.05 [0.92-1.19],0.4999142132267599
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ERP44,Endoplasmic reticulum resident protein 44,22431,209,1.11 [0.69-1.80],0.655483667475053
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ERVV-1,Endogenous retrovirus group V member 1 Env polyprotein,18980,160,0.74 [0.50-1.10],0.1327604612730264
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ESAM,Endothelial cell-selective adhesion molecule,22865,212,1.68 [1.17-2.42],0.0046790705636211
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ESM1,Endothelial cell-specific molecule 1,22569,205,0.92 [0.64-1.32],0.653834851078382
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ESPL1,Separin,18946,158,1.04 [0.81-1.34],0.7579489448931721
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ESR1,Estrogen receptor,19069,160,1.05 [0.80-1.37],0.7186247397397831
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ESYT2,Extended synaptotagmin-2,19617,166,1.07 [0.89-1.28],0.467396176103698
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EVI2B,Protein EVI2B,18946,158,0.92 [0.61-1.39],0.6906709610129711
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EVI5,Ecotropic viral integration site 5 protein homolog,19069,160,0.99 [0.83-1.17],0.8946039192858819
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EVPL,Envoplakin,19299,165,1.28 [0.87-1.89],0.2033630621711273
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EXOSC10,Exosome component 10,18980,160,0.79 [0.58-1.08],0.134711947966955
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EXTL1,Exostosin-like 1,18980,160,0.87 [0.61-1.23],0.424540055310478
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),EZR,Ezrin,22765,209,1.03 [0.62-1.70],0.9208269720817438
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),F10,Coagulation factor X,19664,165,0.94 [0.55-1.62],0.8335057846511332
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),F11,Coagulation factor XI,19404,162,1.52 [1.02-2.27],0.0398623272582979
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),F11R,Junctional adhesion molecule A,22610,209,1.29 [1.04-1.59],0.020154593236913
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),F12,Coagulation factor XII,19683,165,1.15 [0.80-1.66],0.4462450602237007
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),F13B,Coagulation factor XIII B chain,19571,164,0.86 [0.48-1.54],0.6059269041691674
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),F2,Prothrombin,19683,165,0.69 [0.26-1.84],0.4571383954082421
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),F2R,Proteinase-activated receptor 1,22636,206,1.33 [1.07-1.66],0.0092389512034592
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),F3,Tissue factor,22627,210,1.50 [0.96-2.32],0.072538950786182
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),F7,Coagulation factor VII,22669,212,1.14 [0.76-1.70],0.5256592213355964
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),F9,Coagulation factor IX,22659,212,1.19 [0.61-2.35],0.6069403688056201
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FABP1,"Fatty acid-binding protein, liver",22569,205,1.34 [1.19-1.51],2.178387352179046e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FABP2,"Fatty acid-binding protein, intestinal",22584,212,1.27 [1.10-1.47],0.0009844653982823
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FABP3,"Fatty acid-binding protein, heart",19653,166,1.43 [1.10-1.86],0.0073815068897776
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FABP4,"Fatty acid-binding protein, adipocyte",22865,212,1.28 [1.01-1.61],0.0370750713505917
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FABP5,Fatty acid-binding protein 5,22680,209,1.24 [1.04-1.47],0.0150650534490251
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FABP6,Gastrotropin,22121,197,1.20 [0.98-1.46],0.0759018160171272
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FABP9,Fatty acid-binding protein 9,22522,211,1.08 [0.87-1.34],0.4796539404736232
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FADD,FAS-associated death domain protein,22584,212,1.06 [0.90-1.24],0.4877312371587994
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FAM13A,Protein FAM13A,19559,166,1.07 [0.86-1.34],0.5330148248063387
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FAM171A2,Protein FAM171A2,19611,164,0.97 [0.88-1.07],0.4979608236080415
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FAM171B,Protein FAM171B,19559,167,1.13 [0.68-1.87],0.6493421808277535
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FAM172A,Cotranscriptional regulator FAM172A,19166,163,1.04 [0.81-1.33],0.7595796540859434
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FAM20A,Pseudokinase FAM20A,19653,166,1.05 [0.62-1.78],0.8534451259615992
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FAM3B,Protein FAM3B,22474,209,1.73 [1.20-2.47],0.0030424820601655
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FAM3C,Protein FAM3C,22541,212,2.02 [1.38-2.95],0.0002877957662704
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FAM3D,Protein FAM3D,19559,166,1.15 [0.97-1.37],0.1163996651787507
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FAP,Prolyl endopeptidase FAP,22865,212,0.59 [0.38-0.92],0.019752741643435
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FARSA,Phenylalanine--tRNA ligase alpha subunit,19122,159,0.91 [0.72-1.15],0.4348630807245303
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FAS,Tumor necrosis factor receptor superfamily member 6,22799,212,1.51 [1.18-1.94],0.0011973652106688
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FASLG,Tumor necrosis factor ligand superfamily member 6,22801,212,0.93 [0.67-1.29],0.6730619582478853
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FBLN2,Fibulin-2,19664,164,0.98 [0.61-1.57],0.9398710695280192
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FBN2,Fibrillin-2,19122,159,0.93 [0.72-1.21],0.5900918010378937
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FBP1,"Fructose-1,6-bisphosphatase 1",22584,212,1.05 [0.89-1.24],0.5606756539515585
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,19653,166,1.04 [0.85-1.27],0.7071175999360235
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FCAR,Immunoglobulin alpha Fc receptor,22522,211,0.94 [0.73-1.21],0.6470586981202237
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,19611,164,1.09 [0.59-2.03],0.7859337802776788
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FCER2,Low affinity immunoglobulin epsilon Fc receptor,22610,209,0.88 [0.69-1.12],0.2874095127279654
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,22514,211,1.00 [0.81-1.22],0.9859787002422352
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,22080,202,1.17 [0.95-1.44],0.1378528533642758
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,22633,212,1.19 [0.93-1.53],0.1671754201877341
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FCN1,Ficolin-1,19619,165,0.87 [0.68-1.11],0.2644261306556584
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FCN2,Ficolin-2,22516,210,1.07 [0.79-1.45],0.6742526903440416
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FCRL1,Fc receptor-like protein 1,22584,212,0.94 [0.72-1.22],0.637507505183907
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FCRL2,Fc receptor-like protein 2,22685,210,1.22 [0.98-1.51],0.0723034120080273
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FCRL3,Fc receptor-like protein 3,22144,200,1.17 [0.94-1.45],0.1630563876486103
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FCRL5,Fc receptor-like protein 5,22610,209,0.91 [0.74-1.13],0.4069586489537379
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FCRL6,Fc receptor-like protein 6,22522,211,1.08 [0.91-1.29],0.3623604850328292
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FCRLB,Fc receptor-like B,22080,202,1.12 [0.93-1.34],0.2218343764891534
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FDX1,"Adrenodoxin, mitochondrial",18980,160,1.10 [0.88-1.39],0.3912991270532281
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FDX2,"Ferredoxin-2, mitochondrial",18980,160,0.98 [0.75-1.29],0.9057426120261332
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FEN1,Flap endonuclease 1,22080,202,1.02 [0.85-1.23],0.8050923740222196
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FES,Tyrosine-protein kinase Fes/Fps,22080,202,0.91 [0.69-1.19],0.4799062069258204
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FETUB,Fetuin-B,22659,212,1.06 [0.72-1.56],0.7635041814261329
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGA,Fibrinogen alpha chain,19226,162,0.53 [0.32-0.87],0.0126347328363812
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",19611,164,1.02 [0.85-1.23],0.8368546333784741
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGF12,Fibroblast growth factor 12,19069,160,0.85 [0.57-1.26],0.4134957242209882
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGF16,Fibroblast growth factor 16,19069,160,0.94 [0.68-1.32],0.7395699271991127
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGF19,Fibroblast growth factor 19,22676,208,0.97 [0.83-1.13],0.6917665246007194
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGF2,Fibroblast growth factor 2,22522,211,1.21 [1.02-1.43],0.0292640819952509
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGF20,Fibroblast growth factor 20,19069,160,0.71 [0.47-1.08],0.1129457069411263
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGF21,Fibroblast growth factor 21,22724,210,1.08 [0.97-1.20],0.1434020284567015
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGF23,Fibroblast growth factor 23,22728,210,1.25 [1.02-1.53],0.0283265200549275
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGF3,Fibroblast growth factor 3,19069,160,0.56 [0.30-1.06],0.0736908402582343
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGF5,Fibroblast growth factor 5,22144,200,1.51 [1.06-2.16],0.0230045298224468
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGF6,Fibroblast growth factor 6,19069,160,0.87 [0.57-1.31],0.493903709716559
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGF7,Fibroblast growth factor 7,18946,158,0.91 [0.74-1.13],0.412912733180955
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGF9,Fibroblast growth factor 9,18916,158,0.72 [0.51-1.03],0.0697872467255088
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGFBP1,Fibroblast growth factor-binding protein 1,22673,210,0.58 [0.40-0.84],0.0039159268282445
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGFBP2,Fibroblast growth factor-binding protein 2,19664,164,0.87 [0.64-1.17],0.3530358653417358
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGFBP3,Fibroblast growth factor-binding protein 3,19617,166,0.84 [0.56-1.26],0.3903456221221859
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGFR2,Fibroblast growth factor receptor 2,22673,210,1.67 [0.98-2.85],0.060543965081435
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGFR4,Fibroblast growth factor receptor 4,19241,159,1.07 [0.80-1.42],0.6566409353220845
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGL1,Fibrinogen-like protein 1,19664,165,1.39 [1.11-1.74],0.0041512436522032
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FGR,Tyrosine-protein kinase Fgr,22060,200,1.10 [0.91-1.33],0.3099029173836993
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FH,"Fumarate hydratase, mitochondrial",19004,158,1.01 [0.84-1.21],0.923739468551053
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FHIP2A,FHF complex subunit HOOK interacting protein 2A,18980,160,1.14 [0.86-1.50],0.3651102362997606
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FHIT,Bis(5'-adenosyl)-triphosphatase,22060,200,1.04 [0.88-1.24],0.6170615566183166
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FIS1,Mitochondrial fission 1 protein,22580,208,1.09 [0.93-1.28],0.2763669492152677
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,19611,164,1.10 [0.95-1.28],0.2123541777506148
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,22620,206,1.06 [0.95-1.18],0.3084955069570236
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,22387,210,1.25 [0.94-1.66],0.1297470063595883
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,22387,210,1.13 [0.99-1.30],0.0614915039635569
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,22025,200,1.16 [0.92-1.46],0.2032228562974138
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FKBPL,FK506-binding protein-like,19559,166,1.10 [0.86-1.42],0.4495434404505346
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FLI1,Friend leukemia integration 1 transcription factor,22080,202,1.12 [1.00-1.25],0.0424035796844678
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FLRT2,Leucine-rich repeat transmembrane protein FLRT2,22387,210,1.64 [1.08-2.50],0.0207721925456225
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FLT1,Vascular endothelial growth factor receptor 1,22437,208,0.90 [0.51-1.60],0.7180545401462551
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FLT3,Receptor-type tyrosine-protein kinase FLT3,22080,202,1.05 [0.71-1.57],0.7999867991506843
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FLT3LG,Fms-related tyrosine kinase 3 ligand,22801,212,0.98 [0.69-1.40],0.9180882413084904
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FLT4,Vascular endothelial growth factor receptor 3,22673,210,0.99 [0.69-1.43],0.9625383661716408
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FMNL1,Formin-like protein 1,22060,200,1.08 [0.91-1.29],0.360613682305503
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FMR1,Synaptic functional regulator FMR1,22080,202,1.25 [0.88-1.77],0.218261604073455
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FN1,Fibronectin,19683,165,0.91 [0.52-1.60],0.7446039295857794
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FNDC1,Fibronectin type III domain-containing protein 1,19617,166,1.07 [0.78-1.48],0.6632169775755912
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,19559,167,1.15 [0.77-1.73],0.4922491255441303
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FOLH1,Glutamate carboxypeptidase 2,19069,160,1.07 [0.94-1.23],0.3050441231393583
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FOLR1,Folate receptor alpha,22574,209,1.44 [0.97-2.14],0.0721106818638179
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FOLR2,Folate receptor beta,22765,209,1.88 [1.26-2.82],0.0022042795794068
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FOLR3,Folate receptor gamma,22602,210,1.01 [0.94-1.07],0.850320776910736
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FOS,Proto-oncogene c-Fos,18916,158,0.94 [0.61-1.44],0.7670262793709581
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FOSB,Protein fosB,22060,200,0.99 [0.71-1.37],0.9281130206708618
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FOXJ3,Forkhead box protein J3,19069,160,1.02 [0.72-1.43],0.9235895252983026
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FOXO1,Forkhead box protein O1,22522,211,1.03 [0.89-1.18],0.7323481252446042
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FOXO3,Forkhead box protein O3,22080,202,1.06 [0.93-1.21],0.3980062857321479
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FRMD4B,FERM domain-containing protein 4B,18980,160,1.00 [0.80-1.24],0.981369500779309
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FRMD7,FERM domain-containing protein 7,19122,159,0.71 [0.45-1.11],0.134829872625508
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FRZB,Secreted frizzled-related protein 3,22318,208,0.66 [0.41-1.07],0.0900730612638605
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FSHB,Follitropin subunit beta,19166,163,1.09 [0.83-1.43],0.5431101730207311
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FST,Follistatin,22636,206,1.00 [0.78-1.29],0.9952772780936476
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FSTL1,Follistatin-related protein 1,19166,163,1.24 [0.63-2.42],0.5350920958656671
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FSTL3,Follistatin-related protein 3,22529,205,1.89 [1.34-2.67],0.0003118284190168
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FTCD,Formimidoyltransferase-cyclodeaminase,19575,166,1.07 [0.90-1.27],0.4694433136106619
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FUCA1,Tissue alpha-L-fucosidase,22743,211,0.96 [0.83-1.10],0.548228731789351
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FUOM,Fucose mutarotase,19241,159,1.14 [0.90-1.45],0.2693300821266042
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FURIN,Furin,22673,210,0.99 [0.68-1.44],0.940755432745149
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FUS,RNA-binding protein FUS,22048,202,1.16 [0.86-1.58],0.3264543183216029
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",19258,165,1.01 [0.80-1.28],0.9446363178822716
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,22765,209,1.02 [0.78-1.32],0.90385598062503
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FUT8,"Alpha-(1,6)-fucosyltransferase",22387,210,1.05 [0.85-1.29],0.6545462925015696
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FXN,"Frataxin, mitochondrial",22761,210,1.12 [0.95-1.32],0.1889901139680326
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FXYD5,FXYD domain-containing ion transport regulator 5,22144,200,1.18 [0.99-1.42],0.0707404295574826
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FYB1,FYN-binding protein 1,22567,209,1.09 [0.96-1.25],0.1934440210598209
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FZD10,Frizzled-10,19122,159,1.10 [0.87-1.38],0.4415721633875031
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),FZD8,Frizzled-8,19004,158,1.24 [0.92-1.66],0.1568968347722602
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GABARAP,Gamma-aminobutyric acid receptor-associated protein,19559,167,1.03 [0.77-1.39],0.8364603689836697
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,19299,165,1.00 [0.79-1.26],0.9819993873116712
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,19004,158,0.85 [0.65-1.12],0.2384337633032525
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GAD1,Glutamate decarboxylase 1,18946,158,0.83 [0.46-1.50],0.5342365638813302
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GAD2,Glutamate decarboxylase 2,19069,160,0.86 [0.60-1.24],0.4241473688048088
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,19299,165,0.93 [0.67-1.30],0.6819194270782533
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,19166,163,1.03 [0.77-1.37],0.8388007517856657
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GAGE2A,G antigen 2A,18946,158,0.99 [0.79-1.26],0.9541418675424737
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GAL,Galanin peptides,22676,208,0.87 [0.72-1.06],0.1659558864169135
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,22474,209,1.57 [1.02-2.43],0.0420840917616122
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,22761,210,0.58 [0.37-0.91],0.017325598182625
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,22144,200,1.02 [0.76-1.37],0.8926325471027972
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,19653,166,1.22 [0.73-2.04],0.4535201408965317
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GALNT7,N-acetylgalactosaminyltransferase 7,22474,209,1.01 [0.57-1.81],0.9622338948538636
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GAMT,Guanidinoacetate N-methyltransferase,18980,160,0.90 [0.58-1.39],0.6266139766963981
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,18804,155,1.13 [0.69-1.84],0.6355424134443972
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GART,Trifunctional purine biosynthetic protein adenosine-3,19611,164,0.92 [0.52-1.64],0.7868656866695245
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GAS2,Growth arrest-specific protein 2,19299,165,1.07 [0.82-1.41],0.6096770189689746
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GAS6,Growth arrest-specific protein 6,22734,212,2.07 [1.28-3.35],0.0031200547093429
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GASK1A,Golgi-associated kinase 1A,18980,160,1.03 [0.72-1.47],0.85535084351489
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GAST,Gastrin,19617,166,1.07 [0.97-1.18],0.1874196611686407
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GATA3,Trans-acting T-cell-specific transcription factor GATA-3,18946,158,0.84 [0.47-1.51],0.5660271744084785
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",19166,163,1.08 [0.88-1.31],0.4624069042736245
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GBA,Lysosomal acid glucosylceramidase,19122,159,0.89 [0.67-1.19],0.4372092289008166
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GBP1,Guanylate-binding protein 1,19583,166,1.08 [0.86-1.36],0.4996237093743557
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GBP2,Guanylate-binding protein 2,22144,200,1.05 [0.85-1.29],0.6756587371642718
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GBP4,Guanylate-binding protein 4,22060,200,1.29 [1.02-1.63],0.0309917922996466
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GBP6,Guanylate-binding protein 6,18980,160,0.83 [0.56-1.22],0.3322637651285212
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GC,Vitamin D-binding protein,19683,165,0.93 [0.52-1.66],0.8048709102908225
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GCC1,GRIP and coiled-coil domain-containing protein 1,19617,166,1.01 [0.88-1.16],0.8567720298293338
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GCG,Pro-glucagon,22080,202,1.09 [0.99-1.21],0.0717947093544306
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,18766,153,1.02 [0.74-1.40],0.9230502872526212
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GCLM,Glutamate--cysteine ligase regulatory subunit,18980,160,0.92 [0.65-1.30],0.6404187994558861
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",22474,209,1.48 [1.05-2.09],0.0255206102646194
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GDF15,Growth/differentiation factor 15,22865,212,1.95 [1.58-2.41],6.702755265285281e-10
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GDF2,Growth/differentiation factor 2,22584,212,0.91 [0.65-1.28],0.5835562244313839
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GDNF,Glial cell line-derived neurotrophic factor,22060,200,1.29 [0.95-1.76],0.102399646404674
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GET3,ATPase GET3,19653,166,0.97 [0.73-1.27],0.805610876198923
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GFAP,Glial fibrillary acidic protein,22042,202,1.44 [1.14-1.83],0.002563008789932
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GFER,FAD-linked sulfhydryl oxidase ALR,22080,202,1.23 [1.01-1.49],0.0381647372776072
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,22080,202,0.93 [0.82-1.04],0.1971697639603301
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GFRA1,GDNF family receptor alpha-1,22724,210,2.24 [1.52-3.31],5.0818141494602805e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GFRA2,GDNF family receptor alpha-2,22474,209,1.12 [0.63-2.00],0.6919769823878055
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GFRA3,GDNF family receptor alpha-3,22323,210,1.22 [0.80-1.87],0.3523992187295662
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GFRAL,GDNF family receptor alpha-like,19019,160,0.96 [0.75-1.24],0.7700714291734572
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GGA1,ADP-ribosylation factor-binding protein GGA1,22060,200,1.07 [0.89-1.28],0.4867461515279907
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GGACT,Gamma-glutamylaminecyclotransferase,19653,166,1.13 [0.92-1.39],0.2414383789492148
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GGCT,Gamma-glutamylcyclotransferase,19614,166,1.01 [0.74-1.38],0.969189910279273
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GGH,Gamma-glutamyl hydrolase,22252,209,0.79 [0.55-1.13],0.1985026119092951
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GGT1,Glutathione hydrolase 1 proenzyme,22578,209,1.41 [1.13-1.76],0.0021745986312981
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GGT5,Glutathione hydrolase 5 proenzyme,22387,210,1.72 [1.04-2.86],0.0358822005776112
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GH1,Somatotropin,22541,212,1.05 [0.98-1.12],0.1837351776375104
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GH2,Growth hormone variant,22080,202,0.98 [0.91-1.06],0.6521956646723461
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GHR,Growth hormone receptor,19241,159,0.44 [0.26-0.76],0.0029230841933675
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GHRHR,Growth hormone-releasing hormone receptor,22060,200,1.06 [0.85-1.31],0.6180882131188472
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GHRL,Appetite-regulating hormone,22584,212,0.97 [0.84-1.12],0.6859464324449406
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GID8,Glucose-induced degradation protein 8 homolog,19611,164,0.97 [0.61-1.53],0.8797368943350242
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GIGYF2,GRB10-interacting GYF protein 2,19611,164,1.06 [0.87-1.29],0.5597415740546579
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GIMAP7,GTPase IMAP family member 7,19241,159,0.87 [0.53-1.44],0.5942815161322406
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GIMAP8,GTPase IMAP family member 8,18946,158,1.16 [0.89-1.51],0.2798732130293841
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GIP,Gastric inhibitory polypeptide,19166,163,0.91 [0.70-1.18],0.4631583442095353
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GIPC2,PDZ domain-containing protein GIPC2,19617,166,1.13 [0.70-1.83],0.6047467562431819
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GIPC3,PDZ domain-containing protein GIPC3,19559,166,1.06 [0.91-1.23],0.4866360867489347
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GIPR,Gastric inhibitory polypeptide receptor,19069,160,0.79 [0.55-1.15],0.2200003358936353
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GIT1,ARF GTPase-activating protein GIT1,19069,160,0.95 [0.81-1.12],0.5633523269689933
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GJA8,Gap junction alpha-8 protein,18946,158,0.87 [0.66-1.13],0.2969459184328773
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GKN1,Gastrokine-1,21640,195,1.59 [1.03-2.44],0.0369389359806066
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GLA,Alpha-galactosidase A,19213,159,1.25 [0.84-1.88],0.2761070355117863
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GLB1,Beta-galactosidase,22387,210,1.25 [0.93-1.67],0.1337742744983041
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GLI2,Zinc finger protein GLI2,19069,160,1.04 [0.64-1.69],0.8727186703176557
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GLO1,Lactoylglutathione lyase,22162,199,0.92 [0.74-1.14],0.4535440017440013
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GLOD4,Glyoxalase domain-containing protein 4,22540,206,1.12 [0.79-1.60],0.5167355458377954
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GLP1R,Glucagon-like peptide 1 receptor,19004,158,0.91 [0.60-1.40],0.6770624661442313
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GLRX,Glutaredoxin-1,22433,210,0.81 [0.65-1.00],0.0534734060692546
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GLRX5,"Glutaredoxin-related protein 5, mitochondrial",19241,159,1.00 [0.84-1.19],0.9799280831620292
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GLT8D2,Glycosyltransferase 8 domain-containing protein 2,22060,200,0.88 [0.65-1.20],0.4281505885564269
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GLYR1,Putative oxidoreductase GLYR1,19559,167,1.09 [0.86-1.39],0.4791325812593054
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GM2A,Ganglioside GM2 activator,19164,159,1.06 [0.73-1.55],0.7518484392787487
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GMFG,Glia maturation factor gamma,19653,166,1.05 [0.85-1.29],0.6678724078255931
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GMPR,GMP reductase 1,22801,212,0.92 [0.72-1.17],0.4834223497497533
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GMPR2,GMP reductase 2,19241,159,1.05 [0.84-1.32],0.6692348320295332
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GNAS,Neuroendocrine secretory protein 55,19611,164,0.94 [0.78-1.13],0.5105024492525614
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,22080,202,1.14 [0.95-1.37],0.1589905532919622
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,19122,159,1.05 [0.79-1.39],0.7393724394037233
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GNLY,Granulysin,22610,209,1.05 [0.83-1.32],0.6864958141198849
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GNPDA1,Glucosamine-6-phosphate isomerase 1,19166,163,0.75 [0.45-1.27],0.2844696342908674
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GNPDA2,Glucosamine-6-phosphate isomerase 2,19241,159,1.31 [0.87-1.97],0.1954325252327606
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GOLGA3,Golgin subfamily A member 3,19611,164,1.04 [0.86-1.26],0.6730797056401872
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GOLM2,Protein GOLM2,22765,209,1.57 [0.98-2.52],0.0626215923875195
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,22522,211,1.02 [0.91-1.15],0.7147016411787963
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GORASP2,Golgi reassembly-stacking protein 2,19559,166,1.22 [0.90-1.66],0.1942983971692594
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GOT1,"Aspartate aminotransferase, cytoplasmic",19664,164,1.03 [0.71-1.47],0.8919323135921665
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GP1BA,Platelet glycoprotein Ib alpha chain,22511,210,1.24 [0.86-1.79],0.2506774959670413
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GP1BB,Platelet glycoprotein Ib beta chain,18980,160,1.14 [0.92-1.43],0.2356468041342294
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GP2,Pancreatic secretory granule membrane major glycoprotein GP2,21886,196,1.07 [0.93-1.24],0.3577661608909533
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GP5,Platelet glycoprotein V,19241,159,0.97 [0.64-1.48],0.8883740059370671
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GP6,Platelet glycoprotein VI,22567,209,1.10 [0.95-1.26],0.1997592524256917
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GPA33,Cell surface A33 antigen,22474,209,1.01 [0.93-1.11],0.7464932872927706
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GPC1,Glypican-1,22761,210,1.23 [0.82-1.86],0.3160558327416035
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GPC5,Glypican-5,22387,210,1.06 [0.85-1.31],0.6262941822583309
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GPD1,Glycerol-3-phosphate dehydrogenase,19559,167,1.03 [0.77-1.37],0.8566209793981604
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GPHA2,Glycoprotein hormone alpha-2,19559,166,0.96 [0.68-1.34],0.7883765220196202
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GPI,Glucose-6-phosphate isomerase,19664,165,1.20 [0.88-1.64],0.2424345814151432
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,19559,166,0.93 [0.76-1.13],0.4500185714472434
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GPKOW,G-patch domain and KOW motifs-containing protein,22060,200,1.29 [0.92-1.82],0.1438323698680113
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GPNMB,Transmembrane glycoprotein NMB,21965,209,2.09 [1.37-3.19],0.0006253278714878
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GPR101,Probable G-protein coupled receptor 101,19004,158,0.85 [0.63-1.15],0.2873540007651224
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GPR158,Probable G-protein coupled receptor 158,19611,164,1.00 [0.66-1.52],0.996605450291867
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GPR15L,Protein GPR15L,19559,166,1.37 [1.09-1.73],0.0074857072812105
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GPR37,Prosaposin receptor GPR37,22162,199,1.45 [1.20-1.75],9.165505541296724e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GPRC5C,G-protein coupled receptor family C group 5 member C,19559,167,1.37 [1.10-1.71],0.0045975795175428
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GRAP2,GRB2-related adapter protein 2,22584,212,1.02 [0.93-1.12],0.6840162024234251
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,19653,166,1.06 [0.84-1.34],0.6299523496680062
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GRIK2,"Glutamate receptor ionotropic, kainate 2",19611,164,1.09 [0.79-1.50],0.5988247994305593
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",19004,158,0.83 [0.60-1.15],0.2604730480136119
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GRK5,G protein-coupled receptor kinase 5,22162,199,1.11 [0.87-1.40],0.402967707690935
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GRN,Progranulin,22503,207,1.55 [0.94-2.55],0.0862711417998052
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GRP,Gastrin-releasing peptide,19166,163,1.03 [0.78-1.35],0.8488289224398425
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GRPEL1,"GrpE protein homolog 1, mitochondrial",22474,209,1.40 [1.16-1.68],0.000426775462015
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GRSF1,G-rich sequence factor 1,18847,158,1.01 [0.83-1.22],0.932740024940518
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GSAP,Gamma-secretase-activating protein,22080,202,0.97 [0.83-1.13],0.6748853427071639
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GSN,Gelsolin,19599,164,0.89 [0.42-1.90],0.7647449142351361
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GSR,"Glutathione reductase, mitochondrial",19546,164,1.31 [0.66-2.58],0.4389968556286194
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GSTA1,Glutathione S-transferase A1,22545,212,1.07 [0.93-1.24],0.339992203364139
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GSTA3,Glutathione S-transferase A3,22080,202,1.05 [0.89-1.23],0.5604718060794602
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GSTM4,Glutathione S-transferase Mu 4,18980,160,1.07 [0.88-1.30],0.5106201015194842
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GSTP1,Glutathione S-transferase P,21920,200,1.16 [0.98-1.37],0.0890363477942446
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GSTT2B,Glutathione S-transferase theta-2B,19617,166,1.02 [0.96-1.09],0.5322880897010892
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,19299,165,1.09 [0.90-1.32],0.3641310340484825
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GTPBP2,GTP-binding protein 2,19122,159,0.95 [0.78-1.15],0.606831094342442
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GUCA2A,Guanylin,22495,207,1.84 [1.33-2.54],0.0002367639666232
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GUCY2C,Heat-stable enterotoxin receptor,19299,165,1.05 [0.88-1.25],0.5818839368103907
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GUK1,Guanylate kinase,18980,160,0.93 [0.61-1.41],0.7185734891743858
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GUSB,Beta-glucuronidase,22708,211,1.06 [0.87-1.29],0.5386554838237665
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GYS1,"Glycogen [starch] synthase, muscle",22162,199,1.08 [0.94-1.24],0.2648033286734573
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GZMA,Granzyme A,22801,212,1.13 [0.80-1.59],0.4818232927663836
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GZMB,Granzyme B,22522,211,0.95 [0.79-1.15],0.6088611627139404
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),GZMH,Granzyme H,22162,199,1.00 [0.85-1.18],0.9924050605282824
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),H2AP,Huntingtin-interacting protein M,18946,158,1.20 [0.95-1.52],0.1251609536540101
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",18980,160,0.97 [0.77-1.22],0.8049149077723468
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",22688,210,0.87 [0.73-1.03],0.1001603932039744
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HAO1,Hydroxyacid oxidase 1,22761,210,1.10 [1.00-1.21],0.047770691434941
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HARS1,"Histidine--tRNA ligase, cytoplasmic",22610,209,1.15 [0.98-1.34],0.0961619643405985
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HAVCR1,Hepatitis A virus cellular receptor 1,22725,210,1.40 [1.17-1.67],0.0001858801765814
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HAVCR2,Hepatitis A virus cellular receptor 2,22610,209,1.97 [1.45-2.70],1.8878457964292653e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HBEGF,Proheparin-binding EGF-like growth factor,22688,210,1.12 [0.95-1.33],0.1680020976293876
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HBQ1,Hemoglobin subunit theta-1,22761,210,0.79 [0.64-0.97],0.0220770326722722
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HBZ,Hemoglobin subunit zeta,19653,166,0.93 [0.81-1.08],0.3442894144975057
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HCG22,Protein PBMUCL2,18980,160,0.72 [0.48-1.06],0.0940598650083223
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HCLS1,Hematopoietic lineage cell-specific protein,22801,212,1.06 [0.85-1.32],0.6048131424529041
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HDAC8,Histone deacetylase 8,19069,160,1.16 [0.93-1.44],0.1933791996860216
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HDAC9,Histone deacetylase 9,19004,158,1.00 [0.79-1.26],0.974472677582228
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HDDC2,5'-deoxynucleotidase HDDC2,19559,166,1.00 [0.71-1.40],0.9954646141882666
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HDGF,Hepatoma-derived growth factor,22719,210,1.09 [0.96-1.24],0.1985381879626307
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HDGFL2,Hepatoma-derived growth factor-related protein 2,19617,166,1.00 [0.79-1.26],0.9717511151785858
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HEBP1,Heme-binding protein 1,22162,199,1.02 [0.81-1.28],0.8887815973738704
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HEG1,Protein HEG homolog 1,19241,159,1.00 [0.57-1.78],0.988519785513942
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HEPACAM2,HEPACAM family member 2,19617,166,0.65 [0.46-0.93],0.0177131989429376
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HEPH,Hephaestin,19653,166,1.77 [0.98-3.20],0.0588832989991226
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HEXIM1,Protein HEXIM1,22522,211,1.02 [0.88-1.19],0.7613740020629651
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HGF,Hepatocyte growth factor,22801,212,1.20 [0.85-1.71],0.3041681371195978
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HGFAC,Hepatocyte growth factor activator,19478,163,0.92 [0.55-1.55],0.7535684169020134
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,22080,202,1.14 [0.98-1.34],0.0912630860612917
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HHEX,Hematopoietically-expressed homeobox protein HHEX,19617,166,1.09 [0.90-1.33],0.3721036213282692
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HIF1A,Hypoxia-inducible factor 1-alpha,19069,160,0.94 [0.73-1.22],0.6555084177559429
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HIP1,Huntingtin-interacting protein 1,18980,160,0.93 [0.57-1.50],0.7541070432865007
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HIP1R,Huntingtin-interacting protein 1-related protein,19572,166,1.18 [0.87-1.58],0.281700782675272
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HJV,Hemojuvelin,19611,164,1.14 [0.84-1.57],0.398433416185549
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HK2,Hexokinase-2,22162,199,1.37 [0.89-2.12],0.1497697455906337
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HLA-A,"HLA class I histocompatibility antigen, A alpha chain",19611,164,0.91 [0.58-1.44],0.6950817406363377
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",22455,210,1.19 [0.86-1.65],0.302947036121944
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HLA-E,"HLA class I histocompatibility antigen, alpha chain E",22522,211,1.59 [1.09-2.33],0.0160709140731607
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HMBS,Porphobilinogen deaminase,22761,210,0.79 [0.60-1.04],0.0923653824205147
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HMCN2,Hemicentin-2,19210,159,1.09 [0.83-1.43],0.5181933882350118
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",19166,163,1.05 [0.77-1.43],0.7425377875480363
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",18980,160,1.09 [0.78-1.52],0.6047948043776654
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HMMR,Hyaluronan mediated motility receptor,18905,158,0.96 [0.70-1.32],0.8005299780949245
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HMOX1,Heme oxygenase 1,22331,211,1.05 [0.81-1.35],0.7078213182455169
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HMOX2,Heme oxygenase 2,22060,200,1.49 [1.20-1.84],0.0002511463814697
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HNF1A,Hepatocyte nuclear factor 1-alpha,19122,159,0.91 [0.71-1.16],0.4442497333133759
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HNMT,Histamine N-methyltransferase,22284,209,1.36 [1.05-1.75],0.0182531553783114
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HNRNPK,Heterogeneous nuclear ribonucleoprotein K,22103,198,1.14 [0.97-1.34],0.1082204901801587
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,19611,164,1.06 [0.78-1.42],0.7158555938466789
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HPCAL1,Hippocalcin-like protein 1,22801,212,1.03 [0.87-1.21],0.7369546633886974
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HPGDS,Hematopoietic prostaglandin D synthase,22080,202,0.79 [0.56-1.11],0.1778822510400485
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HPSE,Heparanase,19398,163,0.97 [0.83-1.14],0.702699190499436
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HRAS,GTPase Hras,19252,165,1.00 [0.86-1.16],0.9985427320029956
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,19166,163,0.82 [0.52-1.30],0.399701833504231
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HRG,Histidine-rich glycoprotein,19571,164,1.22 [0.76-1.96],0.407753108905909
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HS1BP3,HCLS1-binding protein 3,19166,163,1.05 [0.88-1.24],0.6021791217401151
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,22474,209,1.20 [0.87-1.66],0.2681797544568816
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,22761,210,1.10 [0.78-1.55],0.5976650179867486
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,19069,160,1.43 [0.94-2.19],0.0939149883387873
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HSBP1,Heat shock factor-binding protein 1,19166,163,1.02 [0.87-1.19],0.8384039575141109
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,22522,211,1.20 [0.89-1.64],0.2376329241327589
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,19617,166,1.14 [0.90-1.44],0.2781321455587315
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HSD17B3,Testosterone 17-beta-dehydrogenase 3,18980,160,0.99 [0.72-1.35],0.9379572037747688
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HSDL2,Hydroxysteroid dehydrogenase-like protein 2,19166,163,0.90 [0.66-1.25],0.5402784392516139
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HSP90B1,Endoplasmin,21948,200,0.98 [0.81-1.20],0.8511393002501099
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HSPA1A,Heat shock 70 kDa protein 1A,22646,208,1.03 [0.87-1.23],0.7237317717610212
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HSPA2,Heat shock-related 70 kDa protein 2,19559,167,1.35 [0.91-2.01],0.1345591121740682
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HSPB1,Heat shock protein beta-1,22245,209,1.15 [0.96-1.39],0.1362167072001934
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HSPB6,Heat shock protein beta-6,22761,210,1.56 [1.16-2.09],0.003094992097396
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,22439,211,1.68 [1.10-2.55],0.015497226485744
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HTR1A,5-hydroxytryptamine receptor 1A,19004,158,1.10 [0.92-1.31],0.3033835677310525
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HTR1B,5-hydroxytryptamine receptor 1B,19004,158,0.90 [0.63-1.31],0.5912692463181233
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HTRA2,"Serine protease HTRA2, mitochondrial",22673,210,1.24 [1.02-1.51],0.032411822130697
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HYAL1,Hyaluronidase-1,22492,211,1.43 [0.85-2.41],0.1729405573405641
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),HYOU1,Hypoxia up-regulated protein 1,22865,212,2.20 [1.32-3.69],0.0026651396857735
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ICA1,Islet cell autoantigen 1,22144,200,1.12 [0.96-1.31],0.1468666988711288
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ICAM1,Intercellular adhesion molecule 1,22507,211,1.40 [0.93-2.12],0.1101338703841837
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ICAM2,Intercellular adhesion molecule 2,22865,212,1.17 [0.80-1.70],0.4195638518671899
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ICAM3,Intercellular adhesion molecule 3,22865,212,1.18 [0.75-1.86],0.4749221660764855
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ICAM4,Intercellular adhesion molecule 4,22522,211,0.89 [0.70-1.11],0.2967667638846005
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ICAM5,Intercellular adhesion molecule 5,22584,212,0.90 [0.69-1.17],0.4316636253169527
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ICOSLG,ICOS ligand,22474,209,1.21 [0.64-2.29],0.5508866428318127
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ID4,DNA-binding protein inhibitor ID-4,19299,165,1.18 [0.87-1.59],0.292465389830559
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IDI2,Isopentenyl-diphosphate delta-isomerase 2,22060,200,1.33 [1.06-1.67],0.014624294115598
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IDO1,"Indoleamine 2,3-dioxygenase 1",19166,163,1.08 [0.86-1.36],0.5018041946941265
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IDS,Iduronate 2-sulfatase,22801,212,1.06 [0.27-4.24],0.933468504797334
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IDUA,Alpha-L-iduronidase,22761,210,0.84 [0.65-1.08],0.1700268200399734
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IFI30,Gamma-interferon-inducible lysosomal thiol reductase,19068,163,1.48 [1.03-2.13],0.0326541144041683
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,19299,165,1.04 [0.78-1.37],0.7981606161001333
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,19299,165,1.23 [0.85-1.78],0.2786326903014381
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IFNAR1,Interferon alpha/beta receptor 1,19559,166,1.01 [0.56-1.80],0.9827435539227866
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IFNG,Interferon gamma,22144,200,1.00 [0.89-1.12],0.9814188967419496
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IFNGR1,Interferon gamma receptor 1,22676,208,1.99 [1.16-3.41],0.0121059993060836
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IFNGR2,Interferon gamma receptor 2,22387,210,1.03 [0.81-1.30],0.8228132752260705
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IFNL1,Interferon lambda-1,22060,200,1.36 [1.05-1.75],0.0185862808055566
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IFNL2,Interferon lambda-2,19004,158,0.75 [0.55-1.03],0.075559391849046
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IFNLR1,Interferon lambda receptor 1,22522,211,1.13 [0.82-1.57],0.4476600909712233
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IFNW1,Interferon omega-1,18980,160,1.17 [0.81-1.69],0.4056592816636039
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IFT20,Intraflagellar transport protein 20 homolog,19122,159,1.01 [0.71-1.44],0.9528477032689951
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGBP1,Immunoglobulin-binding protein 1,19611,164,0.95 [0.75-1.22],0.7076933909834267
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGDCC3,Immunoglobulin superfamily DCC subclass member 3,19004,158,0.84 [0.58-1.20],0.3292261374135561
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGDCC4,Immunoglobulin superfamily DCC subclass member 4,19664,164,0.65 [0.38-1.13],0.1302390412106835
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGF1R,Insulin-like growth factor 1 receptor,22474,209,1.32 [0.76-2.31],0.3255267514797464
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,18980,160,0.85 [0.59-1.23],0.3856421599989795
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGF2R,Cation-independent mannose-6-phosphate receptor,22610,209,1.95 [1.16-3.31],0.0125159086914274
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGFBP1,Insulin-like growth factor-binding protein 1,22829,212,1.07 [0.97-1.19],0.1760019148677736
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGFBP2,Insulin-like growth factor-binding protein 2,22837,212,1.28 [1.05-1.56],0.0160172741587694
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGFBP3,Insulin-like growth factor-binding protein 3,22706,212,0.62 [0.44-0.89],0.008522333958046
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGFBP4,Insulin-like growth factor-binding protein 4,22317,205,1.57 [1.24-2.00],0.0002090580014751
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGFBP6,Insulin-like growth factor-binding protein 6,22506,209,1.50 [1.05-2.17],0.028031962208108
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGFBP7,Insulin-like growth factor-binding protein 7,22865,212,1.44 [1.01-2.04],0.0427851112837593
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGFBPL1,Insulin-like growth factor-binding protein-like 1,22584,212,1.39 [0.98-1.96],0.0616120595562677
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGFL4,Insulin growth factor-like family member 4,19069,160,0.87 [0.68-1.11],0.2499655798528272
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGHMBP2,DNA-binding protein SMUBP-2,18980,160,1.01 [0.76-1.33],0.9687180017659628
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGLC2,Immunoglobulin lambda constant 2,19643,165,1.30 [0.80-2.10],0.2862564074766068
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGLON5,IgLON family member 5,18946,158,0.95 [0.80-1.13],0.5796316526255677
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGSF21,Immunoglobulin superfamily member 21,19166,163,0.81 [0.53-1.23],0.3245228151439808
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGSF3,Immunoglobulin superfamily member 3,22474,209,1.08 [0.76-1.52],0.6768031904749268
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGSF8,Immunoglobulin superfamily member 8,22584,212,1.66 [1.15-2.40],0.0066945293503593
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IGSF9,Protein turtle homolog A,19653,166,0.98 [0.82-1.18],0.8564828619310723
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IKBKG,NF-kappa-B essential modulator,22522,211,1.00 [0.87-1.14],0.9915747690648046
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IKZF2,Zinc finger protein Helios,22080,202,1.03 [0.89-1.18],0.711795937459291
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL10,Interleukin-10,22144,200,0.95 [0.81-1.11],0.5145415698973024
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL10RA,Interleukin-10 receptor subunit alpha,22144,200,1.13 [0.94-1.36],0.1777776050067593
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL10RB,Interleukin-10 receptor subunit beta,22676,208,1.47 [0.99-2.18],0.0550388868920766
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL11,Interleukin-11,22144,200,0.86 [0.69-1.08],0.2022596059851046
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL12A_IL12B,Interleukin-12,22474,209,1.14 [0.98-1.33],0.0817608152351547
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL12B,Interleukin-12 subunit beta,22801,212,1.14 [0.92-1.42],0.2207903686866195
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL12RB1,Interleukin-12 receptor subunit beta-1,22144,200,1.46 [1.07-1.99],0.0181729766454596
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL12RB2,Interleukin-12 receptor subunit beta-2,19069,160,1.12 [0.78-1.60],0.5283783387546819
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL13,Interleukin-13,22144,200,0.74 [0.53-1.04],0.0841348148196262
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL13RA1,Interleukin-13 receptor subunit alpha-1,22329,207,1.00 [0.57-1.76],0.993773859460196
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL13RA2,Interleukin-13 receptor subunit alpha-2,19004,158,0.97 [0.57-1.64],0.901975733775192
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL15,Interleukin-15,22522,211,1.35 [0.94-1.93],0.1007568088018724
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL15RA,Interleukin-15 receptor subunit alpha,22144,200,1.78 [1.26-2.53],0.0012215985217433
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL16,Pro-interleukin-16,22801,212,1.09 [0.82-1.44],0.559873530485745
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL17A,Interleukin-17A,22112,198,1.14 [0.87-1.49],0.3581203109838593
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL17C,Interleukin-17C,22144,200,1.34 [1.17-1.54],2.4112048906022565e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL17D,Interleukin-17D,22144,200,0.98 [0.67-1.44],0.930215841839748
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL17F,Interleukin-17F,22144,200,1.08 [0.93-1.26],0.3309908188135971
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL17RA,Interleukin-17 receptor A,22610,209,0.99 [0.75-1.31],0.9567157959319365
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL17RB,Interleukin-17 receptor B,22251,208,1.13 [0.89-1.42],0.3070759777718635
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL18,Interleukin-18,22500,205,1.25 [0.97-1.62],0.0859024787238423
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL18BP,Interleukin-18-binding protein,22706,212,1.72 [1.20-2.45],0.0029876376248146
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL18R1,Interleukin-18 receptor 1,22801,212,1.62 [1.13-2.33],0.0081232227727742
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL18RAP,Interleukin-18 receptor accessory protein,22247,209,1.00 [0.93-1.07],0.9718514060510848
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL19,Interleukin-19,22017,211,1.16 [0.99-1.37],0.0729311788378835
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL1A,Interleukin-1 alpha,22144,200,1.07 [0.88-1.30],0.4830300143554458
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL1B,Interleukin-1 beta,22045,200,1.01 [0.82-1.26],0.8991502953070484
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL1R1,Interleukin-1 receptor type 1,22578,209,1.62 [0.97-2.71],0.0677037406056463
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL1R2,Interleukin-1 receptor type 2,22532,205,1.88 [1.00-3.52],0.0501630733811347
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL1RAP,Interleukin-1 receptor accessory protein,22610,209,1.03 [0.79-1.35],0.8197551882376768
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL1RL1,Interleukin-1 receptor-like 1,22799,212,1.54 [1.18-2.02],0.0015987438641792
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL1RL2,Interleukin-1 receptor-like 2,22144,200,1.01 [0.72-1.41],0.9630752175426724
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL1RN,Interleukin-1 receptor antagonist protein,22537,208,1.22 [0.99-1.50],0.056784065468925
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL2,Interleukin-2,22144,200,1.07 [0.72-1.58],0.743388741389421
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL20,Interleukin-20,22144,200,1.10 [0.87-1.38],0.4430967798507741
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL20RA,Interleukin-20 receptor subunit alpha,22144,200,0.97 [0.73-1.29],0.8319923378555204
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL20RB,Interleukin-20 receptor subunit beta,19069,160,0.73 [0.50-1.06],0.0988419038995306
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL21R,Interleukin-21 receptor,19069,160,0.99 [0.76-1.31],0.9677891795865444
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL22,Interleukin-22,19559,167,1.23 [1.01-1.49],0.0419620176088765
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL22RA1,Interleukin-22 receptor subunit alpha-1,22144,200,1.17 [0.91-1.49],0.2142770107086455
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL24,Interleukin-24,22144,200,0.99 [0.77-1.27],0.933438308442151
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL25,Interleukin-25,18879,158,0.92 [0.59-1.43],0.7038363180868842
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL2RA,Interleukin-2 receptor subunit alpha,22403,203,1.47 [1.12-1.94],0.005957073586514
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL2RB,Interleukin-2 receptor subunit beta,22144,200,1.08 [0.80-1.47],0.6145976862686706
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL2RG,Cytokine receptor common subunit gamma,19559,167,1.22 [0.88-1.68],0.2290826393678506
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL3,Interleukin-3,18946,158,0.96 [0.75-1.23],0.7731344415598953
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL31,Interleukin-31,19069,160,0.97 [0.74-1.29],0.8546599530385213
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL31RA,Interleukin-31 receptor subunit alpha,18989,160,0.92 [0.61-1.37],0.668996483848615
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL32,Interleukin-32,22522,211,1.06 [0.80-1.40],0.69116105344736
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL33,Interleukin-33,22144,200,1.23 [0.89-1.70],0.2084765361625834
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL34,Interleukin-34,22026,200,1.05 [0.74-1.48],0.8030239309989137
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL36A,Interleukin-36 alpha,19069,160,0.88 [0.65-1.19],0.4107410086293971
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL36G,Interleukin-36 gamma,18980,160,0.96 [0.76-1.21],0.7061512367840665
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL3RA,Interleukin-3 receptor subunit alpha,22144,200,1.40 [0.97-2.03],0.0760686536055671
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL4,Interleukin-4,22144,200,0.96 [0.84-1.09],0.5270825490275202
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL4R,Interleukin-4 receptor subunit alpha,22522,211,1.38 [1.01-1.89],0.0461806972704173
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL5,Interleukin-5,22144,200,0.96 [0.88-1.06],0.4251476296683492
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL5RA,Interleukin-5 receptor subunit alpha,22522,211,0.94 [0.76-1.17],0.5637630650085104
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL6,Interleukin-6,22474,209,1.07 [0.92-1.24],0.3749417183624649
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL6R,Interleukin-6 receptor subunit alpha,22481,211,0.86 [0.60-1.23],0.407922401023661
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL6ST,Interleukin-6 receptor subunit beta,22584,212,1.92 [0.97-3.81],0.0625816405116744
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL7,Interleukin-7,22522,211,1.02 [0.84-1.23],0.8458121878013984
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL7R,Interleukin-7 receptor subunit alpha,22610,209,1.00 [0.79-1.27],0.9695941514279744
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IL9,Interleukin-9,19299,165,1.11 [0.87-1.40],0.3991130248184982
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,22021,200,1.12 [0.91-1.38],0.2841253035137613
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IMMT,MICOS complex subunit MIC60,19559,167,1.47 [1.12-1.92],0.005644994991088
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IMPA1,Inositol monophosphatase 1,22387,210,1.06 [0.87-1.30],0.545654628717307
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IMPACT,Protein IMPACT,19617,166,0.91 [0.70-1.19],0.4834428290151499
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IMPG1,Interphotoreceptor matrix proteoglycan 1,19004,158,0.96 [0.57-1.61],0.8634514375437836
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ING1,Inhibitor of growth protein 1,22025,200,1.24 [0.99-1.56],0.0578656601522843
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),INHBB,Inhibin beta B chain,19241,159,1.06 [0.80-1.41],0.6673789690933061
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),INHBC,Inhibin beta C chain,22610,209,1.02 [0.76-1.39],0.8793476456753112
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),INPP1,Inositol polyphosphate 1-phosphatase,22474,209,1.16 [0.93-1.45],0.1914270111732946
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",19166,163,0.80 [0.61-1.06],0.1194235580620035
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",19611,164,0.77 [0.52-1.15],0.2009221929948548
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",22474,209,1.01 [0.89-1.15],0.8586438771413951
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),INSL3,Insulin-like 3,19617,166,0.82 [0.69-0.99],0.0341586236419481
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),INSL4,Early placenta insulin-like peptide,19559,167,0.83 [0.59-1.17],0.2910173661841362
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),INSL5,Insulin-like peptide INSL5,19559,166,1.26 [1.09-1.45],0.0014829344166622
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),INSR,Insulin receptor,19069,160,0.72 [0.29-1.78],0.4795339118864301
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IPCEF1,Interactor protein for cytohesin exchange factors 1,22352,209,1.05 [0.92-1.21],0.4667595647147238
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IQGAP2,Ras GTPase-activating-like protein IQGAP2,22474,209,1.21 [0.97-1.50],0.0902445330079288
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",22162,199,1.09 [0.96-1.25],0.190775937636401
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IRAK1,Interleukin-1 receptor-associated kinase 1,22144,200,1.14 [0.95-1.36],0.161654790359817
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IRAK4,Interleukin-1 receptor-associated kinase 4,22522,211,1.03 [0.91-1.15],0.6696849079999515
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,21767,196,0.78 [0.56-1.11],0.1655633233412705
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ISM1,Isthmin-1,22522,211,0.84 [0.61-1.16],0.2879423285768669
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ISM2,Isthmin-2,19664,164,0.80 [0.55-1.16],0.234328629719967
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IST1,IST1 homolog,19412,165,1.05 [0.90-1.23],0.51911995338014
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITGA11,Integrin alpha-11,22522,211,0.63 [0.44-0.90],0.012098740472832
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITGA2,Integrin alpha-2,19241,159,0.73 [0.47-1.14],0.1708853366706528
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITGA5,Integrin alpha-5,22610,209,1.65 [1.02-2.67],0.0423239111263784
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITGA6,Integrin alpha-6,22522,211,1.01 [0.80-1.28],0.9436134802271772
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITGAL,Integrin alpha-L,19069,160,1.07 [0.75-1.52],0.7106087097900899
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITGAM,Integrin alpha-M,22610,209,1.00 [0.67-1.47],0.9832212913874564
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITGAV,Integrin alpha-V,22761,210,0.39 [0.18-0.81],0.0114642797482951
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITGAX,Integrin alpha-X,19299,165,0.93 [0.70-1.25],0.6419421576980766
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITGB1,Integrin beta-1,22595,212,1.28 [0.73-2.25],0.3851456908872884
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITGB1BP1,Integrin beta-1-binding protein 1,22080,202,0.94 [0.69-1.28],0.6859430192502325
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITGB1BP2,Integrin beta-1-binding protein 2,22162,199,1.07 [0.95-1.20],0.2736360682429214
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITGB2,Integrin beta-2,22469,212,0.99 [0.64-1.52],0.9492225223858276
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITGB5,Integrin beta-5,22673,210,1.29 [0.94-1.76],0.1127119521944308
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITGB6,Integrin beta-6,22144,200,0.89 [0.59-1.35],0.5868791472329998
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITGB7,Integrin beta-7,22761,210,1.28 [0.99-1.65],0.0560344128754973
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITGBL1,Integrin beta-like protein 1,19664,164,1.07 [0.72-1.59],0.7466183971673672
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,19683,165,0.70 [0.31-1.55],0.376245127195478
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,22706,212,1.57 [1.13-2.17],0.0073361277065826
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,19683,165,1.57 [0.92-2.70],0.0991913197102579
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,19559,167,1.09 [0.79-1.49],0.5979663032557496
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITM2A,Integral membrane protein 2A,22522,211,1.02 [0.84-1.25],0.8148805788970082
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITPA,Inosine triphosphate pyrophosphatase,18980,160,0.95 [0.76-1.20],0.665395435052395
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",19166,163,1.17 [0.96-1.42],0.1099845900454838
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",19004,158,0.95 [0.66-1.36],0.7741141666702107
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",22060,200,1.23 [0.98-1.53],0.0698337645113481
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),IZUMO1,Izumo sperm-egg fusion protein 1,18946,158,1.22 [0.93-1.59],0.1500236598807085
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),JAM2,Junctional adhesion molecule B,22765,209,1.58 [1.03-2.42],0.0366775594114833
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),JAM3,Junctional adhesion molecule C,19241,159,1.25 [0.94-1.67],0.1277952468394163
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),JCHAIN,Immunoglobulin J chain,22144,200,1.08 [0.88-1.31],0.4750561500743518
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,18946,158,0.87 [0.65-1.16],0.337192010701659
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),JPT2,Jupiter microtubule associated homolog 2,19559,166,1.12 [0.94-1.33],0.2073551530292166
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),JUN,Transcription factor AP-1,22144,200,1.29 [1.06-1.57],0.0126041229717084
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,22474,209,0.98 [0.75-1.28],0.8737119311712098
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KAZN,Kazrin,19559,166,1.01 [0.87-1.16],0.9278079648837008
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KCNC4,Potassium voltage-gated channel subfamily C member 4,19004,158,1.23 [0.98-1.53],0.0688376352716817
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KCNH2,Potassium voltage-gated channel subfamily H member 2,19122,159,1.02 [0.84-1.24],0.8324913317887255
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KCNIP4,Kv channel-interacting protein 4,22060,200,0.97 [0.75-1.26],0.8040965933888781
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KCTD5,BTB/POZ domain-containing protein KCTD5,19260,164,1.06 [0.76-1.47],0.7328452626598982
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KDM3A,Lysine-specific demethylase 3A,19069,160,1.05 [0.88-1.24],0.5976904299095016
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KDR,Vascular endothelial growth factor receptor 2,22673,210,0.99 [0.60-1.62],0.9624115136291476
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KEL,Kell blood group glycoprotein,22060,200,1.04 [0.73-1.47],0.8271794194732227
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KHDC3L,KH domain-containing protein 3,18946,158,1.09 [0.88-1.33],0.4328903096358438
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KHK,Ketohexokinase,19166,163,1.08 [0.85-1.38],0.5381911146696035
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KIAA0319,Dyslexia-associated protein KIAA0319,19617,166,0.98 [0.60-1.59],0.9278259405552048
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KIAA1549,UPF0606 protein KIAA1549,19299,165,1.01 [0.82-1.24],0.9410056080466036
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KIAA1549L,UPF0606 protein KIAA1549L,19299,165,1.31 [0.82-2.10],0.2563307689752779
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KIAA2013,Uncharacterized protein KIAA2013,19559,167,1.08 [0.84-1.40],0.5326973124056982
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KIF1C,Kinesin-like protein KIF1C,18980,160,1.16 [0.78-1.71],0.4708863820025616
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KIF20B,Kinesin-like protein KIF20B,19004,158,0.92 [0.74-1.13],0.4160246091104925
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KIF22,Kinesin-like protein KIF22,18980,160,0.97 [0.86-1.10],0.6793722478562079
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KIFBP,KIF-binding protein,22474,209,1.12 [0.96-1.30],0.1543728333439868
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,19559,167,1.03 [0.87-1.21],0.7243717904674567
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,22080,202,1.13 [0.97-1.31],0.1273497760349011
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,19559,166,1.05 [0.96-1.14],0.2832510509367864
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,22080,202,1.04 [0.95-1.15],0.3853100366372325
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,18946,158,0.85 [0.67-1.06],0.1488300164354743
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KIRREL1,Kin of IRRE-like protein 1,19004,158,1.19 [0.96-1.48],0.118487814878064
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KIRREL2,Kin of IRRE-like protein 2,22060,200,1.09 [0.80-1.49],0.5750617151135133
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KIT,Mast/stem cell growth factor receptor Kit,22659,212,0.79 [0.53-1.18],0.2501129535879876
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KITLG,Kit ligand,22584,212,0.85 [0.62-1.18],0.3453921117313644
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLB,Beta-klotho,22060,200,1.07 [0.90-1.26],0.4600388932140978
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLF4,Krueppel-like factor 4,19004,158,1.13 [0.78-1.63],0.5134916023156312
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLHL41,Kelch-like protein 41,19611,164,1.13 [0.84-1.52],0.4091649744603429
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLK1,Kallikrein-1,22379,207,1.00 [0.91-1.10],0.9814305457835568
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLK10,Kallikrein-10,22606,210,1.11 [0.83-1.49],0.4732284109168401
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLK11,Kallikrein-11,22465,210,1.72 [1.33-2.24],4.273981637207728e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLK12,Kallikrein-12,22080,202,1.00 [0.91-1.09],0.994242314982276
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLK13,Kallikrein-13,22089,206,1.00 [0.76-1.30],0.9822760639527672
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLK14,Kallikrein-14,22761,210,1.24 [0.96-1.60],0.1028433020903317
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLK15,Kallikrein-15,19518,166,1.28 [0.97-1.69],0.0800442320793066
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLK3,Prostate-specific antigen,19664,164,0.92 [0.78-1.08],0.3081709675964745
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLK4,Kallikrein-4,22761,210,1.34 [1.13-1.60],0.0009256746311522
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLK6,Kallikrein-6,22630,210,1.53 [1.03-2.25],0.0338224994360642
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLK7,Kallikrein-7,18752,154,1.05 [0.70-1.58],0.7965912310061969
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLK8,Kallikrein-8,21840,206,1.31 [0.95-1.82],0.1010866001992971
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLKB1,Plasma kallikrein,19271,162,0.98 [0.53-1.81],0.9424559010590288
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLRB1,Killer cell lectin-like receptor subfamily B member 1,22801,212,1.63 [1.21-2.19],0.0012160536549732
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLRC1,NKG2-A/NKG2-B type II integral membrane protein,19004,158,1.04 [0.81-1.32],0.7821378410451303
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLRD1,Natural killer cells antigen CD94,22801,212,1.13 [0.87-1.46],0.3541655694244741
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLRF1,Killer cell lectin-like receptor subfamily F member 1,19069,160,1.19 [0.89-1.58],0.2371056666379389
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KLRK1,NKG2-D type II integral membrane protein,19617,166,1.01 [0.74-1.39],0.927055689850918
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KRT14,"Keratin, type I cytoskeletal 14",21373,195,1.10 [0.72-1.68],0.6581861044227935
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KRT17,"Keratin, type I cytoskeletal 17",18980,160,0.73 [0.47-1.11],0.140909561246507
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KRT18,"Keratin, type I cytoskeletal 18",22474,209,1.17 [1.01-1.35],0.0345722497792434
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KRT19,"Keratin, type I cytoskeletal 19",22475,210,1.23 [1.04-1.46],0.0152531410822611
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KRT5,"Keratin, type II cytoskeletal 5",22060,200,1.32 [1.05-1.67],0.0164483823522251
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KRT6C,"Keratin, type II cytoskeletal 6C",18980,160,0.86 [0.55-1.34],0.5052235845872666
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KRT8,"Keratin, type II cytoskeletal 8",19004,158,1.12 [0.95-1.32],0.1776485142558306
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KYAT1,Kynurenine--oxoglutarate transaminase 1,22555,212,0.98 [0.79-1.22],0.857464192207692
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),KYNU,Kynureninase,22801,212,1.27 [0.98-1.66],0.0761470406872663
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),L1CAM,Neural cell adhesion molecule L1,22673,210,0.88 [0.58-1.34],0.5574714150038476
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,19653,166,1.07 [0.91-1.26],0.4325324308809324
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LACRT,Extracellular glycoprotein lacritin,19519,165,0.75 [0.53-1.06],0.1060135895288146
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LACTB2,Endoribonuclease LACTB2,22584,212,1.05 [0.88-1.27],0.5730658863744023
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LAG3,Lymphocyte activation gene 3 protein,22474,209,1.05 [0.78-1.42],0.7552853174674597
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,22569,205,1.75 [1.36-2.26],1.710317210922507e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,22387,210,1.04 [0.93-1.17],0.5073326158165455
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LAMA1,Laminin subunit alpha-1,18980,160,1.16 [0.90-1.48],0.2547049392395937
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LAMA4,Laminin subunit alpha-4,22676,208,1.61 [1.13-2.31],0.0087299492190991
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LAMB1,Laminin subunit beta-1,19166,163,1.07 [0.65-1.77],0.7921171846162551
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LAMP1,Lysosome-associated membrane glycoprotein 1,19104,159,1.36 [0.99-1.88],0.0590856137423197
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LAMP2,Lysosome-associated membrane glycoprotein 2,21901,192,1.33 [0.69-2.57],0.4011951806850992
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LAMP3,Lysosome-associated membrane glycoprotein 3,22768,212,1.17 [0.93-1.47],0.1857924120980552
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LAMTOR5,Ragulator complex protein LAMTOR5,19559,167,1.19 [0.85-1.66],0.3208441552363877
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LAP3,Cytosol aminopeptidase,22144,200,1.33 [1.07-1.65],0.0116565380970623
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LARP1,La-related protein 1,19559,167,0.95 [0.75-1.22],0.702552562084741
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LAT,Linker for activation of T-cells family member 1,22801,212,1.11 [0.95-1.31],0.1964201146853537
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LAT2,Linker for activation of T-cells family member 2,22474,209,1.06 [0.96-1.17],0.2305394611337051
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LATS1,Serine/threonine-protein kinase LATS1,19069,160,1.08 [0.90-1.29],0.4097468508981106
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LAYN,Layilin,22352,210,1.81 [1.34-2.45],0.0001236616325793
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LBP,Lipopolysaccharide-binding protein,22706,212,1.46 [1.19-1.79],0.000325077684959
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LBR,Delta(14)-sterol reductase LBR,22765,209,1.12 [0.95-1.32],0.1644780042707218
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LCAT,Phosphatidylcholine-sterol acyltransferase,19664,165,0.57 [0.35-0.94],0.0268292102207475
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LCN15,Lipocalin-15,19611,164,1.07 [0.85-1.35],0.5571073939655071
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LCN2,Neutrophil gelatinase-associated lipocalin,21944,210,1.11 [0.82-1.50],0.5153312217765302
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LCP1,Plastin-2,19664,164,1.02 [0.75-1.39],0.9061068359848714
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LDLR,Low-density lipoprotein receptor,22646,207,0.77 [0.60-0.98],0.0343481189818929
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LDLRAP1,Low density lipoprotein receptor adapter protein 1,19611,164,1.02 [0.88-1.19],0.7527980623135161
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LECT2,Leukocyte cell-derived chemotaxin-2,19653,166,0.98 [0.78-1.23],0.8683386086786757
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LEFTY2,Left-right determination factor 2,22724,210,1.02 [0.80-1.30],0.8756140588544826
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LEG1,Protein LEG1 homolog,18617,152,0.98 [0.78-1.23],0.8613335311358263
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LELP1,Late cornified envelope-like proline-rich protein 1,19004,158,1.03 [0.84-1.26],0.7686975498688626
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LEO1,RNA polymerase-associated protein LEO1,19611,164,1.36 [1.01-1.85],0.0459703089880262
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LEP,Leptin,22584,212,1.06 [0.88-1.28],0.553461761833273
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LEPR,Leptin receptor,22584,212,1.28 [0.88-1.87],0.1929764291330759
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LETM1,Mitochondrial proton/calcium exchanger protein,19611,164,1.39 [1.08-1.79],0.0106449074166015
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LGALS1,Galectin-1,22584,212,1.44 [1.03-2.01],0.0306314184346306
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LGALS3,Galectin-3,22645,210,1.31 [0.87-1.96],0.1973628328304199
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LGALS3BP,Galectin-3-binding protein,19683,165,1.30 [0.83-2.03],0.2447483748810783
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LGALS4,Galectin-4,22569,205,1.44 [1.17-1.77],0.000556725417911
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LGALS7_LGALS7B,Galectin-7,22485,208,1.15 [0.87-1.52],0.3132439153319961
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LGALS8,Galectin-8,22765,209,1.18 [0.96-1.43],0.1090368199751546
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LGALS9,Galectin-9,22570,206,1.98 [1.38-2.86],0.0002301142312121
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LGMN,Legumain,22676,208,1.34 [0.96-1.88],0.0853410128941016
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LHB,Lutropin subunit beta,22080,202,0.97 [0.83-1.13],0.7010842418374363
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,22603,208,1.01 [0.83-1.24],0.8879380419819869
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LIF,Leukemia inhibitory factor,22060,200,0.98 [0.76-1.27],0.9010707160681896
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LIFR,Leukemia inhibitory factor receptor,22522,211,1.42 [0.86-2.34],0.1724205907809164
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,22610,209,1.21 [0.86-1.72],0.2778119011748498
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,19664,164,1.00 [0.90-1.12],0.9478516609293128
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,18980,160,1.17 [0.90-1.52],0.2498472506150494
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,22541,212,1.47 [1.01-2.15],0.0438582426950109
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,19653,166,1.14 [0.93-1.39],0.2079105738741924
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,22865,212,1.32 [0.85-2.05],0.2199895755605286
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,22771,212,1.31 [0.92-1.88],0.1391631877965994
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,22144,200,1.52 [1.17-1.99],0.0020366952238429
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,22865,212,1.03 [0.87-1.23],0.7033146417482787
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LIPF,Gastric triacylglycerol lipase,19166,163,0.90 [0.70-1.14],0.383369234137203
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LMNB1,Lamin-B1,19526,166,0.94 [0.73-1.20],0.6215853371454536
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LMNB2,Lamin-B2,19617,166,1.19 [0.71-2.01],0.5147859111898883
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LMOD1,Leiomodin-1,19611,164,1.39 [0.97-2.01],0.0753232309171926
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LMOD2,Leiomodin-2,19004,158,0.79 [0.60-1.05],0.1055178327698611
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LONP1,"Lon protease homolog, mitochondrial",19166,163,1.03 [0.87-1.23],0.7312304150620348
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LPA,Apolipoprotein(a),19233,159,0.98 [0.90-1.06],0.6019499590297166
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LPCAT2,Lysophosphatidylcholine acyltransferase 2,22474,209,1.12 [0.88-1.44],0.3534964506989795
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LPL,Lipoprotein lipase,22584,212,0.99 [0.76-1.28],0.9380041594531744
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LPO,Lactoperoxidase,21816,203,1.05 [0.86-1.29],0.630511997311146
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LPP,Lipoma-preferred partner,18980,160,1.06 [0.84-1.34],0.6315291276403182
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,18980,160,1.00 [0.80-1.26],0.9724955022023408
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,19122,159,0.86 [0.60-1.24],0.411304191911003
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRG1,Leucine-rich alpha-2-glycoprotein,19683,165,1.03 [0.59-1.81],0.9064474567366694
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,22688,210,1.38 [0.98-1.95],0.0665014994481204
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,19004,160,0.73 [0.40-1.33],0.2993933882050885
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRP1,Prolow-density lipoprotein receptor-related protein 1,22474,209,1.03 [0.65-1.63],0.9061971764846758
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRP11,Low-density lipoprotein receptor-related protein 11,22584,212,1.55 [1.12-2.13],0.0074360518825421
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRP2,Low-density lipoprotein receptor-related protein 2,19122,159,1.05 [0.70-1.57],0.8201826356302951
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRP2BP,LRP2-binding protein,19122,159,0.99 [0.82-1.18],0.8842290711321734
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRPAP1,Alpha-2-macroglobulin receptor-associated protein,22765,209,1.09 [0.89-1.33],0.4082517297091378
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRRC25,Leucine-rich repeat-containing protein 25,22474,209,1.26 [0.94-1.70],0.1195784264049524
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRRC37A2,Leucine-rich repeat-containing protein 37A2,19559,166,0.86 [0.61-1.22],0.3992481479008444
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRRC38,Leucine-rich repeat-containing protein 38,19122,159,0.79 [0.56-1.11],0.1678769111468594
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRRC59,Leucine-rich repeat-containing protein 59,19653,166,1.13 [0.84-1.52],0.4126234121304236
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,19559,167,1.00 [0.73-1.36],0.9783868157143926
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRRN1,Leucine-rich repeat neuronal protein 1,22144,200,0.84 [0.61-1.15],0.2687621591820776
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,19122,159,0.81 [0.54-1.22],0.3185556066300733
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,19611,164,0.90 [0.50-1.60],0.709179223109489
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LSM1,U6 snRNA-associated Sm-like protein LSm1,22080,202,1.02 [0.82-1.27],0.8534454727021616
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LSM8,U6 snRNA-associated Sm-like protein LSm8,19299,165,1.12 [0.96-1.29],0.1440175128921614
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LSP1,Lymphocyte-specific protein 1,22522,211,1.10 [0.81-1.48],0.5424377786708914
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LTA,Lymphotoxin-alpha,22522,211,0.80 [0.59-1.08],0.1440659360848196
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LTA4H,Leukotriene A-4 hydrolase,22761,210,1.31 [1.08-1.59],0.0070963465387557
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LTB,Lymphotoxin-beta,19559,167,0.96 [0.63-1.48],0.8620865350299356
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LTBP2,Latent-transforming growth factor beta-binding protein 2,22865,212,1.62 [1.13-2.35],0.0096292247795443
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LTBP3,Latent-transforming growth factor beta-binding protein 3,22080,202,1.32 [1.08-1.61],0.0063213468087538
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LTBR,Tumor necrosis factor receptor superfamily member 3,22473,205,1.78 [1.21-2.63],0.0036923274418705
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LTO1,Protein LTO1 homolog,22144,200,1.04 [0.77-1.39],0.8060413630497589
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LUZP2,Leucine zipper protein 2,19559,167,1.02 [0.73-1.41],0.9114964521927816
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LXN,Latexin,22293,210,0.98 [0.82-1.17],0.8163580591575456
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LY6D,Lymphocyte antigen 6D,22470,207,1.57 [1.19-2.07],0.0012891562734492
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LY75,Lymphocyte antigen 75,22522,211,1.03 [0.75-1.42],0.8403338111456427
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LY9,T-lymphocyte surface antigen Ly-9,22292,204,1.18 [0.79-1.79],0.4192748527415744
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LY96,Lymphocyte antigen 96,22387,210,1.42 [1.04-1.95],0.0279871975318574
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LYAR,Cell growth-regulating nucleolar protein,22080,202,1.00 [0.79-1.25],0.981847979887549
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LYN,Tyrosine-protein kinase Lyn,22474,209,1.12 [0.97-1.30],0.1314422378753853
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LYPD1,Ly6/PLAUR domain-containing protein 1,22060,200,0.92 [0.73-1.15],0.4510308022969189
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LYPD3,Ly6/PLAUR domain-containing protein 3,22484,210,0.98 [0.68-1.41],0.9140780447906648
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LYPD8,Ly6/PLAUR domain-containing protein 8,22080,202,1.14 [0.90-1.44],0.2697059047745258
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LYPLA2,Acyl-protein thioesterase 2,19004,158,1.11 [0.99-1.25],0.085507218734814
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,19122,159,1.04 [0.91-1.20],0.5608376942149993
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,19683,165,0.87 [0.41-1.85],0.708338190963357
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LYZL2,Lysozyme-like protein 2,18946,158,1.26 [0.84-1.87],0.2617921049970525
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),LZTFL1,Leucine zipper transcription factor-like protein 1,19241,159,1.01 [0.81-1.26],0.920886253054932
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),M6PR,Cation-dependent mannose-6-phosphate receptor,19166,163,0.76 [0.49-1.19],0.2267533383143326
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,22308,210,1.34 [1.12-1.61],0.0013519263410722
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAEA,E3 ubiquitin-protein transferase MAEA,22080,202,1.11 [0.82-1.51],0.5088472650099912
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAG,Myelin-associated glycoprotein,19122,159,0.76 [0.56-1.04],0.0871335884746828
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAGEA3,Melanoma-associated antigen 3,19299,165,1.00 [0.84-1.19],0.971420857111056
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAGED1,Melanoma-associated antigen D1,22080,202,1.03 [0.80-1.34],0.8036891786237619
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAMDC2,MAM domain-containing protein 2,19653,166,1.21 [0.81-1.83],0.3538568760944698
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAMDC4,Apical endosomal glycoprotein,19559,167,1.08 [0.82-1.41],0.5848138535635615
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",19166,163,0.73 [0.40-1.33],0.3010817851316826
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAN2B2,Epididymis-specific alpha-mannosidase,19653,166,0.99 [0.77-1.26],0.9158442458086588
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",18946,158,0.91 [0.67-1.24],0.5489211456797374
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MANF,Mesencephalic astrocyte-derived neurotrophic factor,22676,208,1.06 [0.95-1.17],0.3055886376529916
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MANSC1,MANSC domain-containing protein 1,22673,210,1.39 [0.90-2.14],0.1384236263605895
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MANSC4,MANSC domain-containing protein 4,18980,160,0.99 [0.80-1.23],0.9209018480871848
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,19004,158,1.13 [0.70-1.83],0.6260768972247042
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,18980,160,1.00 [0.79-1.25],0.9881197405845678
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAP2,Microtubule-associated protein 2,19617,166,1.01 [0.73-1.40],0.9628203135135824
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,19559,166,1.14 [0.90-1.44],0.2642642309271965
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,22522,211,1.05 [0.93-1.19],0.4218617852676913
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAP3K5,Mitogen-activated protein kinase kinase kinase 5,22080,202,1.11 [0.98-1.26],0.0925126833187021
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,22352,210,1.07 [0.96-1.20],0.2140110478937427
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAPK13,Mitogen-activated protein kinase 13,18946,158,1.34 [1.00-1.79],0.0501109245086354
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAPK9,Mitogen-activated protein kinase 9,22522,211,0.87 [0.65-1.17],0.3608680521067018
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAPKAPK2,MAP kinase-activated protein kinase 2,19299,165,1.11 [0.91-1.36],0.2960514875123889
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAPRE3,Microtubule-associated protein RP/EB family member 3,18946,158,0.96 [0.86-1.08],0.5244426352462421
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAPT,Microtubule-associated protein tau,22060,200,1.16 [0.91-1.48],0.2359119104379958
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MARCO,Macrophage receptor MARCO,22584,212,1.03 [0.65-1.65],0.8858228752680434
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MARS1,"Methionine--tRNA ligase, cytoplasmic",19213,159,1.04 [0.87-1.25],0.6583545392876841
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MASP1,Mannan-binding lectin serine protease 1,22352,210,0.83 [0.49-1.40],0.4784002748283114
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MATN2,Matrilin-2,22603,205,1.60 [1.05-2.43],0.027265467235485
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MATN3,Matrilin-3,22352,209,0.81 [0.55-1.19],0.2762027772340377
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAVS,Mitochondrial antiviral-signaling protein,22080,202,1.11 [0.97-1.27],0.1201157224299451
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MAX,Protein max,22060,200,1.12 [1.00-1.27],0.0545236932752832
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MB,Myoglobin,22865,212,1.36 [1.10-1.67],0.0042659359456577
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MBL2,Mannose-binding protein C,19401,163,0.94 [0.82-1.08],0.4156991086995667
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MCAM,Cell surface glycoprotein MUC18,22706,212,1.29 [0.90-1.85],0.1587407001595531
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",19611,164,1.03 [0.73-1.47],0.850823439972006
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MCEMP1,Mast cell-expressed membrane protein 1,19069,160,1.00 [0.85-1.19],0.9540981801290632
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MCFD2,Multiple coagulation factor deficiency protein 2,22469,212,1.46 [1.11-1.91],0.0069559129387626
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MCTS1,Malignant T-cell-amplified sequence 1,19559,166,0.62 [0.33-1.18],0.142405391525727
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,22387,210,1.06 [0.89-1.27],0.5168851328916664
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MDH1,"Malate dehydrogenase, cytoplasmic",19554,164,0.96 [0.65-1.39],0.8119921716907852
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MDK,Midkine,22610,209,1.38 [1.15-1.67],0.0006981614222703
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MDM1,Nuclear protein MDM1,19122,159,1.05 [0.64-1.71],0.8508387227349291
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",19166,163,1.03 [0.87-1.22],0.7307737585868765
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MED18,Mediator of RNA polymerase II transcription subunit 18,22080,202,1.15 [0.97-1.35],0.1046118293860781
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MED21,Mediator of RNA polymerase II transcription subunit 21,18980,160,0.73 [0.49-1.07],0.1069727006449633
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MEGF10,Multiple epidermal growth factor-like domains protein 10,22569,205,1.01 [0.73-1.40],0.9715046137656246
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MEGF11,Multiple epidermal growth factor-like domains protein 11,18980,160,1.20 [0.80-1.81],0.3841632336623592
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MEGF9,Multiple epidermal growth factor-like domains protein 9,22799,212,0.99 [0.53-1.86],0.9703575170715856
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MELTF,Melanotransferrin,19653,166,1.08 [0.66-1.77],0.7502277529180129
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MENT,Protein MENT,19241,159,0.75 [0.39-1.44],0.3863293030525059
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MEP1A,Meprin A subunit alpha,19559,166,1.14 [0.93-1.40],0.1986418689809362
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MEP1B,Meprin A subunit beta,22584,212,0.91 [0.82-1.00],0.049694962640527
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MEPE,Matrix extracellular phosphoglycoprotein,22569,205,0.82 [0.51-1.31],0.4087934228318464
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MERTK,Tyrosine-protein kinase Mer,22801,212,1.85 [1.16-2.94],0.0091602672913133
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MESD,LRP chaperone MESD,22610,209,1.09 [0.98-1.20],0.1052242385137049
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MET,Hepatocyte growth factor receptor,22645,207,1.87 [1.01-3.46],0.0449985180576984
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),METAP1,Methionine aminopeptidase 1,22060,200,1.08 [0.71-1.66],0.7103882388312566
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),METAP1D,"Methionine aminopeptidase 1D, mitochondrial",22522,211,1.10 [0.95-1.27],0.2113697808389159
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),METAP2,Methionine aminopeptidase 2,22724,210,1.09 [0.88-1.35],0.449703381323087
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MFAP3,Microfibril-associated glycoprotein 3,22162,199,0.96 [0.74-1.25],0.7621894064172466
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MFAP3L,Microfibrillar-associated protein 3-like,19122,159,1.07 [0.87-1.33],0.5221391814018512
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MFAP4,Microfibril-associated glycoprotein 4,19241,159,1.33 [0.83-2.13],0.2404858615133516
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MFAP5,Microfibrillar-associated protein 5,22865,212,1.12 [0.83-1.52],0.44461025590567
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MFGE8,Lactadherin,22610,209,1.26 [0.96-1.66],0.0949396524510713
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MGLL,Monoglyceride lipase,22636,206,1.04 [0.91-1.21],0.5474721008257903
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MGMT,Methylated-DNA--protein-cysteine methyltransferase,22522,211,1.09 [0.98-1.21],0.1122743142731326
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MIA,Melanoma-derived growth regulatory protein,22673,210,1.32 [0.96-1.80],0.0869780190919032
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MICALL2,MICAL-like protein 2,19122,159,1.00 [0.80-1.25],0.990220820440506
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,22522,211,1.04 [0.95-1.13],0.3898544182886622
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MIF,Macrophage migration inhibitory factor,22575,209,1.07 [0.89-1.28],0.4746581328316652
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MILR1,Allergin-1,22144,200,1.30 [1.03-1.65],0.0291276296115134
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,19559,167,1.06 [0.93-1.22],0.390154483754061
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MINK1,Misshapen-like kinase 1,19617,166,1.05 [0.90-1.24],0.5198526931072216
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MITD1,MIT domain-containing protein 1,22387,210,1.06 [0.93-1.20],0.3981853658991937
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MKI67,Proliferation marker protein Ki-67,19069,160,1.03 [0.70-1.51],0.8788100331322141
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MLLT1,Protein ENL,18946,158,0.99 [0.79-1.25],0.9658501806437856
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MLN,Promotilin,22522,211,1.09 [0.95-1.26],0.20386953800691
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MME,Neprilysin,22474,209,1.21 [1.05-1.40],0.0099245195765818
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MMP1,Interstitial collagenase,21747,200,1.27 [1.10-1.46],0.0013661881510636
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MMP10,Stromelysin-2,22513,205,1.18 [0.96-1.44],0.1134905403141542
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MMP12,Macrophage metalloelastase,22579,209,1.10 [0.88-1.38],0.3840913427733353
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MMP13,Collagenase 3,22060,200,1.16 [0.79-1.70],0.4474977228139233
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MMP15,Matrix metalloproteinase-15,19653,166,1.07 [0.81-1.42],0.6237135837118875
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MMP3,Stromelysin-1,22610,209,1.33 [1.06-1.68],0.0151545283915165
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MMP7,Matrilysin,22127,199,1.33 [1.02-1.74],0.0332362549294937
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MMP8,Neutrophil collagenase,22723,209,0.97 [0.82-1.15],0.7205650039019431
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MMP9,Matrix metalloproteinase-9,22565,209,1.04 [0.85-1.27],0.7191704537463679
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MMUT,"Methylmalonyl-CoA mutase, mitochondrial",18980,160,1.22 [0.91-1.62],0.1817162884034491
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MN1,Transcriptional activator MN1,19122,159,1.02 [0.79-1.33],0.8660489844160741
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MNAT1,CDK-activating kinase assembly factor MAT1,19299,165,0.98 [0.69-1.38],0.8882877357275447
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MNDA,Myeloid cell nuclear differentiation antigen,22545,212,0.98 [0.87-1.11],0.772580120225449
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MOCS2,Molybdopterin synthase catalytic subunit,19241,159,1.15 [0.92-1.45],0.2204115339187409
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MOG,Myelin-oligodendrocyte glycoprotein,22761,210,1.49 [1.04-2.13],0.0283566760990061
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MORC3,MORC family CW-type zinc finger protein 3,19617,166,0.96 [0.56-1.65],0.8862279746788415
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MORF4L1,Mortality factor 4-like protein 1,19299,165,1.04 [0.73-1.50],0.8224543335773653
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MORF4L2,Mortality factor 4-like protein 2,18946,158,1.19 [0.81-1.73],0.3775412054280209
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MORN4,MORN repeat-containing protein 4,18946,158,0.99 [0.81-1.21],0.9186809284324052
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MPHOSPH8,M-phase phosphoprotein 8,22162,199,1.17 [1.00-1.38],0.0488214881569876
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MPI,Mannose-6-phosphate isomerase,22474,209,1.09 [0.94-1.25],0.256224049847492
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,22636,206,1.12 [0.95-1.33],0.1810815712331268
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MPO,Myeloperoxidase,22610,209,1.19 [0.93-1.52],0.1691258120481511
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MPRIP,Myosin phosphatase Rho-interacting protein,19518,167,0.97 [0.69-1.37],0.863501498230534
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MRC1,Macrophage mannose receptor 1,19664,165,1.75 [1.07-2.86],0.0257738807924921
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MRI1,Methylthioribose-1-phosphate isomerase,19122,159,0.98 [0.78-1.23],0.868570454849385
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MRPL24,"39S ribosomal protein L24, mitochondrial",18980,160,1.18 [0.83-1.70],0.3543473945096291
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MRPL28,"39S ribosomal protein L28, mitochondrial",19611,164,0.86 [0.54-1.38],0.5353959792803918
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MRPL46,"39S ribosomal protein L46, mitochondrial",22060,200,1.38 [0.94-2.02],0.1001969564295771
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MRPL52,"39S ribosomal protein L52, mitochondrial",18905,158,0.73 [0.39-1.35],0.3161156319778145
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",19611,164,0.93 [0.75-1.16],0.5273044847249104
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MRPS16,"28S ribosomal protein S16, mitochondrial",19069,160,0.61 [0.32-1.18],0.1450291692909675
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MSLN,Mesothelin,22429,208,1.18 [0.97-1.44],0.1007886582664145
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MSLNL,Mesothelin-like protein,19122,159,1.09 [0.74-1.61],0.6516890452007624
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MSMB,Beta-microseminoprotein,22541,209,0.97 [0.82-1.15],0.7609062939008874
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MSR1,Macrophage scavenger receptor types I and II,22765,209,1.57 [1.20-2.06],0.0009382602713163
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MSRA,Mitochondrial peptide methionine sulfoxide reductase,22673,210,1.12 [0.95-1.33],0.1890853600848351
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MST1,Hepatocyte growth factor-like protein,19366,163,0.93 [0.75-1.13],0.4555904131739666
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MSTN,Growth/differentiation factor 8,22162,199,0.99 [0.78-1.25],0.9029490050860386
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MTDH,Protein LYRIC,19069,160,1.07 [0.91-1.26],0.3877146145590074
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",19617,166,1.01 [0.58-1.76],0.9844066767766368
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,19299,165,1.02 [0.89-1.16],0.7987179769843253
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MTIF3,"Translation initiation factor IF-3, mitochondrial",19559,166,1.07 [0.90-1.26],0.4455029648092398
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MTPN,Myotrophin,22162,199,1.02 [0.70-1.49],0.915906313701771
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MTR,Methionine synthase,18980,160,0.91 [0.70-1.16],0.440857347643084
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MTSS1,Protein MTSS 1,19559,166,1.03 [0.90-1.18],0.6336618659302722
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MTSS2,Protein MTSS 2,19559,167,1.00 [0.86-1.17],0.970799262945998
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MTUS1,Microtubule-associated tumor suppressor 1,19299,165,1.11 [0.86-1.44],0.4307870393408367
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MUC13,Mucin-13,22060,200,1.35 [1.07-1.71],0.0112943240087561
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MUC16,Mucin-16,22474,209,1.01 [0.95-1.08],0.7438223746640582
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MUC2,Mucin-2,19664,164,0.89 [0.75-1.04],0.1449409011922524
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MUCL3,Mucin-like protein 3,18946,158,1.05 [0.75-1.48],0.7680684266361548
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MVK,Mevalonate kinase,22144,200,1.22 [1.05-1.41],0.0110066313521664
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MXRA8,Matrix remodeling-associated protein 8,19241,159,0.71 [0.43-1.16],0.1664279005586833
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYBPC1,"Myosin-binding protein C, slow-type",19653,166,1.39 [1.15-1.67],0.0005936654044975
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYBPC2,"Myosin-binding protein C, fast-type",19166,163,1.14 [0.98-1.33],0.0924441757606459
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYCBP2,E3 ubiquitin-protein ligase MYCBP2,19611,164,1.19 [0.97-1.46],0.0997471865884671
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYDGF,Myeloid-derived growth factor,19653,166,1.11 [0.95-1.29],0.1799574146486813
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYH4,Myosin-4,18980,160,0.85 [0.59-1.23],0.387410798426378
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYH7B,Myosin-7B,18946,158,1.24 [0.92-1.67],0.1535792263896256
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYH9,Myosin-9,19664,164,0.95 [0.83-1.08],0.4231770146026431
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYL1,"Myosin light chain 1/3, skeletal muscle isoform",18980,160,0.94 [0.64-1.40],0.771730738903887
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYL3,Myosin light chain 3,19166,163,1.27 [1.04-1.55],0.0200410091784914
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYL4,Myosin light chain 4,19166,163,0.74 [0.54-1.02],0.0646254769569699
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYL6B,Myosin light chain 6B,19122,159,0.92 [0.77-1.10],0.3566713791287036
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",19122,159,1.27 [0.98-1.64],0.0662750050892501
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYO6,Unconventional myosin-VI,19611,164,1.12 [0.76-1.65],0.5588316770183598
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYO9B,Unconventional myosin-IXb,22144,200,1.11 [0.93-1.33],0.2656128981416625
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYOC,Myocilin,22610,209,0.96 [0.73-1.26],0.7434982083216317
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYOM1,Myomesin-1,19004,158,1.11 [0.83-1.50],0.4768278182087935
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYOM2,Myomesin-2,18980,160,1.62 [1.27-2.06],0.0001205614312407
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MYOM3,Myomesin-3,19241,159,1.22 [1.03-1.43],0.0178841989800269
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MZB1,Marginal zone B- and B1-cell-specific protein,22643,207,1.12 [0.88-1.41],0.3549246875471203
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),MZT1,Mitotic-spindle organizing protein 1,22080,202,1.04 [0.82-1.33],0.7442421293401749
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NAA10,N-alpha-acetyltransferase 10,18980,160,1.02 [0.76-1.38],0.8854701126198956
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NAA80,N-alpha-acetyltransferase 80,19122,159,1.02 [0.90-1.16],0.7285927391060556
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NAAA,N-acylethanolamine-hydrolyzing acid amidase,22291,210,0.90 [0.72-1.11],0.3074764409668071
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NACC1,Nucleus accumbens-associated protein 1,19559,167,0.88 [0.66-1.17],0.3781600990510392
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NADK,NAD kinase,22584,212,1.08 [0.88-1.33],0.444548614057733
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NAGA,Alpha-N-acetylgalactosaminidase,19024,160,1.07 [0.82-1.39],0.6349358714814879
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NAGK,N-acetyl-D-glucosamine kinase,19131,163,1.02 [0.78-1.34],0.866675110666909
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,19241,159,1.10 [0.54-2.24],0.7923166835078855
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NAMPT,Nicotinamide phosphoribosyltransferase,22080,202,1.07 [0.87-1.33],0.5154830545173592
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NAP1L4,Nucleosome assembly protein 1-like 4,19517,166,1.11 [0.77-1.60],0.5782512398273204
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NAPRT,Nicotinate phosphoribosyltransferase,19617,166,0.95 [0.61-1.50],0.834700595416907
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NARS1,"Asparagine--tRNA ligase, cytoplasmic",19611,164,1.05 [0.76-1.44],0.7645024071394352
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NBL1,Neuroblastoma suppressor of tumorigenicity 1,22673,210,1.95 [1.27-2.99],0.0021023416612356
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NBN,Nibrin,22144,200,1.00 [0.79-1.26],0.9984363995745344
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NCAM1,Neural cell adhesion molecule 1,22706,212,1.00 [0.67-1.50],0.9893168323343464
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NCAM2,Neural cell adhesion molecule 2,22610,209,0.60 [0.38-0.96],0.0314069417422183
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NCAN,Neurocan core protein,22765,209,0.92 [0.67-1.26],0.5891975363591568
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NCF2,Neutrophil cytosol factor 2,22489,210,0.95 [0.82-1.10],0.4624997804526753
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NCK2,Cytoplasmic protein NCK2,22676,208,1.06 [0.95-1.19],0.3010200897162867
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NCLN,Nicalin,22144,200,1.00 [0.78-1.29],0.9783501600742456
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NCR1,Natural cytotoxicity triggering receptor 1,22486,207,1.37 [1.00-1.89],0.0531781573154419
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,19559,166,1.17 [0.76-1.81],0.4712140242281095
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NCS1,Neuronal calcium sensor 1,22761,210,1.53 [1.00-2.33],0.047819691976001
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NDRG1,Protein NDRG1,22060,200,0.97 [0.80-1.18],0.7654194220574261
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,19559,167,1.14 [0.94-1.39],0.1850068502959486
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,19046,160,1.00 [0.65-1.55],0.9991938968425236
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,19559,166,1.02 [0.87-1.21],0.773244803275333
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",22080,202,1.18 [1.03-1.34],0.0146020178046683
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NEB,Nebulin,18980,160,1.18 [0.82-1.68],0.3758409334458458
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NECAP2,Adaptin ear-binding coat-associated protein 2,18980,160,1.08 [0.87-1.34],0.4596573945854932
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NECTIN1,Nectin-1,19069,160,0.92 [0.57-1.49],0.7444002968486254
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NECTIN2,Nectin-2,22541,212,1.94 [1.34-2.80],0.0004095812182326
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NECTIN4,Nectin-4,22673,210,1.86 [1.36-2.54],0.0001001328474153
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,19069,160,0.85 [0.63-1.14],0.2791417126504462
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NEDD9,Enhancer of filamentation 1,19069,160,0.95 [0.60-1.52],0.8443300705023056
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NEFL,Neurofilament light polypeptide,21992,200,1.51 [1.17-1.94],0.0015626167017145
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NEK7,Serine/threonine-protein kinase Nek7,19299,165,1.09 [0.91-1.30],0.3465524368402392
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NELL1,Protein kinase C-binding protein NELL1,22673,210,0.70 [0.53-0.93],0.0128518815570445
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NELL2,Protein kinase C-binding protein NELL2,22676,208,0.91 [0.59-1.39],0.6497055488383012
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NENF,Neudesin,19559,167,1.03 [0.91-1.17],0.6583936673374641
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NEO1,Neogenin,19611,164,0.81 [0.40-1.62],0.5468517300453491
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NEXN,Nexilin,19664,165,1.06 [0.86-1.31],0.5791835795671911
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NFASC,Neurofascin,22801,212,1.70 [1.13-2.55],0.0115490932148204
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NFAT5,Nuclear factor of activated T-cells 5,19069,160,1.03 [0.87-1.23],0.7326778941538639
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",22522,211,1.01 [0.89-1.15],0.8476801273960796
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",22144,200,1.19 [0.97-1.45],0.0942498709011772
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NFE2,Transcription factor NF-E2 45 kDa subunit,19166,163,1.02 [0.83-1.25],0.8740118722002829
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NFIC,Nuclear factor 1 C-type,19611,164,0.96 [0.68-1.36],0.8208687389829806
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NFKB1,Nuclear factor NF-kappa-B p105 subunit,18980,160,1.00 [0.81-1.23],0.9724097542510982
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NFKB2,Nuclear factor NF-kappa-B p100 subunit,19299,165,1.09 [0.86-1.39],0.478847702499565
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NFKBIE,NF-kappa-B inhibitor epsilon,22080,202,1.24 [0.97-1.57],0.0862552855251462
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",19559,166,1.06 [0.92-1.23],0.4240387516949198
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NFX1,Transcriptional repressor NF-X1,18980,160,0.94 [0.74-1.18],0.5761472749336227
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NFYA,Nuclear transcription factor Y subunit alpha,18980,160,1.08 [0.75-1.55],0.6931406023380904
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NGF,Beta-nerve growth factor,22387,210,1.16 [0.42-3.18],0.7736557197431966
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NGFR,Tumor necrosis factor receptor superfamily member 16,19653,166,1.55 [1.07-2.26],0.0217700392681321
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NGRN,Neugrin,19617,166,1.03 [0.54-1.98],0.9226865740458796
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NHLRC3,NHL repeat-containing protein 3,18749,155,1.20 [0.73-1.98],0.464932592889854
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NID1,Nidogen-1,22622,211,1.31 [0.96-1.79],0.0892578689159169
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NID2,Nidogen-2,22610,209,1.24 [1.06-1.45],0.0079338640270454
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NINJ1,Ninjurin-1,22080,202,1.15 [0.93-1.41],0.1917423410358061
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NIT1,Deaminated glutathione amidase,19166,163,0.96 [0.70-1.32],0.8152107258651471
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NIT2,Omega-amidase NIT2,19579,164,0.99 [0.81-1.22],0.9578180532596254
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NLGN1,Neuroligin-1,19122,159,0.77 [0.58-1.03],0.0747145346338092
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NLGN2,Neuroligin-2,19004,158,1.18 [0.89-1.56],0.2471703602879706
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NME1,Nucleoside diphosphate kinase A,19069,160,1.46 [0.75-2.85],0.2690456988549077
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NME3,Nucleoside diphosphate kinase 3,22603,205,1.01 [0.59-1.71],0.9787029227475348
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NMI,N-myc-interactor,19494,166,1.12 [0.92-1.38],0.2574298598339521
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,22387,210,0.96 [0.81-1.13],0.6213595470683541
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NMRK2,Nicotinamide riboside kinase 2,18946,158,1.14 [0.82-1.58],0.44136150800756
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NMT1,Glycylpeptide N-tetradecanoyltransferase 1,19611,164,1.06 [0.86-1.31],0.5912007403134298
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NOMO1,Nodal modulator 1,22610,209,1.59 [0.94-2.68],0.0850102531189003
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NOP56,Nucleolar protein 56,18980,160,1.12 [1.00-1.26],0.0586662971719156
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NOS1,"Nitric oxide synthase, brain",22060,200,1.62 [1.32-1.98],3.349281658242326e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NOS2,"Nitric oxide synthase, inducible",18980,160,0.90 [0.60-1.34],0.5989256254167643
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NOS3,"Nitric oxide synthase, endothelial",22060,200,1.12 [0.90-1.39],0.3175583490498472
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NOTCH1,Neurogenic locus notch homolog protein 1,22865,212,0.70 [0.33-1.52],0.367993473149578
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NOTCH2,Neurogenic locus notch homolog protein 2,19664,164,0.78 [0.38-1.60],0.4956594912447696
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NOTCH3,Neurogenic locus notch homolog protein 3,22865,212,1.03 [0.72-1.48],0.8540047815405747
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NPC2,NPC intracellular cholesterol transporter 2,19321,162,1.32 [0.85-2.04],0.2177428125067683
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NPDC1,Neural proliferation differentiation and control protein 1,22584,212,1.61 [1.15-2.24],0.005187180611391
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NPHS1,Nephrin,19069,160,0.93 [0.59-1.48],0.772109694648843
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NPHS2,Podocin,19069,160,1.10 [0.97-1.26],0.1512644337920994
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NPL,N-acetylneuraminate lyase,19653,166,1.12 [0.81-1.54],0.4848547657808121
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NPPB,Natriuretic peptides B,22162,199,1.07 [0.98-1.17],0.1432476088166947
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NPPC,C-type natriuretic peptide,22522,211,1.18 [0.93-1.49],0.1710917335597427
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NPR1,Atrial natriuretic peptide receptor 1,18980,160,0.99 [0.67-1.46],0.957109779671203
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NPTN,Neuroplastin,22080,202,0.96 [0.82-1.14],0.6748050955960828
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NPTX1,Neuronal pentraxin-1,22610,209,1.09 [0.81-1.48],0.5635535443918054
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NPTX2,Neuronal pentraxin-2,19664,164,1.32 [0.83-2.09],0.2384602387105723
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NPTXR,Neuronal pentraxin receptor,22584,212,1.28 [0.92-1.80],0.1441817652020123
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NPY,Pro-neuropeptide Y,22761,210,0.97 [0.81-1.18],0.7913674873260175
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NRCAM,Neuronal cell adhesion molecule,22584,212,1.49 [0.99-2.24],0.0570018390752173
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NRGN,Neurogranin,19664,165,1.03 [0.87-1.21],0.7519142468994515
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NRN1,Neuritin,19611,164,1.29 [0.95-1.75],0.1045479741358072
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NRP1,Neuropilin-1,22735,212,1.36 [0.88-2.11],0.1636033645446588
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NRP2,Neuropilin-2,22610,209,1.26 [0.83-1.92],0.2724923904706664
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NRTN,Neurturin,22144,200,1.16 [0.92-1.47],0.1987083985883021
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NRXN3,Neurexin-3,19122,159,0.83 [0.52-1.34],0.4473312464726215
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NSFL1C,NSFL1 cofactor p47,22765,209,1.05 [0.87-1.26],0.6408165903254387
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",19653,166,1.02 [0.83-1.26],0.8184692397571043
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NT5C1A,Cytosolic 5'-nucleotidase 1A,19617,166,1.32 [0.87-1.99],0.1875224738594736
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NT5C3A,Cytosolic 5'-nucleotidase 3A,22491,211,1.05 [0.91-1.21],0.4974929943180212
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NT5E,5'-nucleotidase,22673,210,1.10 [0.89-1.36],0.3839052581500337
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NTF3,Neurotrophin-3,22522,211,1.12 [0.80-1.57],0.4975260582664994
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NTF4,Neurotrophin-4,22080,202,1.06 [0.78-1.45],0.702034754100362
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NTRK2,BDNF/NT-3 growth factors receptor,22584,212,0.93 [0.58-1.51],0.7833683877354696
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NTRK3,NT-3 growth factor receptor,22765,209,0.84 [0.48-1.47],0.5372771647937691
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NTproBNP,N-terminal prohormone of brain natriuretic peptide,22584,212,1.16 [1.04-1.28],0.0053120570761812
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NUB1,NEDD8 ultimate buster 1,22522,211,1.05 [0.91-1.21],0.5170693268491505
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,19559,167,0.96 [0.82-1.13],0.6520069577535037
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NUCB2,Nucleobindin-2,22717,210,1.49 [1.08-2.05],0.0152706861015274
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NUDC,Nuclear migration protein nudC,22801,212,1.11 [0.91-1.35],0.3021608076355314
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,19166,163,0.57 [0.28-1.16],0.1203915994424163
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NUDT15,Nucleotide triphosphate diphosphatase NUDT15,18980,160,0.92 [0.67-1.26],0.5966437549441241
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NUDT16,U8 snoRNA-decapping enzyme,19521,166,1.03 [0.87-1.23],0.7189175987727893
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],22474,209,0.98 [0.79-1.22],0.8773619424384431
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NUDT5,ADP-sugar pyrophosphatase,22610,209,1.22 [0.97-1.54],0.0865191243478075
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NUMB,Protein numb homolog,19069,160,0.99 [0.82-1.19],0.9166810376298692
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NUP50,Nuclear pore complex protein Nup50,18980,160,0.97 [0.61-1.55],0.9045826681391264
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NXPE4,NXPE family member 4,18980,160,1.08 [0.69-1.67],0.7445235012565443
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NXPH1,Neurexophilin-1,22060,200,1.23 [0.91-1.65],0.1711071139883842
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),NXPH3,Neurexophilin-3,19069,160,1.12 [0.67-1.86],0.6620390538699522
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OBP2B,Odorant-binding protein 2b,22319,209,1.01 [0.82-1.23],0.9452879944019484
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OCLN,Occludin,19611,164,1.53 [1.12-2.09],0.007276978846615
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ODAM,Odontogenic ameloblast-associated protein,22026,200,0.92 [0.73-1.16],0.4771616178637088
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OFD1,Oral-facial-digital syndrome 1 protein,19299,165,0.91 [0.70-1.17],0.4452168321493155
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OGA,Protein O-GlcNAcase,19559,166,1.07 [0.87-1.33],0.5164071241742996
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OGFR,Opioid growth factor receptor,22474,209,1.24 [0.86-1.79],0.2582408418484805
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OGN,Mimecan,22610,209,1.54 [1.17-2.02],0.0017938838847841
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,19299,165,0.92 [0.72-1.19],0.528613737318389
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OLFM4,Olfactomedin-4,18517,152,1.04 [0.92-1.19],0.5126017735424522
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OLR1,Oxidized low-density lipoprotein receptor 1,22362,211,0.99 [0.80-1.22],0.925457762452873
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OMD,Osteomodulin,22676,208,0.87 [0.65-1.15],0.3290597636181702
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OMG,Oligodendrocyte-myelin glycoprotein,22474,209,0.92 [0.77-1.11],0.3952618452215186
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OMP,Olfactory marker protein,19004,158,0.93 [0.67-1.29],0.6555387058378375
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OPHN1,Oligophrenin-1,19617,166,0.97 [0.85-1.12],0.6823563100882089
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OPLAH,5-oxoprolinase,19166,163,1.00 [0.80-1.25],0.975231962547278
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OPTC,Opticin,22474,209,1.00 [0.77-1.31],0.9737850191510974
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ORM1,Alpha-1-acid glycoprotein 1,19609,164,0.55 [0.26-1.20],0.1329679481515261
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OSBPL2,Oxysterol-binding protein-related protein 2,19617,166,1.03 [0.71-1.49],0.8837631784873023
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OSCAR,Osteoclast-associated immunoglobulin-like receptor,22603,205,1.37 [0.96-1.97],0.0835521306892497
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OSM,Oncostatin-M,22423,211,1.03 [0.86-1.23],0.745796761149761
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OSMR,Oncostatin-M-specific receptor subunit beta,22735,212,1.38 [0.75-2.53],0.2967835777360526
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OSTN,Osteocrin,19122,159,0.77 [0.51-1.18],0.2342490240094691
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OTOA,Otoancorin,19004,158,1.06 [0.81-1.38],0.6885547813825963
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OTUD6B,Deubiquitinase OTUD6B,19559,166,1.09 [0.85-1.40],0.5025036029908547
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OTUD7B,OTU domain-containing protein 7B,19611,164,1.15 [0.90-1.46],0.2606420488637697
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",19166,163,0.94 [0.75-1.17],0.584483355883738
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),OXT,Oxytocin-neurophysin 1,22765,209,1.03 [0.94-1.13],0.4928963142797614
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),P4HB,Protein disulfide-isomerase,22487,209,1.54 [1.13-2.11],0.0066047494401151
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PACS2,Phosphofurin acidic cluster sorting protein 2,18980,160,1.03 [0.80-1.32],0.8287829207693703
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PADI2,Protein-arginine deiminase type-2,22144,200,1.09 [0.89-1.33],0.4066163493501904
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PADI4,Protein-arginine deiminase type-4,22026,200,1.04 [0.89-1.22],0.5852586407253062
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PAEP,Glycodelin,22387,210,1.04 [0.91-1.19],0.5439047671382422
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,19611,164,1.02 [0.90-1.16],0.7118641752488438
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",19299,165,1.00 [0.73-1.36],0.9910627945911142
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,22162,199,1.15 [0.93-1.43],0.2059270318577559
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PAGR1,PAXIP1-associated glutamate-rich protein 1,19166,163,0.69 [0.47-1.02],0.0631341192869707
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PAIP2B,Polyadenylate-binding protein-interacting protein 2B,18916,158,1.22 [0.93-1.59],0.1533908809223679
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PAK4,Serine/threonine-protein kinase PAK 4,22060,200,1.24 [1.03-1.50],0.0232855588631857
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PALLD,Palladin,19069,160,0.93 [0.62-1.40],0.7456811842339008
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PALM,Paralemmin-1,19447,166,1.14 [0.71-1.84],0.5839462860843989
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PALM2,Paralemmin-2,19617,166,1.53 [1.06-2.22],0.0245175029056533
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PALM3,Paralemmin-3,18980,160,1.06 [0.88-1.29],0.5270848112822062
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PAM,Peptidyl-glycine alpha-amidating monooxygenase,22756,212,0.96 [0.63-1.48],0.8642208498844355
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PAMR1,Inactive serine protease PAMR1,22610,209,0.76 [0.48-1.20],0.2383274871863552
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PAPPA,Pappalysin-1,22144,200,1.10 [0.84-1.44],0.5028690130331364
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PARD3,Partitioning defective 3 homolog,19299,165,0.89 [0.71-1.10],0.2788083418385569
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PARK7,Parkinson disease protein 7,22610,209,1.04 [0.83-1.32],0.7210946383613872
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PARP1,Poly [ADP-ribose] polymerase 1,22522,211,0.96 [0.77-1.20],0.7424082418466564
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PAXX,Protein PAXX,19241,159,1.05 [0.75-1.47],0.7875145665606877
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PBK,Lymphokine-activated killer T-cell-originated protein kinase,18946,158,1.17 [0.71-1.92],0.5355786670526099
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PBLD,Phenazine biosynthesis-like domain-containing protein,22060,200,1.24 [0.98-1.57],0.0790046382497352
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,19559,166,0.73 [0.43-1.26],0.2603433896432903
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PCARE,Photoreceptor cilium actin regulator,19004,158,0.79 [0.62-1.00],0.0494533944548955
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PCBD1,Pterin-4-alpha-carbinolamine dehydratase,19211,158,1.17 [0.85-1.61],0.3411051027223531
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PCBP2,Poly(rC)-binding protein 2,19611,164,1.00 [0.81-1.23],0.998535465746346
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PCDH1,Protocadherin-1,22727,212,1.03 [0.59-1.80],0.9125320793423282
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PCDH12,Protocadherin-12,19611,164,1.07 [0.59-1.91],0.8284574329752196
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PCDH17,Protocadherin-17,22584,212,0.97 [0.69-1.35],0.8410491409222494
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PCDH7,Protocadherin-7,19559,166,0.84 [0.53-1.32],0.4493655345868458
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PCDH9,Protocadherin-9,19559,166,0.90 [0.58-1.40],0.6513597458827871
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PCDHB15,Protocadherin beta-15,19559,167,0.76 [0.52-1.12],0.1626649531255676
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PCNA,Proliferating cell nuclear antigen,18946,158,1.12 [0.91-1.39],0.2828092010465938
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PCSK7,Proprotein convertase subtilisin/kexin type 7,19559,167,1.21 [0.91-1.59],0.1915944348612042
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PCSK9,Proprotein convertase subtilisin/kexin type 9,22865,212,1.24 [0.92-1.68],0.1631441602706869
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PCYT2,Ethanolamine-phosphate cytidylyltransferase,19559,166,1.12 [0.92-1.37],0.2523388131460287
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDAP1,28 kDa heat- and acid-stable phosphoprotein,19653,166,1.07 [0.92-1.25],0.3767128692010654
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDCD1,Programmed cell death protein 1,22719,210,1.14 [0.87-1.49],0.3476084989318027
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDCD1LG2,Programmed cell death 1 ligand 2,22474,209,1.59 [1.11-2.29],0.0125209726043299
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDCD5,Programmed cell death protein 5,22765,209,1.02 [0.83-1.26],0.8215143909995417
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDCD6,Programmed cell death protein 6,22584,212,1.18 [0.96-1.44],0.114436575923568
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDCL2,Phosducin-like protein 2,18946,158,1.05 [0.79-1.38],0.7495285959462801
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",18946,158,0.96 [0.71-1.28],0.7613726180056559
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",18980,160,0.93 [0.70-1.22],0.5805932129232934
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",19241,159,0.99 [0.86-1.15],0.9191259184854332
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDGFA,Platelet-derived growth factor subunit A,22865,212,1.07 [0.90-1.26],0.430927587775134
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDGFB,Platelet-derived growth factor subunit B,22676,208,1.09 [0.94-1.26],0.2419068901661819
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDGFC,Platelet-derived growth factor C,22080,202,1.61 [1.10-2.35],0.0140709396687501
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDGFRA,Platelet-derived growth factor receptor alpha,22584,212,1.53 [1.01-2.32],0.0430120391606575
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDGFRB,Platelet-derived growth factor receptor beta,22865,212,1.15 [0.81-1.64],0.4277031844086277
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDIA2,Protein disulfide-isomerase A2,18946,158,1.06 [0.74-1.51],0.7502162480095665
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDIA3,Protein disulfide-isomerase A3,19241,159,1.48 [0.84-2.60],0.1740851571232404
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDIA4,Protein disulfide-isomerase A4,19664,164,1.10 [0.86-1.40],0.4623085164921767
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDIA5,Protein disulfide-isomerase A5,18946,158,0.86 [0.65-1.14],0.2902983733091344
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDLIM5,PDZ and LIM domain protein 5,19611,164,1.03 [0.91-1.17],0.638660240071673
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDLIM7,PDZ and LIM domain protein 7,22676,208,1.06 [0.96-1.17],0.2460778712786676
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",22080,202,1.31 [1.08-1.59],0.0060475533839233
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDRG1,p53 and DNA damage-regulated protein 1,19122,159,1.06 [0.80-1.39],0.6930704137879282
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,18946,158,1.08 [0.86-1.36],0.510955282758014
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDZD2,PDZ domain-containing protein 2,18980,160,1.28 [1.03-1.60],0.0289212653462063
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,19069,160,1.61 [1.21-2.14],0.0012444111133755
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PEAR1,Platelet endothelial aggregation receptor 1,22865,212,1.56 [0.91-2.66],0.1069272753051545
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PEBP1,Phosphatidylethanolamine-binding protein 1,22610,209,1.04 [0.85-1.29],0.6839017335100048
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PECAM1,Platelet endothelial cell adhesion molecule,22610,209,1.28 [0.87-1.91],0.2142991159833877
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PECR,Peroxisomal trans-2-enoyl-CoA reductase,19166,163,0.72 [0.40-1.29],0.2712055281420722
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PENK,Proenkephalin-A,19241,159,1.18 [0.75-1.87],0.4668683376600365
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PEPD,Xaa-Pro dipeptidase,19664,165,1.47 [0.83-2.59],0.1875681586907945
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PER3,Period circadian protein homolog 3,19069,160,1.08 [0.96-1.22],0.1996963239158725
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PF4,Platelet factor 4,19536,163,1.01 [0.87-1.18],0.8606201821435029
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PFDN2,Prefoldin subunit 2,22060,200,1.14 [0.92-1.43],0.2386501303783366
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PFDN4,Prefoldin subunit 4,18946,158,0.93 [0.68-1.26],0.6245708247892667
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PFDN6,Prefoldin subunit 6,19122,159,0.90 [0.69-1.17],0.4247780906407917
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",22431,209,1.09 [0.93-1.28],0.2732003330756248
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PGA4,Pepsin A-4,19664,165,1.00 [0.83-1.20],0.997812816995755
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PGD,"6-phosphogluconate dehydrogenase, decarboxylating",19653,166,1.12 [0.85-1.48],0.4049689904727466
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PGF,Placenta growth factor,22801,212,1.97 [1.31-2.98],0.0011917598169251
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PGLYRP1,Peptidoglycan recognition protein 1,22771,212,1.19 [0.91-1.57],0.2122420486493953
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PGLYRP2,N-acetylmuramoyl-L-alanine amidase,19440,162,0.68 [0.42-1.11],0.1209391714761444
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PGLYRP4,Peptidoglycan recognition protein 4,18980,160,1.13 [0.90-1.41],0.3064628843898653
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PGM2,Phosphoglucomutase-2,19122,159,0.82 [0.60-1.12],0.2174067020295506
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PGR,Progesterone receptor,19069,160,1.02 [0.88-1.19],0.7798625318665324
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PHACTR2,Phosphatase and actin regulator 2,19611,164,1.03 [0.90-1.17],0.7125022099957523
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PHLDB1,Pleckstrin homology-like domain family B member 1,19559,166,1.11 [0.84-1.48],0.4607356513144942
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PHLDB2,Pleckstrin homology-like domain family B member 2,18946,158,0.88 [0.73-1.06],0.1924052410361235
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,22387,210,1.67 [1.14-2.44],0.0087172099235497
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,19241,159,1.16 [0.80-1.69],0.4220714944105352
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PI16,Peptidase inhibitor 16,19664,165,1.06 [0.59-1.92],0.841844595561493
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PI3,Elafin,22307,205,1.16 [0.94-1.43],0.1775865010109844
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",19611,164,1.03 [0.85-1.25],0.7569561076469584
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PIGR,Polymeric immunoglobulin receptor,22308,206,1.77 [1.27-2.46],0.0007276387772044
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,22522,211,1.05 [0.87-1.28],0.601493720069887
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,22610,209,2.03 [1.40-2.96],0.0002055428839541
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,19069,160,0.83 [0.61-1.13],0.2346468827426828
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PILRA,Paired immunoglobulin-like type 2 receptor alpha,22610,209,1.63 [1.22-2.18],0.0011019127638177
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PILRB,Paired immunoglobulin-like type 2 receptor beta,22584,212,1.33 [1.07-1.66],0.0117663187358039
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,19241,159,1.22 [0.97-1.53],0.0854224273869943
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PITHD1,PITH domain-containing protein 1,18916,158,1.03 [0.86-1.24],0.7561010744683017
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PKD1,Polycystin-1,19653,166,1.45 [0.82-2.56],0.196671057224452
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PKD2,Polycystin-2,18980,160,1.03 [0.79-1.34],0.8129306307231068
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PKLR,Pyruvate kinase PKLR,22606,206,0.94 [0.78-1.13],0.5289880941733087
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PKN3,Serine/threonine-protein kinase N3,19299,165,0.88 [0.71-1.08],0.2307588799724396
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLA2G10,Group 10 secretory phospholipase A2,22387,210,1.15 [0.93-1.42],0.1967011031570131
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLA2G15,Phospholipase A2 group XV,22673,210,1.64 [1.05-2.55],0.0291005891976001
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLA2G1B,Phospholipase A2,22834,211,0.90 [0.68-1.17],0.4220065788707214
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLA2G2A,"Phospholipase A2, membrane associated",22544,206,1.15 [0.94-1.40],0.1838911691670895
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLA2G4A,Cytosolic phospholipase A2,22676,208,1.07 [0.93-1.23],0.3486707278330266
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLA2G7,Platelet-activating factor acetylhydrolase,22610,209,0.56 [0.40-0.80],0.0013000317204297
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLAT,Tissue-type plasminogen activator,22799,212,0.94 [0.74-1.19],0.5883549736137075
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLAU,Urokinase-type plasminogen activator,22610,209,0.86 [0.56-1.32],0.4956562099543126
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLAUR,Urokinase plasminogen activator surface receptor,22426,205,2.86 [1.90-4.29],4.165512594024813e-07
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLB1,"Phospholipase B1, membrane-associated",19617,166,0.86 [0.67-1.10],0.2390242711995581
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",19069,160,0.99 [0.68-1.42],0.9360490003811616
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",19617,166,1.07 [0.91-1.24],0.4201301644743448
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLEKHO1,Pleckstrin homology domain-containing family O member 1,19617,166,0.92 [0.74-1.14],0.4563583042041803
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLG,Plasminogen,19191,161,0.87 [0.43-1.77],0.7023869074008
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLIN1,Perilipin-1,22060,200,0.94 [0.65-1.36],0.7413469860383068
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLIN3,Perilipin-3,22584,212,1.24 [0.94-1.63],0.1340177891179233
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLPBP,Pyridoxal phosphate homeostasis protein,22584,212,1.03 [0.86-1.24],0.7324694202813071
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLSCR3,Phospholipid scramblase 3,19575,164,1.10 [0.85-1.42],0.4795974521545874
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLTP,Phospholipid transfer protein,22802,212,0.89 [0.63-1.24],0.4893089711093844
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLXDC1,Plexin domain-containing protein 1,22080,202,1.10 [0.76-1.60],0.6205788639606362
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLXDC2,Plexin domain-containing protein 2,19617,166,1.51 [0.96-2.36],0.0723777999241424
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLXNA4,Plexin-A4,22522,211,1.04 [0.90-1.21],0.61064872623078
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLXNB2,Plexin-B2,22750,212,1.73 [1.07-2.80],0.0267008653093305
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PLXNB3,Plexin-B3,22522,212,1.09 [0.84-1.41],0.5301799749784804
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,22455,212,0.99 [0.92-1.05],0.6793658869660197
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PMCH,Pro-MCH,18980,160,0.94 [0.77-1.15],0.5745641787832438
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PMM2,Phosphomannomutase 2,18980,160,1.04 [0.80-1.34],0.7765443467247793
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PMS1,PMS1 protein homolog 1,19122,159,0.82 [0.59-1.14],0.2406063604318538
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PMVK,Phosphomevalonate kinase,22022,199,1.06 [0.94-1.20],0.3270254308065333
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PNLIP,Pancreatic triacylglycerol lipase,19664,165,0.86 [0.68-1.08],0.2018343052471282
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PNLIPRP1,Inactive pancreatic lipase-related protein 1,19617,166,1.04 [0.87-1.25],0.6609146300078428
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PNLIPRP2,Pancreatic lipase-related protein 2,22569,205,0.98 [0.94-1.02],0.3916784141590916
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PNMA1,Paraneoplastic antigen Ma1,19166,163,0.86 [0.65-1.14],0.2905313967583831
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PNMA2,Paraneoplastic antigen Ma2,19004,158,0.95 [0.67-1.35],0.787994920370515
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",22144,200,1.02 [0.92-1.14],0.6910339328061088
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PODXL,Podocalyxin,22474,209,0.49 [0.22-1.07],0.0748195288088667
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PODXL2,Podocalyxin-like protein 2,22673,210,1.26 [0.82-1.93],0.2959554192993531
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),POF1B,Protein POF1B,19069,160,1.18 [0.87-1.60],0.2847681626215931
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),POLR2A,DNA-directed RNA polymerase II subunit RPB1,19069,160,0.64 [0.36-1.11],0.1133925032212931
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",22474,209,1.26 [0.93-1.71],0.1289449362276738
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),POMC,Pro-opiomelanocortin,19166,163,0.75 [0.61-0.94],0.0112766866813509
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PON1,Serum paraoxonase/arylesterase 1,19664,165,0.76 [0.46-1.26],0.2832120811207639
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PON2,Serum paraoxonase/arylesterase 2,22162,199,1.08 [0.76-1.54],0.6728592777931379
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PON3,Serum paraoxonase/lactonase 3,22676,208,0.88 [0.59-1.29],0.5045920055683262
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),POSTN,Periostin,19664,164,1.23 [0.83-1.82],0.2958214692673162
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPBP,Platelet basic protein,19548,163,1.08 [0.90-1.29],0.3871953534937625
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPCDC,Phosphopantothenoylcysteine decarboxylase,22765,209,0.97 [0.75-1.27],0.8445182687150921
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPIB,Peptidyl-prolyl cis-trans isomerase B,22631,212,1.09 [0.95-1.24],0.2085284544559792
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPIE,Peptidyl-prolyl cis-trans isomerase E,19299,165,0.94 [0.73-1.21],0.6526283306208507
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",19664,164,1.04 [0.83-1.32],0.7142859619116717
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPL,Periplakin,19069,160,1.14 [0.73-1.79],0.571515273000156
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPM1A,Protein phosphatase 1A,22080,202,1.17 [0.82-1.67],0.3937017867788293
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPM1B,Protein phosphatase 1B,19069,160,0.98 [0.75-1.27],0.8779105974777948
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPM1F,Protein phosphatase 1F,19653,166,1.03 [0.78-1.37],0.8171044373307785
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPME1,Protein phosphatase methylesterase 1,22474,209,1.01 [0.82-1.23],0.9534528526506189
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,19559,167,1.08 [0.91-1.29],0.381805259324438
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,22673,210,1.10 [0.97-1.25],0.1200573632296181
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,19299,165,1.12 [0.93-1.35],0.2422639943922289
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,19611,164,1.03 [0.86-1.24],0.7545472272036461
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,19611,164,0.95 [0.64-1.41],0.8020664714793375
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPP1R2,Protein phosphatase inhibitor 2,22584,212,1.10 [0.95-1.29],0.1999683108869544
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPP1R9B,Neurabin-2,22801,212,1.08 [0.95-1.22],0.259074123286626
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,19559,166,1.08 [0.95-1.22],0.2333465237680526
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPP3R1,Calcineurin subunit B type 1,22387,210,1.44 [1.07-1.93],0.0157778196502003
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPT1,Palmitoyl-protein thioesterase 1,19122,159,1.02 [0.84-1.25],0.8180155559756471
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PPY,Pancreatic prohormone,22579,210,0.99 [0.88-1.11],0.8324518512285892
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PQBP1,Polyglutamine-binding protein 1,22080,202,1.08 [0.88-1.32],0.4663414022411597
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRAME,Melanoma antigen preferentially expressed in tumors,18946,158,1.00 [0.55-1.83],0.9900622871720278
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRAP1,Proline-rich acidic protein 1,19664,164,1.16 [0.80-1.68],0.4406464038950473
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRC1,Protein regulator of cytokinesis 1,19559,167,1.07 [0.79-1.45],0.672456995043577
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRCP,Lysosomal Pro-X carboxypeptidase,22743,210,1.00 [0.68-1.48],0.9946067526841218
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRDX1,Peroxiredoxin-1,21925,210,1.08 [0.94-1.23],0.2899159798595589
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRDX2,Peroxiredoxin-2,19322,164,0.82 [0.64-1.04],0.1022221716869451
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",22144,200,1.26 [1.06-1.49],0.0076915155125749
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRDX5,"Peroxiredoxin-5, mitochondrial",22801,212,1.09 [0.91-1.32],0.3464645777397825
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRDX6,Peroxiredoxin-6,22761,210,1.01 [0.83-1.24],0.8869686479514121
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PREB,Prolactin regulatory element-binding protein,22144,200,1.63 [1.16-2.31],0.0052915574363555
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRELP,Prolargin,22569,205,1.49 [0.88-2.53],0.1401823359568776
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRG2,Bone marrow proteoglycan,19664,164,1.01 [0.76-1.35],0.9234876933008628
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRG3,Proteoglycan 3,19664,164,1.03 [0.76-1.39],0.8467665890577469
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRKAB1,5'-AMP-activated protein kinase subunit beta-1,22144,200,1.25 [1.01-1.56],0.0424899754298726
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,19122,159,0.81 [0.48-1.35],0.4146244197283689
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,22584,212,1.02 [0.88-1.18],0.8140624899299854
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,19581,166,1.06 [0.88-1.28],0.5222501101899129
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRKCQ,Protein kinase C theta type,22144,200,1.19 [0.92-1.54],0.1866866946798817
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRKD2,Serine/threonine-protein kinase D2,18980,160,0.96 [0.67-1.36],0.81242787111776
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRKG1,cGMP-dependent protein kinase 1,19241,159,1.03 [0.92-1.17],0.5913510536394335
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,22080,202,1.04 [0.86-1.25],0.6755493775004833
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRL,Prolactin,22765,209,1.15 [0.98-1.34],0.0951611656907533
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRND,Prion-like protein doppel,19617,166,1.01 [0.76-1.34],0.9517434906733356
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PROC,Vitamin K-dependent protein C,22659,212,1.01 [0.62-1.65],0.968761582378252
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PROCR,Endothelial protein C receptor,18980,160,0.86 [0.53-1.38],0.5274245255270644
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PROK1,Prokineticin-1,22522,211,1.05 [0.84-1.30],0.6815285371237729
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PROS1,Vitamin K-dependent protein S,19683,165,0.67 [0.37-1.20],0.1734353033522901
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRR4,Proline-rich protein 4,19082,156,1.02 [0.82-1.27],0.8826215771312655
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRR5,Proline-rich protein 5,19069,160,1.01 [0.72-1.40],0.9677194223801108
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRRT3,Proline-rich transmembrane protein 3,19166,163,1.07 [0.72-1.57],0.7382640513464598
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRSS2,Trypsin-2,22706,212,1.19 [0.96-1.47],0.115471258224296
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRSS22,Brain-specific serine protease 4,19069,160,0.74 [0.46-1.20],0.223279530741294
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRSS27,Serine protease 27,22520,212,1.16 [0.86-1.57],0.321942259121886
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRSS53,Serine protease 53,19617,166,1.03 [0.70-1.52],0.8877866953672966
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRSS8,Prostasin,22492,208,1.63 [1.23-2.17],0.000780879075874
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,22060,200,1.04 [0.93-1.17],0.5019455412276843
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRTG,Protogenin,22761,210,1.09 [0.67-1.79],0.7251658518060431
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRTN3,Myeloblastin,22015,207,1.03 [0.80-1.32],0.8148616751591374
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PRUNE2,Protein prune homolog 2,19299,165,1.21 [0.76-1.93],0.41500123867526
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PSAP,Prosaposin,19470,164,1.14 [0.68-1.92],0.611200248294361
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PSAPL1,Proactivator polypeptide-like 1,19559,166,1.00 [0.75-1.34],0.9913484551951344
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PSCA,Prostate stem cell antigen,19559,166,1.03 [0.97-1.09],0.3787839036385545
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PSG1,Pregnancy-specific beta-1-glycoprotein 1,22387,210,1.10 [0.98-1.23],0.089935956795454
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PSIP1,PC4 and SFRS1-interacting protein,22522,211,1.05 [0.87-1.25],0.6204996492164516
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PSMA1,Proteasome subunit alpha type-1,22080,202,0.77 [0.57-1.05],0.0947958041766018
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PSMC3,26S proteasome regulatory subunit 6A,18946,158,0.95 [0.57-1.56],0.8267675014225224
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PSMD1,26S proteasome non-ATPase regulatory subunit 1,19611,164,0.96 [0.71-1.30],0.7753492689508459
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PSMD5,26S proteasome non-ATPase regulatory subunit 5,19122,159,1.04 [0.80-1.35],0.7790321590005436
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PSMD9,26S proteasome non-ATPase regulatory subunit 9,22474,209,0.80 [0.63-1.00],0.0542495838046757
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PSME1,Proteasome activator complex subunit 1,22337,210,0.96 [0.69-1.34],0.826085048037422
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PSME2,Proteasome activator complex subunit 2,22273,209,0.97 [0.69-1.36],0.8697908631924979
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PSMG3,Proteasome assembly chaperone 3,22522,211,0.84 [0.67-1.07],0.1632587675712614
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PSMG4,Proteasome assembly chaperone 4,19069,160,0.73 [0.55-0.97],0.0309265444268726
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PSPN,Persephin,22522,211,1.03 [0.90-1.17],0.652195487515344
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PSRC1,Proline/serine-rich coiled-coil protein 1,22080,202,1.21 [1.00-1.47],0.0545184223959227
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,18578,155,1.01 [0.87-1.17],0.9054977016902732
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",22060,200,1.49 [0.99-2.23],0.0535617620404864
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTGDS,Prostaglandin-H2 D-isomerase,22429,211,1.75 [1.24-2.47],0.001401219645022
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTGES2,Prostaglandin E synthase 2,18926,160,1.26 [0.96-1.66],0.0929681928926492
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTGR1,Prostaglandin reductase 1,19653,166,1.03 [0.86-1.23],0.7458619890527229
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTH,Parathyroid hormone,19122,159,0.98 [0.81-1.19],0.8569982043547542
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,22522,211,1.21 [0.93-1.58],0.1520766441325239
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTK7,Inactive tyrosine-protein kinase 7,22060,200,1.42 [1.02-1.97],0.0383644029033433
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTN,Pleiotrophin,22162,199,1.27 [0.99-1.63],0.0582632160050165
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTP4A3,Protein tyrosine phosphatase type IVA 3,19069,160,1.02 [0.77-1.35],0.8906151844852633
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTPN1,Tyrosine-protein phosphatase non-receptor type 1,22387,210,1.13 [0.97-1.31],0.1230718252852087
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTPN6,Tyrosine-protein phosphatase non-receptor type 6,22636,206,1.05 [0.92-1.21],0.461787246218054
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTPN9,Tyrosine-protein phosphatase non-receptor type 9,19040,160,0.71 [0.45-1.13],0.1467243636369522
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTPRB,Receptor-type tyrosine-protein phosphatase beta,19653,166,0.72 [0.43-1.21],0.2160720404930035
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTPRC,Receptor-type tyrosine-protein phosphatase C,19664,164,1.54 [0.84-2.83],0.1645253326939633
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTPRF,Receptor-type tyrosine-protein phosphatase F,22865,212,1.37 [0.90-2.09],0.1381003014865778
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTPRH,Receptor-type tyrosine-protein phosphatase H,19559,166,1.03 [0.75-1.40],0.8697235562545393
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTPRK,Receptor-type tyrosine-protein phosphatase kappa,19559,166,1.57 [0.88-2.79],0.1261929370646888
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTPRM,Receptor-type tyrosine-protein phosphatase mu,22492,211,0.65 [0.40-1.08],0.0971726927779859
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTPRN2,Receptor-type tyrosine-protein phosphatase N2,22321,210,1.60 [1.13-2.28],0.0087976542291019
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTPRR,Receptor-type tyrosine-protein phosphatase R,19617,166,1.03 [0.69-1.54],0.8982762903782187
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTPRS,Receptor-type tyrosine-protein phosphatase S,22865,212,1.11 [0.68-1.81],0.6716215589226467
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,19653,166,0.97 [0.61-1.55],0.912223440264166
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,19241,159,1.00 [0.77-1.29],0.9883564495596776
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTS,6-pyruvoyl tetrahydrobiopterin synthase,21950,200,1.14 [0.91-1.42],0.247337513847012
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTTG1,Securin,19299,165,0.95 [0.65-1.38],0.7721593870756087
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PTX3,Pentraxin-related protein PTX3,22522,211,1.08 [0.83-1.39],0.5734473478696696
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PVALB,Parvalbumin alpha,22642,210,1.03 [0.92-1.15],0.5741257976448455
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PVR,Poliovirus receptor,22765,209,1.24 [0.90-1.72],0.1919033949921577
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PXDNL,Peroxidasin-like protein,19559,167,0.97 [0.74-1.27],0.8250283418058657
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PXN,Paxillin,22060,200,1.11 [0.88-1.40],0.3847914318442278
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PYDC1,Pyrin domain-containing protein 1,19166,163,0.92 [0.63-1.34],0.6693237437994745
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PYY,Peptide YY,18980,160,1.12 [0.97-1.29],0.1365316544350779
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),PZP,Pregnancy zone protein,19683,165,0.73 [0.54-0.99],0.0449573840909745
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),QDPR,Dihydropteridine reductase,22475,211,1.11 [0.84-1.48],0.4686565190750624
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),QPCT,Glutaminyl-peptide cyclotransferase,22641,209,1.33 [0.85-2.07],0.217491393429922
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),QSOX1,Sulfhydryl oxidase 1,19294,164,0.96 [0.64-1.42],0.8290994768148588
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RAB10,Ras-related protein Rab-10,19653,166,0.96 [0.73-1.27],0.78250835446125
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RAB11FIP3,Rab11 family-interacting protein 3,19653,166,1.01 [0.88-1.16],0.8414240101766592
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RAB27B,Ras-related protein Rab-27B,19653,166,1.03 [0.86-1.23],0.7606393602281236
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RAB2B,Ras-related protein Rab-2B,19559,167,1.13 [0.89-1.44],0.3225000053273501
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RAB33A,Ras-related protein Rab-33A,18980,160,1.11 [0.89-1.40],0.3488987252099598
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RAB37,Ras-related protein Rab-37,22144,200,1.01 [0.87-1.18],0.8738688580306282
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RAB39B,Ras-related protein Rab-39B,18980,160,1.04 [0.88-1.22],0.6724236665808467
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,19004,158,1.08 [0.84-1.39],0.5485364778907681
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RAB44,Ras-related protein Rab-44,19559,167,1.02 [0.74-1.42],0.8888494578689689
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RAB6A,Ras-related protein Rab-6A,22522,211,0.99 [0.76-1.28],0.9147788761147172
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RAB6B,Ras-related protein Rab-6B,22060,200,1.27 [1.02-1.58],0.0352582643728702
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RABEP1,Rab GTPase-binding effector protein 1,19241,159,1.04 [0.85-1.26],0.7187272134486974
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RABEPK,Rab9 effector protein with kelch motifs,22080,202,1.16 [0.96-1.42],0.132193133742975
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RABGAP1L,Rab GTPase-activating protein 1-like,22144,200,1.06 [0.86-1.30],0.5681743355846971
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RAC3,Ras-related C3 botulinum toxin substrate 3,19122,159,1.04 [0.85-1.29],0.6838279783533091
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RAD23B,UV excision repair protein RAD23 homolog B,22080,202,1.16 [0.90-1.50],0.2592620224361441
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RAD51,DNA repair protein RAD51 homolog 1,19299,165,0.94 [0.70-1.27],0.697405326785439
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RALB,Ras-related protein Ral-B,19069,160,1.22 [0.74-2.01],0.4420503819819914
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RALY,RNA-binding protein Raly,19559,167,1.07 [0.80-1.43],0.6295150765442681
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RANBP1,Ran-specific GTPase-activating protein,19166,163,0.87 [0.66-1.16],0.3585090388326488
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RANBP2,E3 SUMO-protein ligase RanBP2,19004,158,1.30 [0.84-2.02],0.2402907141315222
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RANGAP1,Ran GTPase-activating protein 1,22080,202,1.09 [0.84-1.41],0.4994343356360864
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RAP1A,Ras-related protein Rap-1A,19069,160,1.08 [0.88-1.32],0.4700557245408976
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RAPGEF2,Rap guanine nucleotide exchange factor 2,19299,165,1.03 [0.78-1.37],0.8174286570122545
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RARRES1,Retinoic acid receptor responder protein 1,22080,202,1.37 [1.04-1.82],0.0275470167318216
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RARRES2,Retinoic acid receptor responder protein 2,22735,212,1.28 [1.01-1.63],0.0443207234923729
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RASA1,Ras GTPase-activating protein 1,22060,200,1.29 [0.92-1.83],0.1439994066619329
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,18946,158,0.78 [0.55-1.11],0.172333353388551
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RASSF2,Ras association domain-containing protein 2,22080,202,1.08 [0.88-1.33],0.4439656039852658
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RBFOX3,RNA binding protein fox-1 homolog 3,19611,164,1.58 [1.18-2.10],0.0019765932838604
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RBKS,Ribokinase,22048,207,0.83 [0.66-1.04],0.1066240602910797
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RBM17,Splicing factor 45,19611,164,1.05 [0.86-1.28],0.6197551624964394
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RBM19,Probable RNA-binding protein 19,18980,160,0.80 [0.55-1.17],0.2486046561850488
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RBM25,RNA-binding protein 25,18946,158,0.89 [0.64-1.25],0.5082615524646215
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RBP1,Retinol-binding protein 1,19122,159,0.98 [0.78-1.23],0.8811272182878713
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RBP2,Retinol-binding protein 2,22474,209,1.30 [1.12-1.51],0.0006363509100286
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RBP5,Retinol-binding protein 5,22474,209,1.33 [1.08-1.64],0.0064730896572053
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RBP7,Retinoid-binding protein 7,19559,166,1.03 [0.81-1.31],0.793875501284656
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RBPMS,RNA-binding protein with multiple splicing,19069,160,0.85 [0.65-1.13],0.2619155348696648
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RBPMS2,RNA-binding protein with multiple splicing 2,19166,163,1.03 [0.89-1.19],0.7061178478304782
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RCC1,Regulator of chromosome condensation,19559,167,1.02 [0.76-1.35],0.9058577925947924
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RCOR1,REST corepressor 1,22162,199,0.88 [0.63-1.22],0.4303041002943141
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,19166,163,0.66 [0.32-1.37],0.2670456829569404
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),REEP4,Receptor expression-enhancing protein 4,19611,164,0.94 [0.73-1.21],0.6352929370730085
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),REG1A,Lithostathine-1-alpha,22460,209,1.52 [1.24-1.87],4.828451300154898e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),REG1B,Lithostathine-1-beta,22865,212,1.35 [1.12-1.62],0.0015306806206432
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),REG3A,Regenerating islet-derived protein 3-alpha,22865,212,1.30 [1.09-1.54],0.0033735246383019
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),REG3G,Regenerating islet-derived protein 3-gamma,19559,167,0.99 [0.68-1.43],0.9419939742576784
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),REG4,Regenerating islet-derived protein 4,22603,205,1.58 [1.27-1.98],4.429833470990467e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RELB,Transcription factor RelB,19069,160,1.13 [0.85-1.50],0.3920244605611356
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RELT,Tumor necrosis factor receptor superfamily member 19L,22610,209,1.83 [1.25-2.67],0.0018245801737009
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),REN,Renin,22584,212,1.20 [1.05-1.37],0.008123797834504
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),REPS1,RalBP1-associated Eps domain-containing protein 1,19069,160,0.92 [0.61-1.37],0.6678390359607103
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),REST,RE1-silencing transcription factor,18946,158,0.99 [0.63-1.54],0.9501368429067676
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RET,Proto-oncogene tyrosine-protein kinase receptor Ret,22474,209,0.87 [0.64-1.19],0.3941537223892607
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RETN,Resistin,22548,211,1.23 [0.93-1.61],0.1461407398086326
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),REXO2,"Oligoribonuclease, mitochondrial",18980,160,1.04 [0.78-1.40],0.7770712139450695
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RFC4,Replication factor C subunit 4,19559,167,0.72 [0.35-1.51],0.3893699579367948
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RGCC,Regulator of cell cycle RGCC,19611,164,0.94 [0.78-1.15],0.5745264547315996
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RGL2,Ral guanine nucleotide dissociation stimulator-like 2,19299,165,1.07 [0.86-1.33],0.5482325470550673
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RGMA,Repulsive guidance molecule A,22765,209,1.24 [0.84-1.82],0.2746537524985568
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RGMB,RGM domain family member B,22765,209,1.27 [0.82-1.97],0.2762079855643449
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RGS10,Regulator of G-protein signaling 10,19611,164,1.18 [0.93-1.50],0.1800427364612394
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RGS8,Regulator of G-protein signaling 8,22144,200,0.94 [0.76-1.15],0.5336541573081199
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RHOC,Rho-related GTP-binding protein RhoC,22257,208,1.08 [0.97-1.20],0.1766780868924807
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RICTOR,Rapamycin-insensitive companion of mTOR,19069,160,0.65 [0.43-0.98],0.0417249441728062
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RIDA,2-iminobutanoate/2-iminopropanoate deaminase,19241,159,1.20 [0.89-1.61],0.2236793620224695
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RILP,Rab-interacting lysosomal protein,22688,210,1.08 [0.88-1.32],0.4660803945866585
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RILPL2,RILP-like protein 2,19653,166,1.04 [0.89-1.21],0.6368124984708654
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RIPK4,Receptor-interacting serine/threonine-protein kinase 4,18980,160,1.09 [0.90-1.33],0.3787105346654644
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RLN1,Prorelaxin H1,19611,164,0.92 [0.65-1.31],0.6401825076777666
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RLN2,Prorelaxin H2,19202,157,1.00 [0.73-1.37],0.9874749256544236
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RNASE1,Ribonuclease pancreatic,19664,165,1.46 [0.88-2.42],0.1412162837916574
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RNASE10,Inactive ribonuclease-like protein 10,19166,163,0.87 [0.63-1.19],0.3764218070443058
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RNASE3,Eosinophil cationic protein,22481,212,0.95 [0.85-1.06],0.3570380089800631
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RNASE4,Ribonuclease 4,18982,159,1.26 [0.74-2.12],0.3907660020423772
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RNASE6,Ribonuclease K6,19520,163,1.47 [1.04-2.08],0.0296779367540018
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RNASEH2A,Ribonuclease H2 subunit A,19611,164,0.87 [0.63-1.22],0.4294824797724983
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RNASET2,Ribonuclease T2,22772,210,1.71 [1.15-2.55],0.0079106370975122
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RNF149,E3 ubiquitin-protein ligase RNF149,19166,163,1.28 [0.81-2.03],0.2911545732607173
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RNF168,E3 ubiquitin-protein ligase RNF168,19069,160,1.06 [0.73-1.54],0.7695226119652906
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RNF31,E3 ubiquitin-protein ligase RNF31,19069,160,1.08 [0.72-1.61],0.7212235104314446
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RNF4,E3 ubiquitin-protein ligase RNF4,19299,165,0.86 [0.67-1.11],0.2444647177941627
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RNF41,E3 ubiquitin-protein ligase NRDP1,22080,202,1.15 [0.96-1.39],0.1255438971622054
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RNF43,E3 ubiquitin-protein ligase RNF43,19299,165,1.01 [0.78-1.30],0.9439714190108608
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RNF5,E3 ubiquitin-protein ligase RNF5,19166,163,0.89 [0.72-1.09],0.2527134333677976
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ROBO1,Roundabout homolog 1,22603,205,1.37 [0.84-2.25],0.2053077649523702
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ROBO2,Roundabout homolog 2,22765,209,1.02 [0.60-1.73],0.9516801278716324
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ROBO4,Roundabout homolog 4,19166,163,0.54 [0.23-1.25],0.1512647052720956
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,22584,212,1.34 [0.92-1.95],0.1238740501459278
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RP2,Protein XRP2,22474,209,1.14 [0.85-1.51],0.3840426038851742
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RPA2,Replication protein A 32 kDa subunit,19069,160,1.06 [0.65-1.72],0.8199592457087604
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RPE,Ribulose-phosphate 3-epimerase,19299,165,1.01 [0.82-1.25],0.8961506741933997
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RPGR,X-linked retinitis pigmentosa GTPase regulator,19122,159,1.07 [0.75-1.52],0.6988876904131509
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RPL14,60S ribosomal protein L14,19166,163,0.90 [0.60-1.34],0.5991785274320398
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RPS10,40S ribosomal protein S10,18980,160,1.36 [1.01-1.83],0.0406429763818907
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RRAS,Ras-related protein R-Ras,19122,159,1.03 [0.91-1.15],0.6755877369394341
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RRM2,Ribonucleoside-diphosphate reductase subunit M2,22080,202,1.17 [0.96-1.44],0.1214801835352547
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,22080,202,1.03 [0.86-1.24],0.7413171153407248
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RRP15,RRP15-like protein,19004,158,0.89 [0.76-1.06],0.1877439465276687
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RSPO1,R-spondin-1,22387,210,1.43 [1.00-2.02],0.0474647862056986
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RSPO3,R-spondin-3,22761,210,1.61 [1.08-2.41],0.0199495160913159
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RTBDN,Retbindin,22474,209,1.10 [0.73-1.65],0.6444812992894604
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RTKN2,Rhotekin-2,18980,160,1.03 [0.78-1.38],0.8215730102419861
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",19611,164,1.03 [0.88-1.21],0.7183370730074423
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RTN4R,Reticulon-4 receptor,22761,210,1.24 [0.88-1.76],0.217315873067302
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RUVBL1,RuvB-like 1,22080,202,1.13 [1.02-1.26],0.0167891352601572
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RWDD1,RWD domain-containing protein 1,22765,209,1.11 [0.91-1.34],0.3047094083785194
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),RYR1,Ryanodine receptor 1,18980,160,1.07 [0.71-1.62],0.7510706844099191
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),S100A11,Protein S100-A11,22410,210,1.02 [0.79-1.31],0.8876963864733928
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),S100A12,Protein S100-A12,22257,208,0.95 [0.81-1.12],0.5613966519215257
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),S100A13,Protein S100-A13,19069,160,1.00 [0.66-1.54],0.9880410318138704
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),S100A14,Protein S100-A14,19611,164,1.31 [1.02-1.68],0.0368992063544064
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),S100A16,Protein S100-A16,22026,200,1.21 [1.01-1.46],0.0422493590190533
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),S100A3,Protein S100-A3,19559,167,0.86 [0.58-1.26],0.4280814515293876
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),S100A4,Protein S100-A4,22673,210,0.89 [0.72-1.11],0.3120878500442764
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),S100G,Protein S100-G,19611,164,1.12 [0.82-1.51],0.4760080246145602
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),S100P,Protein S100-P,22162,199,1.02 [0.82-1.28],0.8292730844162134
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SAA4,Serum amyloid A-4 protein,19683,165,0.58 [0.25-1.35],0.2084882645402368
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SAFB2,Scaffold attachment factor B2,19611,164,1.12 [0.68-1.86],0.6491605393859378
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SAG,S-arrestin,19004,158,1.11 [0.84-1.46],0.477401470015004
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SAMD9L,Sterile alpha motif domain-containing protein 9-like,22522,211,1.10 [0.93-1.30],0.2503099283473919
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SAP18,Histone deacetylase complex subunit SAP18,19299,165,1.08 [0.89-1.30],0.4452396645041542
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SARG,Specifically androgen-regulated gene protein,19563,165,1.02 [0.89-1.17],0.7845300160592881
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SART1,U4/U6.U5 tri-snRNP-associated protein 1,18980,160,0.98 [0.65-1.49],0.9243912023288884
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SAT1,Diamine acetyltransferase 1,18980,160,0.98 [0.72-1.33],0.8995904599629342
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SAT2,Thialysine N-epsilon-acetyltransferase,19299,165,1.18 [0.97-1.44],0.0969147837686858
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SATB1,DNA-binding protein SATB1,19611,164,1.80 [1.27-2.54],0.0009207190352308
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SBSN,Suprabasin,19626,164,1.09 [0.71-1.67],0.6818341296454908
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCAMP3,Secretory carrier-associated membrane protein 3,22474,209,1.11 [0.96-1.28],0.1617887035326553
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCARA5,Scavenger receptor class A member 5,22765,209,1.60 [1.08-2.38],0.0191852907871197
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCARB1,Scavenger receptor class B member 1,22060,200,1.26 [1.07-1.49],0.0056739404397177
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCARB2,Lysosome membrane protein 2,21964,209,1.77 [1.28-2.45],0.000582930357325
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCARF1,Scavenger receptor class F member 1,22865,212,1.27 [0.96-1.69],0.094414177917996
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCARF2,Scavenger receptor class F member 2,22765,209,1.57 [1.04-2.37],0.0309726976444348
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCG2,Secretogranin-2,22644,210,1.52 [1.06-2.18],0.0215961845382913
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCG3,Secretogranin-3,22603,205,1.77 [1.23-2.54],0.0020262422153177
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCGB1A1,Uteroglobin,22586,208,1.09 [0.87-1.36],0.4469273036243389
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCGB2A2,Mammaglobin-A,18980,160,1.14 [0.72-1.82],0.5738982763470902
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCGB3A1,Secretoglobin family 3A member 1,19241,159,1.19 [0.66-2.14],0.5609571847258867
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCGB3A2,Secretoglobin family 3A member 2,22636,206,1.02 [0.89-1.17],0.7548730250416129
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCGN,Secretagogin,22144,200,1.34 [1.03-1.74],0.0296126031103327
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCIN,Adseverin,19004,158,1.03 [0.83-1.26],0.8067137719774741
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCLY,Selenocysteine lyase,22688,210,1.10 [0.85-1.42],0.4793823637819171
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCN2A,Sodium channel protein type 2 subunit alpha,19004,158,0.77 [0.54-1.11],0.1658738247757679
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCN2B,Sodium channel subunit beta-2,19122,159,0.83 [0.48-1.44],0.5115011522308235
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCN3A,Sodium channel protein type 3 subunit alpha,19122,159,1.10 [0.74-1.65],0.6379518444759572
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCN3B,Sodium channel subunit beta-3,19004,158,1.14 [0.87-1.50],0.3456502472978756
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCN4B,Sodium channel subunit beta-4,19166,163,0.80 [0.56-1.14],0.2091440275689765
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCP2,Non-specific lipid-transfer protein,22080,202,1.04 [0.88-1.23],0.6233565560766599
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCPEP1,Retinoid-inducible serine carboxypeptidase,19089,162,1.22 [0.90-1.66],0.1906907830746119
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCRG1,Scrapie-responsive protein 1,19653,166,0.85 [0.49-1.47],0.5672910254211669
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCRIB,Protein scribble homolog,19166,163,0.88 [0.73-1.06],0.1755518634236015
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCRN1,Secernin-1,22522,211,1.19 [0.97-1.47],0.0984961557544646
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SCT,Secretin,19122,159,1.13 [0.83-1.54],0.4292127257488115
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SDC1,Syndecan-1,22584,212,1.40 [1.04-1.88],0.024229386376427
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SDC4,Syndecan-4,22584,212,1.02 [0.79-1.33],0.8623720847422816
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SDCCAG8,Serologically defined colon cancer antigen 8,19559,167,1.00 [0.88-1.14],0.9539968049409288
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SDHB,Succinate dehydrogenase,19559,166,1.20 [0.98-1.47],0.0799023990322984
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SDK2,Protein sidekick-2,19241,159,0.98 [0.66-1.45],0.9072590560127998
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SEC31A,Protein transport protein Sec31A,19166,163,0.95 [0.78-1.16],0.6298652572183907
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SEL1L,Protein sel-1 homolog 1,19166,163,1.19 [0.78-1.80],0.4198359001617244
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SELE,E-selectin,22865,212,0.95 [0.75-1.20],0.6418310954863359
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SELENOP,Selenoprotein P,19683,165,0.86 [0.44-1.66],0.6501323024519521
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SELL,L-selectin,19683,165,0.74 [0.39-1.41],0.359496593541893
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SELP,P-selectin,22706,212,1.12 [0.90-1.39],0.3001775645474144
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SELPLG,P-selectin glycoprotein ligand 1,22522,211,0.86 [0.56-1.32],0.4983649196839068
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SEMA3F,Semaphorin-3F,22584,212,1.24 [0.79-1.95],0.35727884648577
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SEMA3G,Semaphorin-3G,19241,159,1.02 [0.72-1.43],0.9264338643879066
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SEMA4C,Semaphorin-4C,22474,209,0.88 [0.56-1.39],0.5844572463953941
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SEMA4D,Semaphorin-4D,22765,209,1.13 [0.75-1.70],0.559769708014772
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SEMA6C,Semaphorin-6C,19069,160,1.13 [0.65-1.97],0.6677258926487313
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SEMA7A,Semaphorin-7A,22799,212,1.01 [0.66-1.55],0.9688268399412368
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SEPTIN3,Neuronal-specific septin-3,19611,164,0.94 [0.76-1.15],0.5334474744203399
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SEPTIN7,Septin-7,19299,165,0.74 [0.53-1.05],0.0940444742159537
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SEPTIN8,Septin-8,19588,166,1.21 [0.77-1.88],0.411939967558806
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SEPTIN9,Septin-9,22474,209,1.27 [0.86-1.88],0.2354730338265057
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINA1,Alpha-1-antitrypsin,19296,162,1.33 [0.21-8.45],0.7625492739731102
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINA11,Serpin A11,22865,212,1.08 [0.80-1.46],0.6034162651748706
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINA12,Serpin A12,21909,210,1.08 [0.97-1.20],0.1777132853974896
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINA3,Alpha-1-antichymotrypsin,19598,165,1.07 [0.40-2.88],0.8868726325651262
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINA4,Kallistatin,19315,163,1.26 [0.66-2.37],0.4835936507419294
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINA5,Plasma serine protease inhibitor,19391,161,0.90 [0.55-1.48],0.6845361056056254
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINA6,Corticosteroid-binding globulin,19683,165,2.86 [1.15-7.15],0.0242782202412421
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINA7,Thyroxine-binding globulin,19683,165,0.43 [0.19-0.95],0.0379760882622913
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINA9,Serpin A9,22366,208,0.99 [0.83-1.17],0.8657563420881225
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINB1,Leukocyte elastase inhibitor,22530,209,1.08 [0.94-1.23],0.2912763769156099
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINB5,Serpin B5,22162,199,1.10 [0.84-1.42],0.4944133411282193
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINB6,Serpin B6,22694,209,1.22 [0.99-1.50],0.0622325726745001
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINB8,Serpin B8,22801,212,0.99 [0.81-1.22],0.9518026477052436
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINB9,Serpin B9,22387,210,0.94 [0.65-1.36],0.725429046035219
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINC1,Antithrombin-III,19650,164,1.10 [0.40-3.03],0.8468754315282114
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPIND1,Heparin cofactor 2,19650,164,1.35 [0.79-2.31],0.2742438949480072
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINE1,Plasminogen activator inhibitor 1,22865,212,1.05 [0.87-1.26],0.6016366748977818
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINE2,Glia-derived nexin,19653,166,1.29 [1.03-1.61],0.0262193606264213
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINF1,Pigment epithelium-derived factor,19385,163,1.08 [0.61-1.90],0.7882420002522689
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINF2,Alpha-2-antiplasmin,19314,162,0.49 [0.16-1.50],0.2114475826409692
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPING1,Plasma protease C1 inhibitor,19650,164,2.82 [1.26-6.31],0.0119027200710782
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINH1,Serpin H1,19299,165,1.02 [0.91-1.15],0.6959044598169577
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINI1,Neuroserpin,19213,159,1.15 [0.70-1.90],0.5750103316063084
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SERPINI2,Serpin I2,19559,166,0.81 [0.61-1.07],0.140463274203217
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SESTD1,SEC14 domain and spectrin repeat-containing protein 1,22060,200,1.24 [1.04-1.49],0.0186590389229225
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SETMAR,Histone-lysine N-methyltransferase SETMAR,22310,209,1.46 [1.00-2.14],0.0493337609087164
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SEZ6,Seizure protein 6 homolog,19122,159,1.34 [0.84-2.14],0.2155962686000942
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SEZ6L,Seizure 6-like protein,22673,210,1.41 [0.92-2.18],0.1177049842989468
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SEZ6L2,Seizure 6-like protein 2,22474,209,1.12 [0.66-1.89],0.6677780723215389
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SF3B4,Splicing factor 3B subunit 4,22474,209,1.09 [0.92-1.28],0.3078150910144039
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SFRP1,Secreted frizzled-related protein 1,22321,209,1.26 [0.96-1.64],0.097230819306803
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SFRP4,Secreted frizzled-related protein 4,19241,159,0.93 [0.64-1.37],0.7299799720810234
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SFTPA1,Pulmonary surfactant-associated protein A1,22080,202,1.07 [0.87-1.32],0.5101310259055034
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SFTPA2,Pulmonary surfactant-associated protein A2,22080,202,1.06 [0.83-1.34],0.6409627112773155
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SFTPD,Pulmonary surfactant-associated protein D,22584,212,1.01 [0.84-1.21],0.9106790925392152
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SGSH,N-sulphoglucosamine sulphohydrolase,19297,164,0.92 [0.70-1.21],0.5510536781114613
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SH2B3,SH2B adapter protein 3,22080,202,1.07 [0.94-1.22],0.2936751881486232
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SH2D1A,SH2 domain-containing protein 1A,22522,211,1.06 [0.86-1.29],0.5854440224256301
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,19004,158,1.30 [1.08-1.57],0.0052931069689115
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SH3BP1,SH3 domain-binding protein 1,19559,166,1.06 [0.79-1.42],0.7140036839824755
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SH3GL3,Endophilin-A3,19204,164,0.99 [0.83-1.19],0.9335776575856842
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SH3GLB2,Endophilin-B2,19617,166,0.91 [0.73-1.13],0.3927929514169542
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SHBG,Sex hormone-binding globulin,19664,165,1.10 [0.81-1.49],0.5309083609516719
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SHC1,SHC-transforming protein 1,18946,158,0.92 [0.80-1.06],0.2660908799784742
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SHD,SH2 domain-containing adapter protein D,18935,160,1.11 [0.96-1.29],0.1677833630662953
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SHH,Sonic hedgehog protein,19069,160,1.00 [0.70-1.43],0.997723883095126
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SHISA5,Protein shisa-5,19664,164,1.17 [0.68-2.01],0.5700223215019908
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SHMT1,"Serine hydroxymethyltransferase, cytosolic",22636,206,0.98 [0.85-1.13],0.786066980895922
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SHPK,Sedoheptulokinase,19299,165,1.06 [0.75-1.51],0.7435602262351217
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIAE,Sialate O-acetylesterase,22637,209,1.35 [1.04-1.75],0.0243501454722139
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIGLEC1,Sialoadhesin,22676,208,1.77 [1.34-2.32],4.491100133212176e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIGLEC10,Sialic acid-binding Ig-like lectin 10,22522,211,1.24 [0.88-1.74],0.2246830070156082
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIGLEC15,Sialic acid-binding Ig-like lectin 15,22060,200,1.10 [0.95-1.27],0.218847084790237
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIGLEC5,Sialic acid-binding Ig-like lectin 5,22610,209,1.05 [0.94-1.17],0.3852966561526001
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIGLEC6,Sialic acid-binding Ig-like lectin 6,22761,210,0.94 [0.66-1.36],0.7595491557437215
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIGLEC7,Sialic acid-binding Ig-like lectin 7,22584,212,1.16 [0.75-1.80],0.5085317200355507
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIGLEC8,Sialic acid-binding Ig-like lectin 8,19166,163,1.58 [1.14-2.19],0.006082214465455
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIGLEC9,Sialic acid-binding Ig-like lectin 9,22725,210,1.12 [0.74-1.69],0.5932359573022186
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIL1,Nucleotide exchange factor SIL1,19166,163,0.85 [0.50-1.45],0.5485569439970944
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,22653,212,1.09 [0.88-1.35],0.4305924382424262
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIRPB1,Signal-regulatory protein beta-1,22539,205,1.26 [0.98-1.63],0.0764275336317528
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIRT1,NAD-dependent protein deacetylase sirtuin-1,19069,160,1.05 [0.88-1.25],0.5866013406025514
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIRT2,NAD-dependent protein deacetylase sirtuin-2,22474,209,1.09 [0.95-1.25],0.2340992596131837
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",22060,200,1.12 [0.91-1.39],0.2866758778453853
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SIT1,Signaling threshold-regulating transmembrane adapter 1,22144,200,1.19 [0.95-1.49],0.1216166054407776
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SKAP1,Src kinase-associated phosphoprotein 1,22352,210,0.97 [0.82-1.14],0.6879131923950783
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SKAP2,Src kinase-associated phosphoprotein 2,22676,208,1.05 [0.93-1.18],0.4583635652408013
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SKIV2L,Helicase SKI2W,18980,160,0.95 [0.64-1.41],0.7961454753267796
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLA2,Src-like-adapter 2,19611,164,1.01 [0.87-1.16],0.9183087627986596
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLAMF1,Signaling lymphocytic activation molecule,22144,200,1.31 [1.06-1.62],0.0131689657910647
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLAMF6,SLAM family member 6,22080,202,1.57 [1.16-2.12],0.003526737736565
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLAMF7,SLAM family member 7,22522,211,1.19 [0.97-1.45],0.0962640902117603
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLAMF8,SLAM family member 8,22080,202,1.35 [1.07-1.70],0.0120584289710784
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLC12A2,Solute carrier family 12 member 2,18980,160,0.87 [0.48-1.55],0.6301070154445523
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLC13A1,Solute carrier family 13 member 1,19559,167,1.09 [0.88-1.36],0.4208223402308909
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLC16A1,Monocarboxylate transporter 1,22060,200,1.24 [1.03-1.49],0.0241961970241715
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLC1A4,Neutral amino acid transporter A,19122,159,1.01 [0.75-1.37],0.9438935855301244
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLC27A4,Long-chain fatty acid transport protein 4,22060,200,1.23 [1.05-1.45],0.0126644064463631
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLC28A1,Sodium/nucleoside cotransporter 1,18946,158,1.15 [0.91-1.44],0.2380626512430751
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLC34A3,Sodium-dependent phosphate transport protein 2C,18946,158,0.73 [0.50-1.06],0.0969891553733043
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLC39A14,Zinc transporter ZIP14,22060,200,1.60 [1.21-2.12],0.0008811641533744
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLC39A5,Zinc transporter ZIP5,22522,211,1.03 [0.82-1.29],0.8212534390842963
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLC44A4,Choline transporter-like protein 4,19122,159,1.03 [0.83-1.27],0.8052885517210339
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLC4A1,Band 3 anion transport protein,19664,164,0.76 [0.55-1.05],0.0909080558792366
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLC51B,Organic solute transporter subunit beta,18980,160,1.10 [0.91-1.33],0.305721793577797
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,19241,159,1.08 [0.90-1.29],0.4156508806610538
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,19559,166,1.02 [0.77-1.37],0.8694275963558222
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",18946,158,1.22 [0.97-1.54],0.0855564960157482
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLIT2,Slit homolog 2 protein,22060,200,1.10 [0.88-1.38],0.3934418938740029
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLITRK1,SLIT and NTRK-like protein 1,19069,160,0.88 [0.54-1.41],0.587737873336895
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLITRK2,SLIT and NTRK-like protein 2,22761,210,1.10 [0.81-1.50],0.5475713001299403
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLITRK6,SLIT and NTRK-like protein 6,22162,199,1.24 [0.87-1.77],0.2305828402094574
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLK,STE20-like serine/threonine-protein kinase,19299,165,1.02 [0.85-1.23],0.8313431933603815
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLMAP,Sarcolemmal membrane-associated protein,19559,166,1.09 [0.91-1.30],0.3657287597465648
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SLURP1,Secreted Ly-6/uPAR-related protein 1,19522,163,1.27 [0.90-1.79],0.1697505382182798
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SMAD1,Mothers against decapentaplegic homolog 1,22080,202,1.13 [0.97-1.31],0.1100905414645122
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SMAD2,Mothers against decapentaplegic homolog 2,19559,167,1.07 [0.87-1.32],0.527174877050465
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SMAD3,Mothers against decapentaplegic homolog 3,19559,167,1.03 [0.78-1.38],0.8175173489118672
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SMAD5,Mothers against decapentaplegic homolog 5,22474,209,1.04 [0.56-1.95],0.8979620380428546
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SMARCA2,Probable global transcription activator SNF2L2,22060,200,1.05 [0.89-1.25],0.564007623515167
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SMC3,Structural maintenance of chromosomes protein 3,18946,158,0.81 [0.59-1.11],0.1969478133968406
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SMNDC1,Survival of motor neuron-related-splicing factor 30,19559,166,1.05 [0.83-1.32],0.7109805142525937
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SMOC1,SPARC-related modular calcium-binding protein 1,22761,210,1.31 [0.91-1.88],0.1457845665693647
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SMOC2,SPARC-related modular calcium-binding protein 2,22676,208,1.11 [0.81-1.53],0.5043789438863455
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SMPD1,Sphingomyelin phosphodiesterase,22655,209,1.18 [0.93-1.51],0.1821519716547061
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SMPD3,Sphingomyelin phosphodiesterase 3,19069,160,0.99 [0.74-1.32],0.949991064368554
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,22646,208,1.10 [0.91-1.34],0.3022371437256846
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,19559,167,0.93 [0.75-1.14],0.4737146004275147
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SMS,Spermine synthase,19004,158,0.98 [0.77-1.25],0.8552728208267381
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SMTN,Smoothelin,19588,166,1.00 [0.85-1.18],0.9832181135456384
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SNAP23,Synaptosomal-associated protein 23,22584,212,1.00 [0.87-1.15],0.9943043292147768
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SNAP25,Synaptosomal-associated protein 25,19004,158,1.19 [0.86-1.64],0.290785738551966
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SNAP29,Synaptosomal-associated protein 29,22673,210,1.12 [0.98-1.28],0.1046179158779742
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SNAPIN,SNARE-associated protein Snapin,19611,164,1.17 [0.91-1.51],0.2216719918933455
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SNCA,Alpha-synuclein,19241,159,0.95 [0.83-1.08],0.4222073363492228
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SNCG,Gamma-synuclein,22387,210,1.15 [0.96-1.39],0.1230772236781682
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",19166,163,0.88 [0.55-1.42],0.6091632191840008
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SNRPB2,U2 small nuclear ribonucleoprotein B'',19617,166,1.14 [0.87-1.51],0.3382739236866436
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SNU13,NHP2-like protein 1,18980,160,1.01 [0.79-1.29],0.9384839390508346
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SNX15,Sorting nexin-15,19241,159,0.96 [0.73-1.28],0.8017448748352962
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SNX18,Sorting nexin-18,19559,166,0.98 [0.70-1.39],0.9250477386457956
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SNX2,Sorting nexin-2,19559,167,1.04 [0.88-1.24],0.6248770705018954
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SNX5,Sorting nexin-5,19166,163,0.83 [0.49-1.42],0.502299331182437
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SNX9,Sorting nexin-9,22584,212,1.09 [0.91-1.31],0.3296011740657163
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SOD1,Superoxide dismutase [Cu-Zn],22175,209,0.89 [0.69-1.15],0.3831297594545771
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SOD2,"Superoxide dismutase [Mn], mitochondrial",22610,209,1.62 [1.22-2.15],0.0008894714400812
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SOD3,Extracellular superoxide dismutase,19664,165,0.99 [0.77-1.27],0.920398127688369
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SORBS1,Sorbin and SH3 domain-containing protein 1,19611,164,1.21 [0.89-1.64],0.2217790308534339
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SORCS2,VPS10 domain-containing receptor SorCS2,22080,202,1.72 [1.25-2.39],0.0010130545541365
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SORD,Sorbitol dehydrogenase,22657,210,1.08 [0.90-1.30],0.3977390906910687
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SORT1,Sortilin,22541,212,1.21 [0.87-1.67],0.2544476960954765
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SOST,Sclerostin,22541,212,0.90 [0.66-1.23],0.4965515631208113
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,19122,159,1.18 [0.92-1.51],0.1960312755147108
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SOX2,Transcription factor SOX-2,19570,164,0.58 [0.30-1.13],0.1093724258682483
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SOX9,Transcription factor SOX-9,19122,159,0.99 [0.56-1.73],0.9594065497799938
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPACA5_SPACA5B,Sperm acrosome-associated protein 5,19611,164,1.40 [0.92-2.13],0.1134784415276384
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPAG1,Sperm-associated antigen 1,19611,164,0.84 [0.63-1.12],0.2306683690667766
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPARC,SPARC,22673,210,1.03 [0.87-1.23],0.7210764506751911
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPARCL1,SPARC-like protein 1,22628,212,1.09 [0.71-1.67],0.6984783909383834
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPART,Spartin,19241,159,1.06 [0.87-1.30],0.5361663349146865
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPESP1,Sperm equatorial segment protein 1,19653,166,1.20 [0.76-1.89],0.4243068237501007
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPINK1,Serine protease inhibitor Kazal-type 1,22610,209,1.62 [1.26-2.06],0.0001238226415037
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPINK2,Serine protease inhibitor Kazal-type 2,19241,159,0.90 [0.60-1.35],0.6036676285868134
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPINK4,Serine protease inhibitor Kazal-type 4,22522,211,1.05 [0.88-1.25],0.6135024499023773
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPINK5,Serine protease inhibitor Kazal-type 5,22610,209,1.26 [0.88-1.80],0.201849126373234
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPINK6,Serine protease inhibitor Kazal-type 6,22761,210,1.29 [1.02-1.63],0.0338617469333462
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPINK8,Serine protease inhibitor Kazal-type 8,18980,160,1.17 [0.82-1.67],0.3971447490616939
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPINT1,Kunitz-type protease inhibitor 1,22543,209,1.70 [1.09-2.67],0.0198468035543132
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPINT2,Kunitz-type protease inhibitor 2,22676,208,1.65 [1.22-2.24],0.0012760309087952
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPINT3,Kunitz-type protease inhibitor 3,19559,166,0.98 [0.88-1.08],0.6384012487493311
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPOCK1,Testican-1,22387,210,0.99 [0.62-1.60],0.981579221025378
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPON1,Spondin-1,22603,205,1.60 [1.16-2.22],0.0047319033399562
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPON2,Spondin-2,22477,211,1.97 [1.41-2.74],6.028621302292978e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPP1,Osteopontin,22837,212,1.39 [1.08-1.80],0.0117987050010748
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",19069,160,0.90 [0.62-1.31],0.585844220386506
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPRING1,SREBP regulating gene protein,18946,158,0.84 [0.62-1.14],0.2616948369917061
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPRR1B,Cornifin-B,19299,165,0.96 [0.79-1.16],0.6740212112494206
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPRR3,Small proline-rich protein 3,19617,166,0.97 [0.78-1.20],0.7677012249632889
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPRY2,Protein sprouty homolog 2,22144,200,1.07 [0.94-1.22],0.3258573039896001
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPTBN2,"Spectrin beta chain, non-erythrocytic 2",19004,158,0.85 [0.52-1.40],0.5239173405575666
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SPTLC1,Serine palmitoyltransferase 1,19617,166,1.23 [0.89-1.71],0.2100612963029587
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SRC,Proto-oncogene tyrosine-protein kinase Src,22632,210,1.07 [0.97-1.19],0.1836936839881899
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SRP14,Signal recognition particle 14 kDa protein,22474,209,1.12 [0.92-1.37],0.2519986457250487
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SRPK2,SRSF protein kinase 2,22522,211,1.05 [0.91-1.21],0.5080316504940652
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SRPX,Sushi repeat-containing protein SRPX,19653,166,1.53 [1.01-2.32],0.0448884217464108
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SSB,Lupus La protein,22060,200,1.04 [0.85-1.29],0.6834571577143853
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SSBP1,"Single-stranded DNA-binding protein, mitochondrial",19069,160,0.93 [0.59-1.46],0.749907085120451
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,22541,212,0.95 [0.85-1.06],0.3359362292447074
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,22706,212,0.89 [0.67-1.19],0.4422560266526971
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SSH3,Protein phosphatase Slingshot homolog 3,18946,158,0.89 [0.51-1.53],0.6676471789175284
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SSNA1,Sjoegren syndrome nuclear autoantigen 1,19559,166,1.08 [0.81-1.43],0.5994480306631669
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ST13,Hsc70-interacting protein,19241,159,0.91 [0.69-1.19],0.4808924715223284
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",22474,209,1.31 [1.01-1.70],0.0403823977815409
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",22865,212,1.49 [1.03-2.15],0.0352711258367414
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",19069,160,0.94 [0.67-1.33],0.7344659465133944
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STAB2,Stabilin-2,19664,164,1.08 [0.63-1.85],0.7728162045754831
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STAM,Signal transducing adapter molecule 1,19559,167,0.91 [0.60-1.37],0.6436609812612609
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STAMBP,STAM-binding protein,22352,210,1.10 [0.90-1.33],0.3560410003959453
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STAT2,Signal transducer and activator of transcription 2,19069,160,1.03 [0.84-1.26],0.7801669585978649
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STAT5B,Signal transducer and activator of transcription 5B,22474,209,1.02 [0.93-1.12],0.6226068082540583
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STAU1,Double-stranded RNA-binding protein Staufen homolog 1,18946,158,0.99 [0.78-1.26],0.9596418400669176
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STC1,Stanniocalcin-1,22765,209,1.11 [0.84-1.45],0.4579959422004828
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STC2,Stanniocalcin-2,22579,208,1.24 [0.75-2.07],0.4010193076624637
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STEAP4,Metalloreductase STEAP4,19004,158,0.86 [0.67-1.09],0.2114051229622655
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STIP1,Stress-induced-phosphoprotein 1,22575,209,1.09 [0.91-1.32],0.3420961861205244
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STK11,Serine/threonine-protein kinase STK11,22162,199,1.10 [0.93-1.31],0.2663957929110414
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STK24,Serine/threonine-protein kinase 24,22060,200,1.15 [0.94-1.40],0.1830676604589166
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STK4,Serine/threonine-protein kinase 4,22584,212,1.11 [0.97-1.28],0.1342962270772825
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STOML2,"Stomatin-like protein 2, mitochondrial",18946,158,1.04 [0.88-1.23],0.637456610972321
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STX16,Syntaxin-16,22080,202,1.03 [0.83-1.27],0.8139802509773311
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STX1B,Syntaxin-1B,19122,159,0.81 [0.53-1.24],0.336952000087072
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STX3,Syntaxin-3,19617,166,0.76 [0.49-1.19],0.230180996274366
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STX4,Syntaxin-4,22474,209,1.19 [0.99-1.42],0.0615507177297187
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STX5,Syntaxin-5,19069,160,1.16 [0.83-1.62],0.3824921665116364
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STX6,Syntaxin-6,22080,202,1.18 [1.00-1.41],0.0553408637294255
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STX7,Syntaxin-7,19069,160,0.78 [0.57-1.06],0.1169908548862416
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STX8,Syntaxin-8,22522,211,1.13 [0.88-1.45],0.3227259921924504
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STXBP1,Syntaxin-binding protein 1,19611,164,1.01 [0.83-1.23],0.9251429492920692
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),STXBP3,Syntaxin-binding protein 3,22080,202,1.27 [0.97-1.65],0.0790110038752202
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SUGP1,SURP and G-patch domain-containing protein 1,19559,166,1.03 [0.71-1.50],0.8681762722854478
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SUGT1,Protein SGT1 homolog,22080,202,1.12 [0.96-1.32],0.1458107379190231
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SULT1A1,Sulfotransferase 1A1,22765,209,1.06 [0.97-1.17],0.2075136843202938
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SULT2A1,Bile salt sulfotransferase,22522,211,1.18 [0.96-1.43],0.1093672007518433
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SUMF1,Formylglycine-generating enzyme,19069,160,1.10 [0.89-1.35],0.3827670221524157
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,22765,209,1.19 [0.93-1.51],0.1581292685574584
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SUOX,"Sulfite oxidase, mitochondrial",19611,164,1.14 [0.91-1.43],0.260244747610778
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SUSD1,Sushi domain-containing protein 1,22162,199,1.13 [0.87-1.46],0.3644611011841993
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SUSD2,Sushi domain-containing protein 2,22610,209,1.10 [0.72-1.67],0.673200900465698
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SUSD4,Sushi domain-containing protein 4,19559,167,1.21 [0.87-1.68],0.2636916404477343
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SUSD5,Sushi domain-containing protein 5,19128,159,0.78 [0.50-1.21],0.2619721666541068
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SV2A,Synaptic vesicle glycoprotein 2A,19122,159,1.09 [0.86-1.37],0.4874456528877701
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SWAP70,Switch-associated protein 70,19559,166,1.39 [0.97-1.99],0.0765130490668546
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SYAP1,Synapse-associated protein 1,19241,159,1.03 [0.79-1.35],0.8278971844894251
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,19004,158,1.02 [0.79-1.32],0.8760008772940926
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SYT1,Synaptotagmin-1,19617,166,1.07 [0.76-1.51],0.6905955489887803
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),SYTL4,Synaptotagmin-like protein 4,19653,166,1.07 [0.87-1.30],0.5266223209876303
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,19299,165,1.03 [0.89-1.19],0.7059403320619417
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TACC3,Transforming acidic coiled-coil-containing protein 3,22474,209,1.03 [0.93-1.15],0.5551973382179849
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TACSTD2,Tumor-associated calcium signal transducer 2,19939,188,0.84 [0.53-1.32],0.4522123228976635
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TADA3,Transcriptional adapter 3,19559,167,1.02 [0.70-1.49],0.9150581375348176
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TAFA5,Chemokine-like protein TAFA-5,22474,209,1.32 [0.96-1.81],0.0898969828014834
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TAGLN3,Transgelin-3,18946,158,1.08 [0.85-1.38],0.510327769119715
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TALDO1,Transaldolase,19580,164,0.97 [0.69-1.37],0.8758346811559176
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TANK,TRAF family member-associated NF-kappa-B activator,22144,200,1.10 [0.92-1.32],0.3011621978563127
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TAP1,Antigen peptide transporter 1,19299,165,1.05 [0.83-1.33],0.7059653541284283
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TARBP2,RISC-loading complex subunit TARBP2,22060,200,1.14 [0.98-1.34],0.0958414712359474
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",19122,159,0.88 [0.70-1.09],0.24148694232504
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TARS1,"Threonine--tRNA ligase 1, cytoplasmic",19559,167,1.15 [0.78-1.67],0.4797523667666803
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TAX1BP1,Tax1-binding protein 1,19617,166,1.01 [0.80-1.28],0.9367153203466896
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TBC1D17,TBC1 domain family member 17,22060,200,1.04 [0.80-1.37],0.7571065599205234
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TBC1D23,TBC1 domain family member 23,22474,209,1.08 [0.94-1.23],0.2691745027926008
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TBC1D5,TBC1 domain family member 5,22522,211,1.03 [0.88-1.19],0.7445728579713071
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TBCA,Tubulin-specific chaperone A,19241,159,1.04 [0.87-1.25],0.6421118880440957
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TBCB,Tubulin-folding cofactor B,22387,210,1.08 [0.96-1.23],0.2107558729750303
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TBCC,Tubulin-specific chaperone C,22387,210,1.10 [0.94-1.28],0.23200396248013
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TBL1X,F-box-like/WD repeat-containing protein TBL1X,22080,202,1.16 [1.00-1.34],0.0524030101979594
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TBR1,T-box brain protein 1,19122,159,0.87 [0.61-1.24],0.4294815530268018
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TCL1A,T-cell leukemia/lymphoma protein 1A,22365,210,0.96 [0.85-1.09],0.5386419869144785
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TCL1B,T-cell leukemia/lymphoma protein 1B,22162,199,1.04 [0.90-1.21],0.5908193746301977
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TCN1,Transcobalamin-1,19252,160,1.04 [0.67-1.63],0.8570528093276055
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TCN2,Transcobalamin-2,22837,212,1.28 [0.88-1.85],0.1941848275135625
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TCOF1,Treacle protein,19653,166,1.05 [0.66-1.68],0.826796518817732
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TCP11,T-complex protein 11 homolog,19299,165,1.08 [0.85-1.36],0.5404991611208594
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TCTN3,Tectonic-3,19653,166,1.35 [0.82-2.24],0.2350256310986276
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TDGF1,Teratocarcinoma-derived growth factor 1,22060,200,0.98 [0.90-1.07],0.6435347481592255
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TDO2,"Tryptophan 2,3-dioxygenase",19122,159,1.23 [0.87-1.72],0.2434247326422821
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TDP1,Tyrosyl-DNA phosphodiesterase 1,19559,167,0.95 [0.76-1.19],0.6553146602836328
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TDRKH,Tudor and KH domain-containing protein,22060,200,1.18 [1.02-1.36],0.0245236084344512
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TEF,Thyrotroph embryonic factor,18980,160,1.23 [0.90-1.67],0.188797632097462
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TEK,Angiopoietin-1 receptor,22673,210,0.77 [0.44-1.36],0.3730683711137136
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TERF1,Telomeric repeat-binding factor 1,19069,160,1.01 [0.60-1.69],0.97310081258444
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TET2,Methylcytosine dioxygenase TET2,19252,165,1.03 [0.90-1.19],0.6379568278973187
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TEX101,Testis-expressed protein 101,19122,159,1.01 [0.75-1.36],0.929305937300957
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TEX33,Testis-expressed protein 33,19299,165,0.99 [0.67-1.45],0.9524787913000298
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TF,Serotransferrin,19683,165,1.45 [0.73-2.88],0.2894143280287586
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TFAP2A,Transcription factor AP-2-alpha,19004,158,0.98 [0.76-1.27],0.8842564951934085
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TFF1,Trefoil factor 1,22491,208,1.23 [1.07-1.41],0.0028192191577473
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TFF2,Trefoil factor 2,22636,206,1.31 [1.07-1.60],0.008539149655906
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TFF3,Trefoil factor 3,22579,211,1.39 [1.09-1.77],0.0071467399474287
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TFPI,Tissue factor pathway inhibitor,22556,211,1.14 [0.77-1.68],0.525165030520417
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TFPI2,Tissue factor pathway inhibitor 2,22616,210,1.20 [0.93-1.57],0.1670535896877591
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TFRC,Transferrin receptor protein 1,22693,212,0.86 [0.62-1.20],0.3829796627293462
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TG,Thyroglobulin,19559,167,0.97 [0.86-1.11],0.6911270987393782
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TGFA,Protransforming growth factor alpha,22522,211,1.40 [1.10-1.79],0.0062694153661139
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TGFB1,Transforming growth factor beta-1 proprotein,22768,212,1.33 [0.98-1.80],0.0697983083051207
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TGFB2,Transforming growth factor beta-2 proprotein,19559,167,0.84 [0.63-1.12],0.2268862264023774
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TGFBI,Transforming growth factor-beta-induced protein ig-h3,22481,211,1.17 [0.75-1.83],0.4979026394791639
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TGFBR1,TGF-beta receptor type-1,19069,160,0.84 [0.40-1.73],0.6315035900508859
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TGFBR2,TGF-beta receptor type-2,22673,210,1.56 [1.13-2.15],0.0063008249876124
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TGFBR3,Transforming growth factor beta receptor type 3,22865,212,1.76 [1.20-2.59],0.0041545027468857
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TGM2,Protein-glutamine gamma-glutamyltransferase 2,22556,212,0.93 [0.79-1.09],0.3682571394248721
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TGOLN2,Trans-Golgi network integral membrane protein 2,19664,165,1.41 [0.82-2.43],0.2172586525045576
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),THAP12,52 kDa repressor of the inhibitor of the protein kinase,18916,158,1.02 [0.85-1.21],0.8586770955311388
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),THBD,Thrombomodulin,22584,212,1.50 [1.01-2.22],0.045339475704159
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),THBS2,Thrombospondin-2,22610,209,1.42 [1.06-1.92],0.0201591391628919
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),THBS4,Thrombospondin-4,22622,211,0.91 [0.69-1.19],0.4729127405496153
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),THOP1,Thimet oligopeptidase,22462,211,0.81 [0.54-1.21],0.3001274448313297
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),THPO,Thrombopoietin,22162,199,1.40 [1.02-1.92],0.0356777610368946
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),THRAP3,Thyroid hormone receptor-associated protein 3,18980,160,1.02 [0.89-1.17],0.7734388296033509
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),THSD1,Thrombospondin type-1 domain-containing protein 1,18922,160,1.08 [0.69-1.68],0.7455157334363751
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),THTPA,Thiamine-triphosphatase,19527,166,1.02 [0.86-1.22],0.7865322571739718
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),THY1,Thy-1 membrane glycoprotein,22765,209,1.69 [1.13-2.54],0.0104993799997507
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TIA1,Nucleolysin TIA-1 isoform p40,21913,196,1.06 [0.96-1.18],0.252483194465666
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TIE1,Tyrosine-protein kinase receptor Tie-1,22865,212,0.97 [0.73-1.29],0.8252825713343589
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TIGAR,"Fructose-2,6-bisphosphatase TIGAR",22025,200,1.28 [0.99-1.64],0.0551296293658124
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TIGIT,T-cell immunoreceptor with Ig and ITIM domains,19299,165,1.21 [0.84-1.74],0.3155088241604725
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,22706,212,1.01 [0.77-1.34],0.9194364862305074
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,19653,166,1.23 [0.86-1.76],0.2467775152288049
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,19617,166,1.09 [0.92-1.29],0.3411700753517827
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TIMP1,Metalloproteinase inhibitor 1,22368,210,1.96 [1.33-2.88],0.0006046508019984
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TIMP2,Metalloproteinase inhibitor 2,19653,166,1.19 [0.75-1.88],0.4547618616701894
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TIMP3,Metalloproteinase inhibitor 3,22676,208,1.11 [1.02-1.22],0.0184631263681056
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TIMP4,Metalloproteinase inhibitor 4,22610,209,1.43 [1.09-1.89],0.0112146067091022
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TINAGL1,Tubulointerstitial nephritis antigen-like,22509,212,1.17 [0.67-2.03],0.5874313090342491
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TJAP1,Tight junction-associated protein 1,22673,210,1.08 [0.93-1.25],0.3339671141359107
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TJP3,Tight junction protein ZO-3,19004,158,1.04 [0.73-1.49],0.8301350318459173
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TK1,"Thymidine kinase, cytosolic",19299,165,1.04 [0.75-1.44],0.8314778465418072
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TLR1,Toll-like receptor 1,19069,160,1.50 [0.89-2.53],0.1316445872124219
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TLR2,Toll-like receptor 2,19299,165,1.13 [0.60-2.14],0.7050034604493931
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TLR3,Toll-like receptor 3,22801,212,1.09 [0.89-1.33],0.4125771672803955
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TLR4,Toll-like receptor 4,19069,160,0.91 [0.53-1.56],0.7309081380999635
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,19122,159,1.04 [0.79-1.37],0.775686316242328
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TMED1,Transmembrane emp24 domain-containing protein 1,19299,165,0.60 [0.43-0.83],0.0018814158134774
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TMED10,Transmembrane emp24 domain-containing protein 10,18980,160,1.06 [0.80-1.42],0.6826162742450337
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TMED4,Transmembrane emp24 domain-containing protein 4,18980,160,0.81 [0.59-1.11],0.1914668946776698
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TMED8,Protein TMED8,19559,166,1.05 [0.91-1.22],0.4904925674300567
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TMEM106A,Transmembrane protein 106A,19559,167,1.19 [0.98-1.45],0.0765568469712215
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TMEM132A,Transmembrane protein 132A,19166,163,1.00 [0.79-1.28],0.9773954256191858
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TMEM25,Transmembrane protein 25,19611,164,0.96 [0.68-1.34],0.7940647658822827
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TMOD4,Tropomodulin-4,18946,158,1.12 [0.77-1.62],0.5642496148498605
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TMPRSS11B,Transmembrane protease serine 11B,19004,158,0.97 [0.79-1.19],0.7797941656164913
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TMPRSS11D,Transmembrane protease serine 11D,19588,166,1.30 [0.92-1.82],0.1385846314202699
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TMPRSS15,Enteropeptidase,22474,209,1.03 [0.90-1.17],0.7059660194826789
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TMPRSS5,Transmembrane protease serine 5,22290,209,1.19 [0.87-1.65],0.2800593398936564
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TMSB10,Thymosin beta-10,22610,209,1.20 [1.02-1.42],0.0290149556299275
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNC,Tenascin,22706,212,1.05 [0.82-1.35],0.7111458585296682
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNF,Tumor necrosis factor,22133,198,1.20 [0.90-1.60],0.2193385426589962
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFAIP2,Tumor necrosis factor alpha-induced protein 2,19559,166,1.22 [0.91-1.63],0.1941543504246453
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFAIP8,Tumor necrosis factor alpha-induced protein 8,22144,200,0.96 [0.68-1.35],0.7975924138126441
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,19241,159,0.99 [0.78-1.27],0.9606812074580406
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,22387,210,1.78 [1.32-2.39],0.0001473393465252
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,22387,210,1.30 [1.08-1.56],0.0064588903780953
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,22663,212,1.13 [0.88-1.46],0.3232786488271604
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,22801,212,1.82 [1.38-2.38],1.720329547241292e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,22569,205,1.34 [0.88-2.03],0.1727359464086016
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,22673,210,1.84 [1.35-2.50],0.000111002980263
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,22603,205,1.38 [1.03-1.86],0.0329564817797717
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,22144,200,1.25 [0.94-1.67],0.120441947608861
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF14,Tumor necrosis factor receptor superfamily member 14,22603,205,2.13 [1.50-3.03],2.827227693947553e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF17,Tumor necrosis factor receptor superfamily member 17,19241,159,1.00 [0.70-1.44],0.9865745870325648
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF19,Tumor necrosis factor receptor superfamily member 19,22761,210,1.62 [1.16-2.26],0.0049008770564679
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,22610,209,2.24 [1.60-3.15],2.965444590751708e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,22610,209,1.55 [1.25-1.92],5.75199368460612e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF21,Tumor necrosis factor receptor superfamily member 21,22765,209,1.54 [1.01-2.34],0.044748329935119
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF4,Tumor necrosis factor receptor superfamily member 4,22768,212,1.42 [1.06-1.90],0.0192389420131645
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,22387,210,1.45 [1.21-1.74],6.495547602370509e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF8,Tumor necrosis factor receptor superfamily member 8,22765,209,1.16 [0.89-1.50],0.277648270330708
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFRSF9,Tumor necrosis factor receptor superfamily member 9,22387,210,1.39 [1.09-1.77],0.0079080842793514
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFSF10,Tumor necrosis factor ligand superfamily member 10,22801,212,0.97 [0.60-1.56],0.8912090706459347
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFSF11,Tumor necrosis factor ligand superfamily member 11,22522,211,1.04 [0.85-1.27],0.6970643210087939
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFSF12,Tumor necrosis factor ligand superfamily member 12,22801,212,0.70 [0.45-1.08],0.1045923927693119
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFSF13,Tumor necrosis factor ligand superfamily member 13,22676,208,2.43 [1.58-3.73],5.59963140032946e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,22836,212,1.43 [0.96-2.14],0.0798065928025218
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFSF14,Tumor necrosis factor ligand superfamily member 14,22387,210,0.98 [0.79-1.21],0.8467799430303351
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNFSF8,Tumor necrosis factor ligand superfamily member 8,19664,164,1.23 [0.82-1.85],0.3183729191315345
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNIP1,TNFAIP3-interacting protein 1,19617,166,0.95 [0.80-1.13],0.5787796519914054
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNN,Tenascin-N,19664,164,0.93 [0.66-1.30],0.6594240933912006
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNNI3,"Troponin I, cardiac muscle",22162,199,1.14 [0.97-1.34],0.0996750777504626
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNPO1,Transportin-1,19299,165,0.84 [0.54-1.31],0.441604726327377
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNR,Tenascin-R,22387,210,0.82 [0.61-1.09],0.1691322703460276
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TNXB,Tenascin-X,22610,209,0.94 [0.58-1.52],0.7873113680421308
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TOMM20,Mitochondrial import receptor subunit TOM20 homolog,19653,166,1.12 [0.93-1.35],0.2413687054767593
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TOP1,DNA topoisomerase 1,19559,166,0.96 [0.84-1.10],0.547094659841002
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TOP1MT,"DNA topoisomerase I, mitochondrial",18946,158,0.83 [0.59-1.17],0.2970242853981202
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TOP2B,DNA topoisomerase 2-beta,19069,160,0.93 [0.76-1.13],0.4597033625167348
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TOR1AIP1,Torsin-1A-interacting protein 1,19166,163,1.14 [0.88-1.48],0.3233166494260051
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TP53,Cellular tumor antigen p53,22080,202,1.23 [0.92-1.63],0.1576737785211931
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TP53BP1,TP53-binding protein 1,19069,160,1.08 [0.90-1.28],0.414262722416975
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TP53I3,Quinone oxidoreductase PIG3,18821,155,1.00 [0.74-1.34],0.9880834954292056
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TP53INP1,Tumor protein p53-inducible nuclear protein 1,22162,199,1.05 [0.71-1.54],0.8061183614005019
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TP73,Tumor protein p73,19122,159,0.96 [0.61-1.50],0.8554137929725532
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TPBGL,Trophoblast glycoprotein-like,19122,159,0.93 [0.64-1.36],0.7182369186020974
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TPD52L2,Tumor protein D54,19241,159,1.01 [0.87-1.16],0.9261990083558328
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TPK1,Thiamin pyrophosphokinase 1,19653,166,1.36 [0.79-2.34],0.2610832776398714
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TPM3,Tropomyosin alpha-3 chain,18980,160,1.15 [0.83-1.60],0.4047721591045488
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TPMT,Thiopurine S-methyltransferase,22080,202,0.93 [0.78-1.10],0.387813340174421
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TPP1,Tripeptidyl-peptidase 1,22413,203,1.33 [1.04-1.70],0.0209924215998883
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TPPP2,Tubulin polymerization-promoting protein family member 2,19299,165,1.03 [0.86-1.23],0.7575119340424832
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TPPP3,Tubulin polymerization-promoting protein family member 3,22060,200,0.89 [0.63-1.26],0.5077226418313083
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TPR,Nucleoprotein TPR,18980,160,1.01 [0.75-1.37],0.9380703324160964
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TPRKB,EKC/KEOPS complex subunit TPRKB,18946,158,0.87 [0.67-1.14],0.320536094443474
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TPSAB1,Tryptase alpha/beta-1,22769,212,1.39 [1.10-1.75],0.0062005771511687
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TPSD1,Tryptase delta,19611,164,1.20 [0.85-1.70],0.2921154596700932
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TPSG1,Tryptase gamma,19069,160,0.76 [0.42-1.39],0.3780335738769054
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TPT1,Translationally-controlled tumor protein,22144,200,1.09 [0.92-1.30],0.3161994639906555
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TRAF2,TNF receptor-associated factor 2,22522,211,0.94 [0.79-1.13],0.521800815776919
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TRAF3,"TNF receptor-associated factor 3, Isoform 2",19069,160,0.85 [0.55-1.32],0.4654333775755345
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,18980,160,0.92 [0.65-1.29],0.6272322084836712
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,19299,165,0.98 [0.83-1.16],0.8222751939124837
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TREH,Trehalase,19664,164,1.06 [0.87-1.30],0.5475659101010373
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TREM2,Triggering receptor expressed on myeloid cells 2,22569,205,1.43 [1.14-1.79],0.0020500272646306
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TREML1,Trem-like transcript 1 protein,19664,165,1.18 [0.89-1.55],0.249309612229126
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TREML2,Trem-like transcript 2 protein,22610,209,1.58 [1.14-2.20],0.0062919113404718
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TRIAP1,TP53-regulated inhibitor of apoptosis 1,22761,210,1.14 [0.94-1.39],0.1743871144188151
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TRIM21,E3 ubiquitin-protein ligase TRIM21,22522,211,1.01 [0.86-1.18],0.931972917167725
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TRIM24,Transcription intermediary factor 1-alpha,19267,165,1.14 [0.91-1.42],0.2511605334010615
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,19559,166,1.06 [0.92-1.22],0.4116611530048105
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TRIM26,Tripartite motif-containing protein 26,18946,158,0.93 [0.70-1.23],0.6072165352591156
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TRIM40,E3 ubiquitin ligase TRIM40,19122,159,0.97 [0.78-1.20],0.7500061220743875
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TRIM5,Tripartite motif-containing protein 5,22522,211,1.08 [0.94-1.24],0.2944104549419979
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TRIM58,E3 ubiquitin-protein ligase TRIM58,19559,167,1.03 [0.87-1.21],0.7734707058795309
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TRPV3,Transient receptor potential cation channel subfamily V member 3,18980,160,0.95 [0.69-1.31],0.7474104163975015
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TSC1,Hamartin,19069,160,0.83 [0.64-1.08],0.1698507214923719
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TSC22D1,TSC22 domain family protein 1,19611,164,1.02 [0.81-1.28],0.895030204848293
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TSHB,Thyrotropin subunit beta,22584,212,0.83 [0.71-0.96],0.0135628352577968
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TSLP,Thymic stromal lymphopoietin,22162,199,0.95 [0.76-1.18],0.6377881007468702
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TSNAX,Translin-associated protein X,18980,160,0.82 [0.55-1.21],0.3199951903474077
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TSPAN1,Tetraspanin-1,22162,199,0.93 [0.77-1.12],0.4532999837369647
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TSPAN15,Tetraspanin-15,18980,160,0.96 [0.71-1.31],0.8104988173954794
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TSPAN7,Tetraspanin-7,19004,158,0.98 [0.83-1.17],0.8405165069321902
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TSPAN8,Tetraspanin-8,19559,166,1.16 [1.01-1.34],0.0384840480145187
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TSPYL1,Testis-specific Y-encoded-like protein 1,19069,160,0.92 [0.63-1.36],0.679740858772327
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TST,Thiosulfate sulfurtransferase,22018,200,1.12 [0.95-1.32],0.1825822652127594
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TTF2,Transcription termination factor 2,19122,159,0.99 [0.72-1.35],0.9473012980430018
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TTN,Titin,18980,160,1.15 [0.94-1.41],0.1814179983369025
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TTR,Transthyretin,19470,164,0.89 [0.49-1.61],0.6962039315131993
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TUBB3,Tubulin beta-3 chain,19004,158,1.21 [0.71-2.07],0.4764060443769486
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TWF2,Twinfilin-2,19664,164,1.05 [0.88-1.25],0.6176956287981092
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TXK,Tyrosine-protein kinase TXK,19299,165,0.99 [0.81-1.20],0.8918103010690062
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TXLNA,Alpha-taxilin,22387,210,1.07 [0.93-1.23],0.3569829776064011
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TXN,Thioredoxin,19332,163,1.08 [0.79-1.50],0.6222349410534698
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TXNDC15,Thioredoxin domain-containing protein 15,22673,210,1.41 [0.92-2.18],0.1178853165290401
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TXNDC5,Thioredoxin domain-containing protein 5,22765,209,1.21 [1.02-1.45],0.0318635023302407
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TXNDC9,Thioredoxin domain-containing protein 9,19617,166,1.09 [0.83-1.43],0.5438483737547088
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TXNL1,Thioredoxin-like protein 1,18966,158,0.97 [0.83-1.14],0.711646712898077
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TXNRD1,"Thioredoxin reductase 1, cytoplasmic",22610,209,1.20 [0.92-1.55],0.1820222971427936
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TYMP,Thymidine phosphorylase,22432,211,1.16 [0.96-1.40],0.120834630194718
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TYRO3,Tyrosine-protein kinase receptor TYRO3,22584,212,1.02 [0.66-1.56],0.9429277416627718
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",19069,160,0.87 [0.69-1.09],0.2263546596502207
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UBAC1,Ubiquitin-associated domain-containing protein 1,22474,209,0.83 [0.59-1.19],0.3110264130623867
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UBE2B,Ubiquitin-conjugating enzyme E2 B,19559,167,1.11 [0.67-1.82],0.6822125637944734
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,19653,166,1.22 [0.96-1.55],0.1031694890186331
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UBE2Z,Ubiquitin-conjugating enzyme E2 Z,19069,160,0.98 [0.75-1.29],0.8976167238243511
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UBQLN3,Ubiquilin-3,18980,160,1.17 [0.91-1.49],0.2147939466232863
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UBXN1,UBX domain-containing protein 1,19241,159,1.01 [0.81-1.27],0.9125673677453536
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,19559,166,1.05 [0.95-1.17],0.3489430468165172
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UGDH,UDP-glucose 6-dehydrogenase,18980,160,1.04 [0.90-1.21],0.5967042329702871
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UHRF2,E3 ubiquitin-protein ligase UHRF2,18980,160,0.98 [0.64-1.51],0.9323729161969082
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ULBP2,UL16-binding protein 2,22387,210,1.48 [1.09-1.99],0.0108814527603666
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UMOD,Uromodulin,22800,212,0.79 [0.64-0.97],0.0261719568762359
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UNC5D,Netrin receptor UNC5D,19069,160,1.15 [0.65-2.03],0.643000456266578
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UNC79,Protein unc-79 homolog,18946,158,0.96 [0.73-1.28],0.7950100846628916
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UNG,Uracil-DNA glycosylase,19559,167,1.17 [0.77-1.77],0.4590106175532944
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UPB1,Beta-ureidopropionase,19653,166,1.01 [0.85-1.19],0.926266993733732
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UPK3A,Uroplakin-3a,19004,158,1.00 [0.74-1.36],0.975027787198001
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UPK3BL1,Uroplakin-3b-like protein 1,19257,165,0.88 [0.64-1.21],0.4212465942233
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UROD,Uroporphyrinogen decarboxylase,19241,159,0.97 [0.78-1.21],0.8081214527984115
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UROS,Uroporphyrinogen-III synthase,19122,159,0.83 [0.65-1.06],0.1303828012703573
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),USO1,General vesicular transport factor p115,22474,209,1.10 [0.96-1.26],0.1911591807753402
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),USP25,Ubiquitin carboxyl-terminal hydrolase 25,19559,167,1.07 [0.87-1.32],0.5049413949107796
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),USP28,Ubiquitin carboxyl-terminal hydrolase 28,19617,166,1.14 [0.78-1.66],0.5049066369625879
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),USP47,Ubiquitin carboxyl-terminal hydrolase 47,18980,160,1.03 [0.86-1.23],0.7596578754054861
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),USP8,Ubiquitin carboxyl-terminal hydrolase 8,22162,199,1.08 [0.95-1.23],0.249899621953221
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),UXS1,UDP-glucuronic acid decarboxylase 1,22080,202,1.04 [0.82-1.32],0.7360651352562408
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VAMP5,Vesicle-associated membrane protein 5,22162,199,1.21 [1.00-1.47],0.0512624934159422
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VAMP8,Vesicle-associated membrane protein 8,19069,160,1.17 [0.98-1.39],0.0754214259411206
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VASH1,Tubulinyl-Tyr carboxypeptidase 1,22522,211,1.08 [0.93-1.25],0.3043014535380117
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VASN,Vasorin,22249,208,1.30 [0.83-2.04],0.2468678418548962
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VASP,Vasodilator-stimulated phosphoprotein,19664,165,0.98 [0.80-1.21],0.879009111610912
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VAT1,Synaptic vesicle membrane protein VAT-1 homolog,22474,209,0.75 [0.40-1.40],0.3664894832898884
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VAV3,Guanine nucleotide exchange factor VAV3,19004,158,1.07 [0.92-1.25],0.3999422716147339
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VCAM1,Vascular cell adhesion protein 1,22659,212,1.75 [1.15-2.67],0.0092158414196512
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VCAN,Versican core protein,22765,209,1.45 [0.97-2.15],0.0685394504238163
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VCPKMT,Protein-lysine methyltransferase METTL21D,18946,158,1.13 [0.97-1.31],0.1212615965434622
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VEGFA,Vascular endothelial growth factor A,22728,212,1.14 [0.93-1.40],0.1938911038623493
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VEGFB,Vascular endothelial growth factor B,19069,160,0.90 [0.53-1.52],0.6853471573106114
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VEGFC,Vascular endothelial growth factor C,22673,210,1.18 [0.95-1.46],0.1405629635298666
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VEGFD,Vascular endothelial growth factor D,22765,212,1.23 [0.88-1.71],0.2312413889091824
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VGF,Neurosecretory protein VGF,19611,164,1.48 [0.93-2.36],0.0958842848329981
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VIM,Vimentin,22162,199,1.01 [0.91-1.13],0.8357373613724274
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VIPR1,Vasoactive intestinal polypeptide receptor 1,19166,163,0.78 [0.40-1.51],0.46247433515169
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VIT,Vitrin,19653,166,1.29 [0.87-1.90],0.2011485471606386
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VMO1,Vitelline membrane outer layer protein 1 homolog,22474,209,0.99 [0.83-1.18],0.9134371291306508
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VNN1,Pantetheinase,19664,165,1.10 [0.89-1.36],0.3603639124895652
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VNN2,Vascular non-inflammatory molecule 2,22474,209,0.84 [0.65-1.09],0.1847564883030288
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VPS28,Vacuolar protein sorting-associated protein 28 homolog,19299,165,1.25 [1.01-1.54],0.0392709016115821
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VPS37A,Vacuolar protein sorting-associated protein 37A,22474,209,1.05 [0.90-1.23],0.5017875063960515
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VPS4B,Vacuolar protein sorting-associated protein 4B,19559,167,1.08 [0.92-1.26],0.3275582793533239
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VPS53,Vacuolar protein sorting-associated protein 53 homolog,22474,209,1.11 [0.95-1.30],0.1703061639460975
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VSIG10,V-set and immunoglobulin domain-containing protein 10,19559,167,1.34 [0.93-1.92],0.1182858929587888
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,18980,160,1.05 [0.66-1.67],0.823850833443778
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VSIG2,V-set and immunoglobulin domain-containing protein 2,19559,167,1.20 [0.98-1.49],0.0834041118778663
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VSIG4,V-set and immunoglobulin domain-containing protein 4,22579,208,2.19 [1.70-2.82],1.335054255838028e-09
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,22545,212,1.22 [1.02-1.47],0.0329730065878008
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VSNL1,Visinin-like protein 1,19617,166,0.93 [0.62-1.39],0.7172592005829532
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VSTM1,V-set and transmembrane domain-containing protein 1,22060,200,1.20 [0.95-1.52],0.1268423886386889
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VSTM2B,V-set and transmembrane domain-containing protein 2B,19299,165,0.90 [0.61-1.33],0.6021276095445676
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,22162,199,1.23 [1.03-1.47],0.0248536450255347
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,22765,209,1.05 [0.88-1.24],0.5900955875200073
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VTCN1,V-set domain-containing T-cell activation inhibitor 1,22080,202,1.33 [0.90-1.97],0.1509380629799932
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,19241,159,1.07 [0.82-1.39],0.6231395596457866
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VWA1,von Willebrand factor A domain-containing protein 1,22724,210,1.38 [1.03-1.85],0.0301960673688381
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VWA5A,von Willebrand factor A domain-containing protein 5A,18946,158,1.16 [0.99-1.37],0.0627572287602161
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VWC2,Brorin,22317,209,1.50 [1.11-2.03],0.0083081946443929
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VWC2L,von Willebrand factor C domain-containing protein 2-like,19611,164,1.04 [0.75-1.42],0.8289166539068031
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),VWF,von Willebrand factor,22865,212,1.07 [0.90-1.26],0.4504345792129832
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),WARS,"Tryptophan--tRNA ligase, cytoplasmic",22610,209,1.11 [0.80-1.53],0.5400985273828995
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),WAS,Wiskott-Aldrich syndrome protein,22144,200,1.12 [0.93-1.34],0.231939529393534
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),WASF1,Wiskott-Aldrich syndrome protein family member 1,22162,199,1.12 [0.98-1.28],0.0887222936933736
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),WASF3,Wiskott-Aldrich syndrome protein family member 3,22060,200,1.19 [1.03-1.38],0.0219879397107803
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),WASHC3,WASH complex subunit 3,19617,166,1.02 [0.84-1.24],0.855819600661595
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),WASL,Neural Wiskott-Aldrich syndrome protein,19069,160,1.01 [0.78-1.29],0.9656519162977804
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),WDR46,WD repeat-containing protein 46,19559,167,1.10 [0.74-1.62],0.6512758488375925
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),WFDC1,WAP four-disulfide core domain protein 1,19151,163,1.07 [0.84-1.38],0.5764666262487743
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),WFDC12,WAP four-disulfide core domain protein 12,22729,210,1.13 [0.94-1.36],0.209459006776909
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),WFDC2,WAP four-disulfide core domain protein 2,21463,201,1.85 [1.44-2.38],1.7175503669055513e-06
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",22310,209,0.71 [0.53-0.95],0.0230366554739316
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",22603,205,1.27 [0.89-1.81],0.1948832045812042
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),WIF1,Wnt inhibitory factor 1,22761,210,0.95 [0.67-1.36],0.7958680105788958
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),WNT9A,Protein Wnt-9a,22144,200,1.75 [1.21-2.54],0.0030948466520125
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,22387,210,1.02 [0.81-1.29],0.8447571112174581
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),XCL1,Lymphotactin,22761,210,1.16 [0.94-1.43],0.1555159336169764
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),XG,Glycoprotein Xg,22765,209,1.48 [1.04-2.11],0.0290319364812146
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),XIAP,E3 ubiquitin-protein ligase XIAP,19069,160,1.01 [0.77-1.32],0.9345393672678124
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),XPNPEP2,Xaa-Pro aminopeptidase 2,22673,210,0.94 [0.83-1.06],0.3210798580691236
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),XRCC4,DNA repair protein XRCC4,22060,200,1.35 [1.01-1.80],0.0436671892729629
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),YAP1,Transcriptional coactivator YAP1,19617,166,1.36 [0.81-2.28],0.2458463513486508
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),YARS1,"Tyrosine--tRNA ligase, cytoplasmic",19559,166,1.04 [0.94-1.15],0.493751429890875
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),YES1,Tyrosine-protein kinase Yes,22474,209,1.04 [0.93-1.16],0.4765969725653167
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),YJU2,Splicing factor YJU2,19559,167,1.34 [0.88-2.03],0.1674615781357908
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),YOD1,Ubiquitin thioesterase OTU1,18980,160,0.78 [0.61-1.00],0.049517014857261
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),YTHDF3,YTH domain-containing family protein 3,22144,200,1.14 [0.99-1.32],0.0785672842778725
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),YWHAQ,14-3-3 protein theta,19241,159,1.05 [0.85-1.29],0.6489162953839462
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),YY1,Transcriptional repressor protein YY1,19069,160,1.04 [0.61-1.77],0.8942451381230551
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ZBP1,Z-DNA-binding protein 1,19069,160,1.18 [0.83-1.67],0.360856101341072
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ZBTB16,Zinc finger and BTB domain-containing protein 16,22080,202,1.17 [0.99-1.38],0.0644094783665036
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ZBTB17,Zinc finger and BTB domain-containing protein 17,22162,199,1.25 [0.97-1.61],0.0834588001478574
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ZCCHC8,Zinc finger CCHC domain-containing protein 8,18980,160,0.94 [0.72-1.22],0.6207104036848012
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ZFYVE19,Abscission/NoCut checkpoint regulator,19559,166,1.09 [0.93-1.29],0.2946085164596859
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ZHX2,Zinc fingers and homeoboxes protein 2,19617,166,0.99 [0.63-1.55],0.954997203288961
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ZNF174,Zinc finger protein 174,19069,160,0.89 [0.57-1.38],0.590885060294905
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ZNF75D,Zinc finger protein 75D,19299,165,0.66 [0.50-0.89],0.0056354014643704
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ZNF830,Zinc finger protein 830,19559,167,0.97 [0.80-1.19],0.7826531797175718
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ZNRD2,Protein ZNRD2,19559,166,0.87 [0.70-1.08],0.2160004517749929
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ZNRF4,E3 ubiquitin-protein ligase ZNRF4,19559,167,1.17 [0.91-1.51],0.220766703525742
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ZP3,Zona pellucida sperm-binding protein 3,19166,163,1.00 [0.95-1.06],0.9022466883769528
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ZP4,Zona pellucida sperm-binding protein 4,18946,158,1.28 [0.90-1.81],0.1745152315924386
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),ZPR1,Zinc finger protein ZPR1,19004,158,0.98 [0.83-1.15],0.7959941566703125
